1	Seizure	NN	O	seizure	_	0	SENT_1	[p1l933t81r1025b103],
2	20	CD	NUMBER	20	number	3	SENT_1	[p1l1036t82r1066b103],
3	(	CD	NUMBER	(	dep	1	SENT_1	[p1l1077t81r1160b108],
4	2011	CD	DATE	2011	dep	3	SENT_1	[p1l1077t81r1160b108],
5	)	CD	NUMBER	)	num	6	SENT_1	[p1l1077t81r1160b108],
6	431-432	CD	NUMBER	431-432	dep	1	SENT_1	[p1l1170t82r1281b103],

1	Contents	NNS	O	contents	_	0	SENT_2	[p1l778t188r915b213],
2	lists	NNS	O	list	dep	1	SENT_2	[p1l929t188r988b213],
3	available	JJ	O	available	amod	2	SENT_2	[p1l1001t188r1137b213],
4	at	IN	O	at	_	0	SENT_2	[p1l1151t191r1178b213],
5	ScienceDirect	NNP	O	ScienceDirect	prep_at	3	SENT_2	[p1l1191t188r1400b213],

1	Seizure	NN	O	seizure	_	0	SENT_3	[p1l994t287r1184b332],

1	E	NN	O	e	_	0	SENT_4	[p1l15t417r249b453],
2	[	CD	NUMBER	[	number	3	SENT_4	[p1l15t417r249b453],
3	_	CD	NUMBER	_	num	4	SENT_4	[p1l15t417r249b453],
4	SE	NN	O	se	dep	1	SENT_4	[p1l15t417r249b453],
5	\	CD	NUMBER	\	num	4	SENT_4	[p1l15t417r249b453],
6	/	:	O	/	punct	1	SENT_4	[p1l15t417r249b453],
7	[	CD	NUMBER	[	num	10	SENT_4	[p1l15t417r249b453],
8	ER	NN	O	er	nn	10	SENT_4	[p1l15t417r249b453],
9	journal	NN	O	journal	nn	10	SENT_4	[p1l606t418r738b448],
10	homepage	NN	O	homepage	dep	1	SENT_4	[p1l759t418r962b449],
11	:	:	O	:	_	0	SENT_4	[p1l759t418r962b449],
12	www	NN	O	www	dep	10	SENT_4	[p1l980t418r1570b448],
13	.	.	O	.	_	0	SENT_4	[p1l980t418r1570b448],

1	e	LS	O	e	dep	3	SENT_5	[p1l980t418r1570b448],
2	|	SYM	O	|	dep	3	SENT_5	[p1l980t418r1570b448],
3	sevier.com/locate/yseiz	NN	O	sevier.com/locate/yseiz	_	0	SENT_5	[p1l980t418r1570b448],

1	Case	NNP	O	Case	nn	4	SENT_6	[p1l6t539r89b569],
2	report	NN	O	report	nn	4	SENT_6	[p1l107t542r223b577],
3	Phenytoin-induced	JJ	O	phenytoin-induced	amod	4	SENT_6	[p1l7t615r514b672],
4	Stevens	NNP	PERSON	Stevens	_	0	SENT_6	[p1l539t615r991b672],
5	—	CD	NUMBER	—	number	6	SENT_6	[p1l539t615r991b672],
6	]	CD	NUMBER	]	num	8	SENT_6	[p1l539t615r991b672],
7	ohnson	NN	O	ohnson	nn	8	SENT_6	[p1l539t615r991b672],
8	syndrome	NN	O	syndrome	dep	4	SENT_6	[p1l1014t615r1278b672],
9	with	IN	O	with	_	0	SENT_6	[p1l1301t615r1423b661],
10	negative	JJ	O	negative	amod	11	SENT_6	[p1l1446t616r1671b672],
11	HLA	NN	O	hlum	prep_with	8	SENT_6	[p1l1695t615r2018b661],
12	.	.	O	.	_	0	SENT_6	[p1l1695t615r2018b661],

1	—	NN	O	—	_	0	SENT_7	[p1l1695t615r2018b661],
2	.	.	O	.	_	0	SENT_7	[p1l1695t615r2018b661],

1	B	NN	O	b	_	0	SENT_8	[p1l1695t615r2018b661],
2	*	CD	NUMBER	*	number	3	SENT_8	[p1l1695t615r2018b661],
3	1502	CD	DATE	1502	num	4	SENT_8	[p1l1695t615r2018b661],
4	allele	NN	O	allele	dep	1	SENT_8	[p1l6t687r146b732],
5	in	IN	O	in	_	0	SENT_8	[p1l170t688r219b732],
6	mainland	NN	O	mainland	nn	7	SENT_8	[p1l243t687r492b732],
7	China	NNP	LOCATION	China	prep_in	4	SENT_8	[p1l517t687r682b733],
8	:	:	O	:	_	0	SENT_8	[p1l517t687r682b733],
9	Two	CD	NUMBER	two	num	10	SENT_8	[p1l708t690r821b732],
10	cases	NNS	O	case	dep	4	SENT_8	[p1l845t700r981b732],

1	Fa-Yun	NNP	MISC	Fa-Yun	nn	2	SENT_9	[p1l6t795r152b828],
2	Hu	NNP	MISC	Hu	_	0	SENT_9	[p1l171t795r229b828],
3	"	``	O	"	punct	2	SENT_9	[p1l239t785r292b834],
4	"	``	O	"	punct	2	SENT_9	[p1l239t785r292b834],
5	'	''	O	'	_	0	SENT_9	[p1l239t785r292b834],
6	°	CD	NUMBER	°	dep	2	SENT_9	[p1l239t785r292b834],
7	,	,	O	,	_	0	SENT_9	[p1l239t785r292b834],
8	Xin	NNP	PERSON	Xin	appos	6	SENT_9	[p1l310t793r503b837],
9	.	.	O	.	_	0	SENT_9	[p1l310t793r503b837],

1	—	NN	O	—	_	0	SENT_10	[p1l310t793r503b837],
2	.	.	O	.	_	0	SENT_10	[p1l310t793r503b837],

1	Tong	NNP	PERSON	Tong	nn	2	SENT_11	[p1l310t793r503b837],
2	Wu	NNP	PERSON	Wu	_	0	SENT_11	[p1l519t795r593b828],
3	5	CD	NUMBER	5	num	4	SENT_11	[p1l603t792r653b834],
4	“	CD	NUMBER	“	dep	2	SENT_11	[p1l603t792r653b834],
5	,	,	O	,	_	0	SENT_11	[p1l603t792r653b834],
6	Dong-Mei	NNP	O	Dong-Mei	appos	4	SENT_11	[p1l672t793r878b837],
7	An	DT	O	a	det	8	SENT_11	[p1l895t794r952b828],
8	3	CD	NUMBER	3	dep	2	SENT_11	[p1l962t792r987b834],
9	,	,	O	,	_	0	SENT_11	[p1l962t792r987b834],
10	Bo	NNP	PERSON	Bo	nn	11	SENT_11	[p1l1006t795r1056b828],
11	Yan	NNP	PERSON	Yan	appos	8	SENT_11	[p1l1073t795r1151b828],
12	"	``	O	"	punct	11	SENT_11	[p1l1161t792r1186b834],
13	“	NN	O	“	dep	11	SENT_11	[p1l1161t792r1186b834],
14	,	,	O	,	_	0	SENT_11	[p1l1161t792r1186b834],
15	Hermann	NNP	PERSON	Hermann	nn	17	SENT_11	[p1l1205t795r1400b828],
16	Stefan	NNP	PERSON	Stefan	nn	17	SENT_11	[p1l1419t793r1547b828],
17	C	NNP	PERSON	C	appos	2	SENT_11	[p1l1557t792r1581b834],
18	,	,	O	,	_	0	SENT_11	[p1l1557t792r1581b834],
19	Dong	NNP	PERSON	Dong	nn	20	SENT_11	[p1l1600t795r1708b837],
20	Zhou	NNP	PERSON	Zhou	appos	2	SENT_11	[p1l1725t793r1830b828],
21	‘”	CD	NUMBER	‘”	dep	20	SENT_11	[p1l1840t791r1881b812],
22	"	``	O	"	punct	24	SENT_11	[p1l1840t791r1881b812],
23	*	CD	NUMBER	*	num	24	SENT_11	[p1l1840t791r1881b812],
24	aDepartment	NN	O	adepartment	dep	2	SENT_11	[p1l6t868r167b895],
25	of	IN	O	of	_	0	SENT_11	[p1l177t868r203b895],
26	Neurology	NNP	O	Neurology	prep_of	24	SENT_11	[p1l208t868r336b895],
27	,	,	O	,	_	0	SENT_11	[p1l208t868r336b895],
28	West	NNP	ORGANIZATION	West	nn	30	SENT_11	[p1l350t870r410b890],
29	China	NNP	ORGANIZATION	China	nn	30	SENT_11	[p1l419t868r487b890],
30	Hospital	NNP	ORGANIZATION	Hospital	appos	2	SENT_11	[p1l497t868r602b895],
31	,	,	O	,	_	0	SENT_11	[p1l497t868r602b895],
32	Sichuan	NNP	ORGANIZATION	Sichuan	nn	38	SENT_11	[p1l613t868r708b890],
33	University	NNP	ORGANIZATION	University	nn	38	SENT_11	[p1l720t869r846b895],
34	,	,	O	,	_	0	SENT_11	[p1l720t869r846b895],
35	Chengdu	NNP	LOCATION	Chengdu	appos	38	SENT_11	[p1l859t868r968b895],
36	,	,	O	,	_	0	SENT_11	[p1l859t868r968b895],
37	Sichuan	NNP	ORGANIZATION	Sichuan	appos	38	SENT_11	[p1l979t868r1073b890],
38	Province	NNP	ORGANIZATION	Province	appos	2	SENT_11	[p1l1084t869r1187b890],
39	610041	CD	NUMBER	610041	num	38	SENT_11	[p1l1198t869r1293b893],
40	,	,	O	,	_	0	SENT_11	[p1l1198t869r1293b893],
41	China	NNP	LOCATION	China	nn	45	SENT_11	[p1l1305t868r1373b890],
42	"	``	O	"	punct	45	SENT_11	[p1l6t899r169b931],
43	Department	NNP	ORGANIZATION	Department	nn	45	SENT_11	[p1l6t899r169b931],
44	of	IN	ORGANIZATION	of	amod	45	SENT_11	[p1l178t904r204b931],
45	Neurology	NNP	ORGANIZATION	Neurology	appos	2	SENT_11	[p1l210t904r338b931],
46	,	,	O	,	_	0	SENT_11	[p1l210t904r338b931],
47	Renmin	NNP	ORGANIZATION	Renmin	nn	48	SENT_11	[p1l350t904r441b926],
48	Hospital	NNP	ORGANIZATION	Hospital	appos	2	SENT_11	[p1l452t904r556b931],
49	,	,	O	,	_	0	SENT_11	[p1l452t904r556b931],
50	Hubei	NNP	ORGANIZATION	Hubei	nn	51	SENT_11	[p1l568t904r639b926],
51	University	NNP	ORGANIZATION	University	appos	2	SENT_11	[p1l651t904r773b931],
52	of	IN	ORGANIZATION	of	_	0	SENT_11	[p1l783t904r809b931],
53	Medicine	NNP	ORGANIZATION	Medicine	nn	58	SENT_11	[p1l815t904r929b929],
54	,	,	O	,	_	0	SENT_11	[p1l815t904r929b929],
55	Shiyan	NNP	LOCATION	Shiyan	appos	58	SENT_11	[p1l940t904r1026b931],
56	,	,	O	,	_	0	SENT_11	[p1l940t904r1026b931],
57	Hubei	NNP	LOCATION	Hubei	appos	58	SENT_11	[p1l1037t904r1108b926],
58	Province	NNP	LOCATION	Province	prep_of	51	SENT_11	[p1l1118t904r1222b926],
59	442000	CD	NUMBER	442000	num	58	SENT_11	[p1l1231t905r1327b929],
60	,	,	O	,	_	0	SENT_11	[p1l1231t905r1327b929],
61	China	NNP	LOCATION	China	nn	64	SENT_11	[p1l1340t904r1407b926],
62	°	CD	NUMBER	°	num	64	SENT_11	[p1l6t939r119b966],
63	Epilepsy	NNP	O	Epilepsy	nn	64	SENT_11	[p1l6t939r119b966],
64	Center	NNP	O	Center	appos	58	SENT_11	[p1l130t940r211b964],
65	.	.	O	.	_	0	SENT_11	[p1l130t940r211b964],

1	Department	NNP	ORGANIZATION	Department	_	0	SENT_12	[p1l223t941r369b966],
2	of	IN	ORGANIZATION	of	_	0	SENT_12	[p1l379t939r405b966],
3	Neurology	NNP	ORGANIZATION	Neurology	prep_of	1	SENT_12	[p1l410t939r539b966],
4	,	,	O	,	_	0	SENT_12	[p1l410t939r539b966],
5	University	NNP	ORGANIZATION	University	nn	6	SENT_12	[p1l552t940r674b966],
6	Hospital	NNP	ORGANIZATION	Hospital	appos	1	SENT_12	[p1l684t939r784b966],
7	of	IN	O	of	_	0	SENT_12	[p1l794t939r820b966],
8	Erlangen	NNP	LOCATION	Erlangen	prep_of	6	SENT_12	[p1l826t939r1076b966],
9	.	.	O	.	_	0	SENT_12	[p1l826t939r1076b966],

1	—	NN	O	—	_	0	SENT_13	[p1l826t939r1076b966],
2	.	.	O	.	_	0	SENT_13	[p1l826t939r1076b966],

1	Nuernberg	NNP	PERSON	Nuernberg	nn	3	SENT_14	[p1l826t939r1076b966],
2	,	,	O	,	_	0	SENT_14	[p1l826t939r1076b966],
3	Erlangen	NNP	LOCATION	Erlangen	_	0	SENT_14	[p1l1088t939r1194b966],
4	91054	CD	NUMBER	91054	num	3	SENT_14	[p1l1204t940r1284b964],
5	,	,	O	,	_	0	SENT_14	[p1l1204t940r1284b964],
6	Germany	NNP	LOCATION	Germany	appos	3	SENT_14	[p1l1297t940r1406b966],

1	ARTICLEINFO	NNP	O	ARTICLEINFO	_	0	SENT_15	[p1l6t1079r308b1099],
2	ABSTRACT	NN	O	abstract	dep	1	SENT_15	[p1l698t1079r915b1099],

1	Aftifle	JJ	MISC	aftifle	amod	2	SENT_16	[p1l6t1149r82b1171],
2	history	NN	O	history	dep	23	SENT_16	[p1l107t1149r194b1176],
3	:	:	O	:	_	0	SENT_16	[p1l107t1149r194b1176],
4	Antiepileptic	JJ	O	antiepileptic	amod	6	SENT_16	[p1l728t1151r912b1181],
5	drugs-induced	JJ	O	drugs-induced	amod	6	SENT_16	[p1l942t1151r1148b1181],
6	Stevens	NNP	PERSON	Stevens	dep	2	SENT_16	[p1l1178t1151r1420b1181],
7	—	CD	NUMBER	—	number	8	SENT_16	[p1l1178t1151r1420b1181],
8	]	CD	NUMBER	]	num	13	SENT_16	[p1l1178t1151r1420b1181],
9	ohnson	NN	O	ohnson	nn	13	SENT_16	[p1l1178t1151r1420b1181],
10	syndrome	NN	O	syndrome	nn	13	SENT_16	[p1l1451t1151r1592b1181],
11	(	CD	NUMBER	(	num	13	SENT_16	[p1l1622t1151r1685b1181],
12	SJS	NN	O	sj	nn	13	SENT_16	[p1l1622t1151r1685b1181],
13	)	NN	O	)	dep	6	SENT_16	[p1l1622t1151r1685b1181],
14	is	VBZ	O	be	auxpass	23	SENT_16	[p1l1715t1151r1736b1175],
15	a	DT	O	a	det	17	SENT_16	[p1l1767t1158r1781b1175],
16	life-threatening	JJ	O	life-threatening	amod	17	SENT_16	[p1l1811t1151r2035b1181],
17	severe	JJ	O	severe	attr	23	SENT_16	[p1l2065t1158r2154b1175],
18	aneous	JJ	O	aneous	amod	17	SENT_16	[p1l51t1197r150b1214],
19	eived	JJ	O	eived	amod	17	SENT_16	[p1l52t1218r118b1240],
20	5	CD	DATE	5	tmod	19	SENT_16	[p1l130t1219r143b1240],
21	May	NNP	DATE	May	tmod	17	SENT_16	[p1l155t1219r209b1245],
22	2010	CD	DATE	2010	num	21	SENT_16	[p1l219t1219r282b1240],
23	Received	VBN	O	receive	_	0	SENT_16	[p1l7t1254r114b1276],
24	in	IN	O	in	_	0	SENT_16	[p1l125t1254r147b1276],
25	revised	JJ	O	revised	amod	26	SENT_16	[p1l158t1254r244b1276],
26	form	NN	O	form	prep_in	23	SENT_16	[p1l255t1254r312b1276],
27	3	CD	DATE	3	num	26	SENT_16	[p1l323t1255r336b1276],
28	November	NNP	DATE	November	tmod	26	SENT_16	[p1l348t1254r474b1276],
29	2010	CD	DATE	2010	num	28	SENT_16	[p1l484t1255r544b1276],
30	Accepted	JJ	O	accepted	amod	32	SENT_16	[p1l6t1290r122b1317],
31	17	CD	DATE	17	tmod	30	SENT_16	[p1l134t1291r162b1312],
32	January	NNP	DATE	January	tmod	23	SENT_16	[p1l171t1291r270b1317],
33	2011	CD	DATE	2011	nsubjpass	23	SENT_16	[p1l280t1291r340b1312],

1	adverse	JJ	O	adverse	amod	2	SENT_17	[p1l6t1403r114b1427],
2	reaction	NN	O	reaction	_	0	SENT_17	[p1l131t1403r253b1427],
3	.	.	O	.	_	0	SENT_17	[p1l131t1403r253b1427],

1	Recent	JJ	O	recent	amod	2	SENT_18	[p1l269t1404r365b1427],
2	studies	NNS	O	study	nsubj	7	SENT_18	[p1l381t1403r480b1427],
3	in	IN	O	in	_	0	SENT_18	[p1l497t1403r523b1427],
4	Thailand	NNP	LOCATION	Thailand	prep_in	2	SENT_18	[p1l538t1403r662b1427],
5	and	CC	O	and	_	0	SENT_18	[p1l678t1403r729b1427],
6	Taiwan	NNP	LOCATION	Taiwan	prep_in	2	SENT_18	[p1l744t1403r848b1427],
7	showed	VBD	O	show	_	0	SENT_18	[p1l864t1403r973b1427],
8	a	DT	O	a	det	10	SENT_18	[p1l989t1410r1003b1427],
9	signiﬁcant	JJ	O	signiﬁcant	amod	10	SENT_18	[p1l1020t1403r1168b1433],
10	association	NN	O	association	dobj	7	SENT_18	[p1l1183t1403r1341b1427],
11	between	IN	O	between	_	0	SENT_18	[p1l1356t1403r1479b1427],
12	phenytoin	NN	O	phenytoin	nn	14	SENT_18	[p1l6t1443r151b1473],
13	(	CD	NUMBER	(	num	14	SENT_18	[p1l159t1443r366b1473],
14	PHT	NNP	ORGANIZATION	PHT	prep_between	10	SENT_18	[p1l159t1443r366b1473],
15	)	SYM	O	)	dep	17	SENT_18	[p1l159t1443r366b1473],
16	-	:	O	-	_	0	SENT_18	[p1l159t1443r366b1473],
17	induced	VBN	O	induce	rcmod	14	SENT_18	[p1l159t1443r366b1473],
18	SJS	NN	O	sj	dobj	17	SENT_18	[p1l375t1444r415b1473],
19	and	CC	O	and	_	0	SENT_18	[p1l424t1443r475b1467],
20	human	JJ	O	human	amod	23	SENT_18	[p1l484t1443r584b1467],
21	leucocyte	NN	O	leucocyte	nn	23	SENT_18	[p1l593t1443r727b1473],
22	antigen	NN	O	antigen	nn	23	SENT_18	[p1l736t1443r842b1473],
23	HLA	NN	O	hlum	conj_and	18	SENT_18	[p1l851t1443r1024b1467],
24	.	.	O	.	_	0	SENT_18	[p1l851t1443r1024b1467],

1	—	NN	O	—	_	0	SENT_19	[p1l851t1443r1024b1467],
2	.	.	O	.	_	0	SENT_19	[p1l851t1443r1024b1467],

1	B	NN	O	b	_	0	SENT_20	[p1l851t1443r1024b1467],
2	*	CD	NUMBER	*	number	3	SENT_20	[p1l851t1443r1024b1467],
3	1502	CD	DATE	1502	dep	1	SENT_20	[p1l851t1443r1024b1467],
4	allele	NN	O	allele	dep	3	SENT_20	[p1l1033t1443r1115b1467],
5	.	.	O	.	_	0	SENT_20	[p1l1033t1443r1115b1467],

1	Although	IN	O	although	mark	6	SENT_21	[p1l1123t1443r1255b1473],
2	the	DT	O	the	det	4	SENT_21	[p1l1263t1443r1308b1467],
3	US	NNP	ORGANIZATION	US	nn	4	SENT_21	[p1l1316t1444r1353b1467],
4	FDA	NNP	ORGANIZATION	FDA	nsubj	6	SENT_21	[p1l1362t1444r1419b1467],
5	had	VBD	O	have	aux	6	SENT_21	[p1l1427t1443r1478b1467],
6	issued	VBN	O	issue	advcl	15	SENT_21	[p1l6t1483r94b1507],
7	an	DT	O	a	det	8	SENT_21	[p1l102t1490r135b1507],
8	alert	JJ	O	alert	dobj	6	SENT_21	[p1l143t1483r208b1507],
9	to	TO	O	to	_	0	SENT_21	[p1l215t1486r242b1507],
10	clinicians	NNS	O	clinician	prep_to	6	SENT_21	[p1l250t1483r390b1511],
11	,	,	O	,	_	0	SENT_21	[p1l250t1483r390b1511],
12	insufﬁcient	JJ	O	insufﬁcient	amod	13	SENT_21	[p1l399t1483r559b1507],
13	information	NN	O	information	nsubj	15	SENT_21	[p1l566t1483r735b1507],
14	is	VBZ	O	be	cop	15	SENT_21	[p1l743t1483r764b1507],
15	available	JJ	O	available	_	0	SENT_21	[p1l772t1483r899b1507],
16	to	TO	O	to	aux	17	SENT_21	[p1l906t1486r933b1507],
17	recommend	VB	O	recommend	xcomp	15	SENT_21	[p1l942t1483r1112b1507],
18	testing	NN	O	testing	dobj	17	SENT_21	[p1l1119t1483r1217b1513],
19	for	IN	O	for	_	0	SENT_21	[p1l1224t1483r1264b1507],
20	HLA	NN	O	hlum	prep_for	17	SENT_21	[p1l1271t1483r1443b1507],
21	.	.	O	.	_	0	SENT_21	[p1l1271t1483r1443b1507],

1	—	NN	O	—	_	0	SENT_22	[p1l1271t1483r1443b1507],
2	.	.	O	.	_	0	SENT_22	[p1l1271t1483r1443b1507],

1	B	NN	O	b	_	0	SENT_23	[p1l1271t1483r1443b1507],
2	*	CD	NUMBER	*	number	3	SENT_23	[p1l1271t1483r1443b1507],
3	1502	CD	DATE	1502	dep	1	SENT_23	[p1l1271t1483r1443b1507],
4	in	IN	O	in	prep	3	SENT_23	[p1l1453t1483r1479b1507],

1	Asian	JJ	MISC	asian	amod	2	SENT_24	[p1l698t1522r776b1547],
2	patients	NNS	O	patient	_	0	SENT_24	[p1l796t1522r910b1553],
3	in	IN	O	in	_	0	SENT_24	[p1l930t1522r956b1547],
4	line	NN	O	line	prep_in	2	SENT_24	[p1l976t1522r1028b1547],
5	for	IN	O	for	_	0	SENT_24	[p1l1047t1522r1087b1547],
6	PHT	NNP	ORGANIZATION	PHT	nn	7	SENT_24	[p1l1106t1524r1163b1547],
7	treatment	NN	O	treatment	prep_for	2	SENT_24	[p1l1182t1526r1331b1547],
8	.	.	O	.	_	0	SENT_24	[p1l1182t1526r1331b1547],

1	Therefore	RB	O	therefore	advmod	14	SENT_25	[p1l1350t1522r1494b1550],
2	,	,	O	,	_	0	SENT_25	[p1l1350t1522r1494b1550],
3	extended	JJ	O	extended	amod	4	SENT_25	[p1l1514t1522r1645b1547],
4	studies	NNS	O	study	nsubj	14	SENT_25	[p1l1666t1522r1766b1547],
5	are	VBP	O	be	cop	14	SENT_25	[p1l1786t1529r1829b1547],
6	necessary	JJ	O	necessary	amod	14	SENT_25	[p1l1849t1529r1988b1553],
7	to	TO	O	to	_	0	SENT_25	[p1l2006t1526r2034b1547],
8	further	JJ	O	further	amod	13	SENT_25	[p1l2054t1522r2154b1547],
9	evalu	NN	O	evalu	nn	13	SENT_25	[p1l6t1562r81b1586],
10	Keywo	NNP	O	Keywo	nn	13	SENT_25	[p1l6t1587r87b1613],
11	:	:	O	:	_	0	SENT_25	[p1l126t1592r132b1607],
12	Phenytoin	NNP	O	Phenytoin	nn	13	SENT_25	[p1l7t1621r135b1648],
13	Carbamazepine	NNP	O	Carbamazepine	prep_to	6	SENT_25	[p1l7t1657r202b1684],
14	HLA	NN	O	hlum	_	0	SENT_25	[p1l7t1693r161b1714],
15	.	.	O	.	_	0	SENT_25	[p1l7t1693r161b1714],

1	—	NN	O	—	_	0	SENT_26	[p1l7t1693r161b1714],
2	.	.	O	.	_	0	SENT_26	[p1l7t1693r161b1714],

1	B	NN	O	b	_	0	SENT_27	[p1l7t1693r161b1714],
2	*	CD	NUMBER	*	number	3	SENT_27	[p1l7t1693r161b1714],
3	1502	CD	DATE	1502	dep	1	SENT_27	[p1l7t1693r161b1714],
4	Stevens	NNP	PERSON	Stevens	dep	3	SENT_27	[p1l7t1729r221b1756],
5	—	CD	NUMBER	—	number	6	SENT_27	[p1l7t1729r221b1756],
6	]	CD	NUMBER	]	num	8	SENT_27	[p1l7t1729r221b1756],
7	ohnson	NN	O	ohnson	nn	8	SENT_27	[p1l7t1729r221b1756],
8	syndrome	NN	O	syndrome	dep	1	SENT_27	[p1l233t1729r358b1756],
9	Antiepileptic	JJ	MISC	antiepileptic	amod	10	SENT_27	[p1l6t1764r169b1791],
10	drugs	NNS	O	drug	dep	8	SENT_27	[p1l180t1764r250b1791],
11	the	DT	O	the	det	13	SENT_27	[p1l6t1866r51b1890],
12	potential	JJ	O	potential	amod	13	SENT_27	[p1l64t1866r191b1896],
13	association	NN	O	association	dep	1	SENT_27	[p1l205t1866r363b1890],
14	between	IN	O	between	_	0	SENT_27	[p1l375t1866r497b1890],
15	PHT-induced	JJ	O	pht-induced	amod	16	SENT_27	[p1l511t1866r695b1890],
16	SJS	NN	O	sj	prep_between	13	SENT_27	[p1l708t1867r748b1896],
17	and	CC	O	and	_	0	SENT_27	[p1l761t1866r812b1890],
18	HLA	NN	O	hlum	prep_between	13	SENT_27	[p1l826t1866r999b1890],
19	.	.	O	.	_	0	SENT_27	[p1l826t1866r999b1890],

1	—	NN	O	—	_	0	SENT_28	[p1l826t1866r999b1890],
2	.	.	O	.	_	0	SENT_28	[p1l826t1866r999b1890],

1	B	NN	O	b	_	0	SENT_29	[p1l826t1866r999b1890],
2	*	CD	NUMBER	*	number	3	SENT_29	[p1l826t1866r999b1890],
3	1502	CD	DATE	1502	num	4	SENT_29	[p1l826t1866r999b1890],
4	allele	NN	O	allele	dep	1	SENT_29	[p1l1013t1866r1088b1890],
5	in	IN	O	in	_	0	SENT_29	[p1l1101t1866r1128b1890],
6	various	JJ	O	various	amod	7	SENT_29	[p1l1140t1866r1243b1890],
7	populations	NNS	O	population	prep_in	4	SENT_29	[p1l1257t1866r1432b1896],
8	.	.	O	.	_	0	SENT_29	[p1l1257t1866r1432b1896],

1	To	TO	O	to	_	0	SENT_30	[p1l1445t1867r1479b1890],
2	date	NN	O	date	prep_to	7	SENT_30	[p1l6t1906r74b1934],
3	,	,	O	,	_	0	SENT_30	[p1l6t1906r74b1934],
4	no	DT	O	no	det	6	SENT_30	[p1l84t1913r118b1930],
5	similar	JJ	O	similar	amod	6	SENT_30	[p1l129t1906r228b1930],
6	data	NNS	O	datum	nsubj	7	SENT_30	[p1l236t1906r297b1930],
7	exist	VBP	O	exist	_	0	SENT_30	[p1l307t1906r374b1930],
8	in	IN	O	in	_	0	SENT_30	[p1l384t1906r410b1930],
9	mainland	NN	O	mainland	nn	10	SENT_30	[p1l420t1906r554b1930],
10	China	NNP	LOCATION	China	prep_in	7	SENT_30	[p1l564t1906r651b1930],
11	.	.	O	.	_	0	SENT_30	[p1l564t1906r651b1930],

1	Here	RB	O	here	advmod	4	SENT_31	[p1l662t1907r735b1934],
2	,	,	O	,	_	0	SENT_31	[p1l662t1907r735b1934],
3	we	PRP	O	we	nsubj	4	SENT_31	[p1l745t1913r786b1930],
4	describe	VBP	O	describe	_	0	SENT_31	[p1l797t1906r915b1930],
5	two	CD	NUMBER	two	num	8	SENT_31	[p1l925t1909r978b1930],
6	Chinese	JJ	MISC	chinese	amod	8	SENT_31	[p1l989t1906r1099b1930],
7	Han	NN	O	han	nn	8	SENT_31	[p1l1109t1907r1165b1930],
8	cases	NNS	O	case	dobj	4	SENT_31	[p1l1175t1913r1248b1930],
9	of	IN	O	of	_	0	SENT_31	[p1l1259t1906r1288b1930],
10	PHT-induced	JJ	O	pht-induced	amod	11	SENT_31	[p1l1295t1906r1479b1930],
11	SJS	NN	O	sj	prep_of	8	SENT_31	[p1l6t1947r46b1976],
12	with	IN	O	with	_	0	SENT_31	[p1l71t1946r136b1970],
13	negative	JJ	O	negative	amod	14	SENT_31	[p1l162t1946r282b1976],
14	HLA	NN	O	hlum	prep_with	4	SENT_31	[p1l307t1946r480b1970],
15	.	.	O	.	_	0	SENT_31	[p1l307t1946r480b1970],

1	—	NN	O	—	_	0	SENT_32	[p1l307t1946r480b1970],
2	.	.	O	.	_	0	SENT_32	[p1l307t1946r480b1970],

1	B	NN	O	b	_	0	SENT_33	[p1l307t1946r480b1970],
2	*	CD	NUMBER	*	number	3	SENT_33	[p1l307t1946r480b1970],
3	1502	CD	DATE	1502	num	4	SENT_33	[p1l307t1946r480b1970],
4	allele	NN	O	allele	dobj	1	SENT_33	[p1l506t1946r588b1974],
5	,	,	O	,	_	0	SENT_33	[p1l506t1946r588b1974],
6	in	IN	O	in	_	0	SENT_33	[p1l614t1946r640b1970],
7	which	WDT	O	which	rel	11	SENT_33	[p1l664t1946r752b1970],
8	HLA	NN	O	hlum	nn	10	SENT_33	[p1l777t1947r835b1970],
9	high-resolution	JJ	O	high-resolution	amod	10	SENT_33	[p1l860t1946r1080b1976],
10	genotyping	NN	O	genotyping	nsubj	11	SENT_33	[p1l1105t1946r1266b1976],
11	showed	VBD	O	show	rcmod	4	SENT_33	[p1l1291t1946r1400b1970],
12	two	CD	NUMBER	two	num	14	SENT_33	[p1l1425t1949r1479b1970],
13	heterozygous	JJ	O	heterozygous	amod	14	SENT_33	[p1l7t1986r197b2016],
14	HLA	NN	O	hlum	dobj	11	SENT_33	[p1l212t1986r500b2016],
15	.	.	O	.	_	0	SENT_33	[p1l212t1986r500b2016],

1	—	NN	O	—	_	0	SENT_34	[p1l212t1986r500b2016],
2	.	.	O	.	_	0	SENT_34	[p1l212t1986r500b2016],

1	B	NN	O	b	_	0	SENT_35	[p1l212t1986r500b2016],
2	*	CD	NUMBER	*	num	3	SENT_35	[p1l212t1986r500b2016],
3	4601/B	NN	O	4601/b	dep	1	SENT_35	[p1l212t1986r500b2016],
4	*	CD	NUMBER	*	number	5	SENT_35	[p1l212t1986r500b2016],
5	5102	CD	NUMBER	5102	dep	3	SENT_35	[p1l212t1986r500b2016],
6	and	CC	O	and	_	0	SENT_35	[p1l516t1986r567b2010],
7	HLA-B	NN	O	hla-b	nn	9	SENT_35	[p1l583t1986r868b2016],
8	*	CD	NUMBER	*	num	9	SENT_35	[p1l583t1986r868b2016],
9	3701/B	NN	O	3701/b	conj_and	3	SENT_35	[p1l583t1986r868b2016],
10	*	CD	NUMBER	*	number	11	SENT_35	[p1l583t1986r868b2016],
11	4601	CD	NUMBER	4601	num	12	SENT_35	[p1l583t1986r868b2016],
12	allele	NN	O	allele	rcmod	9	SENT_35	[p1l886t1986r968b2014],
13	,	,	O	,	_	0	SENT_35	[p1l886t1986r968b2014],
14	respectively	RB	O	respectively	advmod	12	SENT_35	[p1l983t1986r1161b2016],
15	.	.	O	.	_	0	SENT_35	[p1l983t1986r1161b2016],

1	Our	PRP$	O	we	poss	2	SENT_36	[p1l1177t1987r1229b2010],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_36	[p1l1243t1986r1356b2016],
3	provide	VBP	O	provide	_	0	SENT_36	[p1l1372t1986r1479b2016],
4	evidence	NN	O	evidence	dobj	3	SENT_36	[p1l6t2026r132b2050],
5	to	TO	O	to	aux	6	SENT_36	[p1l153t2029r180b2050],
6	support	VB	O	support	xcomp	3	SENT_36	[p1l203t2029r312b2056],
7	that	IN	O	that	complm	15	SENT_36	[p1l333t2026r391b2050],
8	other	JJ	O	other	amod	10	SENT_36	[p1l412t2026r488b2050],
9	genetic	JJ	O	genetic	amod	10	SENT_36	[p1l508t2026r611b2056],
10	markers	NNS	O	marker	nsubj	15	SENT_36	[p1l633t2026r748b2050],
11	or	CC	O	or	_	0	SENT_36	[p1l770t2033r800b2050],
12	nongenetic	JJ	O	nongenetic	amod	13	SENT_36	[p1l821t2026r978b2056],
13	factors	NNS	O	factor	conj_or	10	SENT_36	[p1l1000t2026r1094b2050],
14	could	MD	O	could	aux	15	SENT_36	[p1l1117t2026r1193b2050],
15	contribute	VB	O	contribute	ccomp	6	SENT_36	[p1l1216t2026r1363b2050],
16	to	TO	O	to	_	0	SENT_36	[p1l1385t2029r1412b2050],
17	the	DT	O	the	det	18	SENT_36	[p1l1434t2026r1479b2050],
18	susceptibility	NN	O	susceptibility	prep_to	15	SENT_36	[p1l6t2060r196b2090],
19	of	IN	O	of	_	0	SENT_36	[p1l224t2060r253b2084],
20	PHT-induced	JJ	O	pht-induced	amod	21	SENT_36	[p1l277t2060r461b2084],
21	SJS	NN	O	sj	prep_of	18	SENT_36	[p1l490t2061r536b2090],
22	,	,	O	,	_	0	SENT_36	[p1l490t2061r536b2090],
23	except	IN	O	except	_	0	SENT_36	[p1l565t2064r658b2090],
24	for	IN	O	for	prepc_except_for	15	SENT_36	[p1l685t2060r725b2084],
25	HLA	NN	O	hlum	pobj	15	SENT_36	[p1l751t2060r924b2084],
26	.	.	O	.	_	0	SENT_36	[p1l751t2060r924b2084],

1	—	NN	O	—	_	0	SENT_37	[p1l751t2060r924b2084],
2	.	.	O	.	_	0	SENT_37	[p1l751t2060r924b2084],

1	B	NN	O	b	_	0	SENT_38	[p1l751t2060r924b2084],
2	*	CD	NUMBER	*	number	3	SENT_38	[p1l751t2060r924b2084],
3	1502	CD	DATE	1502	dep	1	SENT_38	[p1l751t2060r924b2084],
4	allele	NN	O	allele	dep	3	SENT_38	[p1l953t2060r1035b2084],
5	.	.	O	.	_	0	SENT_38	[p1l953t2060r1035b2084],

1	Further	JJ	O	further	amod	2	SENT_39	[p1l1064t2060r1169b2084],
2	studies	NNS	O	study	nsubjpass	4	SENT_39	[p1l1197t2060r1296b2084],
3	are	VBP	O	be	auxpass	4	SENT_39	[p1l1325t2067r1368b2084],
4	encouraged	VBN	O	encourage	_	0	SENT_39	[p1l1395t2060r1560b2090],
5	to	TO	O	to	aux	6	SENT_39	[p1l1587t2064r1615b2084],
6	investigate	VB	O	investigate	xcomp	4	SENT_39	[p1l1639t2060r1794b2090],
7	the	DT	O	the	det	9	SENT_39	[p1l1818t2060r1863b2084],
8	genetic	JJ	O	genetic	amod	9	SENT_39	[p1l1886t2060r1989b2090],
9	link	NN	O	link	dobj	6	SENT_39	[p1l2013t2060r2066b2084],
10	with	IN	O	with	_	0	SENT_39	[p1l2089t2060r2154b2084],
11	PHT-induced	JJ	O	pht-induced	amod	14	SENT_39	[p1l1501t2100r1685b2125],
12	serious	JJ	O	serious	amod	14	SENT_39	[p1l1697t2100r1797b2125],
13	skin	NN	O	skin	nn	14	SENT_39	[p1l1811t2100r1867b2125],
14	reactions	NNS	O	reaction	prep_with	6	SENT_39	[p1l1881t2100r2009b2125],
15	in	IN	O	in	_	0	SENT_39	[p1l2022t2100r2048b2125],
16	future	NN	DATE	future	prep_in	14	SENT_39	[p1l2061t2100r2154b2125],
17	.	.	O	.	_	0	SENT_39	[p1l2061t2100r2154b2125],

1	©	RB	O	©	advmod	2	SENT_40	[p1l963t2143r985b2164],
2	2011	CD	DATE	2011	_	0	SENT_40	[p1l999t2141r1065b2164],
3	British	JJ	O	british	dep	2	SENT_40	[p1l1082t2140r1174b2164],
4	Epilepsy	NNP	ORGANIZATION	Epilepsy	nn	5	SENT_40	[p1l1187t2140r1306b2170],
5	Association	NNP	ORGANIZATION	Association	dep	3	SENT_40	[p1l1317t2140r1486b2164],
6	.	.	O	.	_	0	SENT_40	[p1l1317t2140r1486b2164],

1	Published	VBN	O	publish	_	0	SENT_41	[p1l1500t2140r1638b2164],
2	by	IN	O	by	_	0	SENT_41	[p1l1651t2140r1685b2170],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	4	SENT_41	[p1l1697t2140r1808b2164],
4	Ltd.	NNP	ORGANIZATION	Ltd.	prep_by	1	SENT_41	[p1l1820t2140r1870b2164],
5	.	.	O	.	_	0	SENT_41	[p1l1820t2140r1870b2164],

1	All	DT	O	all	det	2	SENT_42	[p1l1882t2140r1919b2164],
2	rights	NNS	O	rights	nsubj	3	SENT_42	[p1l1933t2140r2013b2170],
3	reserved	VBN	O	reserve	_	0	SENT_42	[p1l2026t2140r2154b2164],
4	.	.	O	.	_	0	SENT_42	[p1l2026t2140r2154b2164],

1	1	LS	NUMBER	1	_	0	SENT_43	[p1l10t2357r64b2409],
2	.	.	O	.	_	0	SENT_43	[p1l10t2357r64b2409],

1	Introduction	NN	O	introduction	_	0	SENT_44	[p1l103t2354r539b2408],

1	Carbamazepine	NNP	O	Carbamazepine	nsubj	19	SENT_45	[p1l112t2533r611b2601],
2	(	CD	NUMBER	(	num	1	SENT_45	[p1l632t2533r805b2601],
3	CBZ	NNP	ORGANIZATION	CBZ	nn	4	SENT_45	[p1l632t2533r805b2601],
4	)	NN	O	)	nsubj	10	SENT_45	[p1l632t2533r805b2601],
5	and	CC	O	and	_	0	SENT_45	[p1l825t2533r942b2588],
6	phenytoin	NN	O	phenytoin	nsubj	10	SENT_45	[p1l963t2533r1293b2601],
7	(	CD	NUMBER	(	num	8	SENT_45	[p1l1313t2533r1493b2601],
8	PHT	NNP	O	PHT	dep	4	SENT_45	[p1l1313t2533r1493b2601],
9	)	CD	NUMBER	)	num	8	SENT_45	[p1l1313t2533r1493b2601],
10	are	VBP	O	be	rcmod	1	SENT_45	[p1l1513t2549r1611b2588],
11	among	IN	O	among	_	0	SENT_45	[p1l1632t2549r1852b2601],
12	the	DT	O	the	det	15	SENT_45	[p1l1870t2533r1972b2588],
13	most	RBS	O	most	advmod	15	SENT_45	[p1l1994t2541r2153b2588],
14	common	JJ	O	common	amod	15	SENT_45	[p1l9t2637r293b2676],
15	causes	NNS	O	cause	prep_among	10	SENT_45	[p1l320t2637r528b2676],
16	of	IN	O	of	_	0	SENT_45	[p1l558t2621r624b2676],
17	antiepileptic	JJ	O	antiepileptic	amod	18	SENT_45	[p1l645t2621r1051b2690],
18	drugs	NNS	O	drug	prep_of	15	SENT_45	[p1l1080t2621r1257b2690],
19	(	VBP	O	(	_	0	SENT_45	[p1l1287t2621r1794b2689],
20	AEDs	NNS	MISC	aed	dobj	19	SENT_45	[p1l1287t2621r1794b2689],
21	)	CD	NUMBER	)	tmod	19	SENT_45	[p1l1287t2621r1794b2689],
22	.	.	O	.	_	0	SENT_45	[p1l1287t2621r1794b2689],

1	—	NN	O	—	_	0	SENT_46	[p1l1287t2621r1794b2689],
2	.	.	O	.	_	0	SENT_46	[p1l1287t2621r1794b2689],

1	induced	VBN	O	induce	_	0	SENT_47	[p1l1287t2621r1794b2689],
2	cutaneous	JJ	O	cutaneous	amod	4	SENT_47	[p1l1823t2629r2151b2676],
3	adverse	JJ	O	adverse	amod	4	SENT_47	[p1l9t2709r256b2764],
4	reactions	NNS	O	reaction	dobj	1	SENT_47	[p1l276t2699r611b2765],
5	?	.	O	?	_	0	SENT_47	[p1l276t2699r611b2765],

1	Recent	JJ	O	recent	amod	2	SENT_48	[p1l637t2713r854b2764],
2	studies	NNS	O	study	nsubj	4	SENT_48	[p1l873t2709r1099b2764],
3	have	VBP	O	have	aux	4	SENT_48	[p1l1120t2709r1270b2764],
4	uncovered	VBN	O	uncover	dep	12	SENT_48	[p1l1289t2709r1626b2764],
5	a	DT	O	a	det	8	SENT_48	[p1l1646t2725r1678b2764],
6	strong	JJ	O	strong	amod	8	SENT_48	[p1l1698t2717r1902b2777],
7	genetic	JJ	O	genetic	amod	8	SENT_48	[p1l1919t2710r2153b2777],
8	association	NN	O	association	dobj	4	SENT_48	[p1l9t2799r368b2853],
9	between	IN	O	between	_	0	SENT_48	[p1l417t2798r695b2853],
10	CBZ	NNP	O	CBZ	nn	11	SENT_48	[p1l745t2798r1156b2853],
11	—	NN	O	—	prep_between	8	SENT_48	[p1l745t2798r1156b2853],
12	induced	VBD	O	induce	_	0	SENT_48	[p1l745t2798r1156b2853],
13	Stevens	NNP	PERSON	Stevens	dobj	12	SENT_48	[p1l1206t2798r1755b2867],
14	—	CD	NUMBER	—	num	13	SENT_48	[p1l1206t2798r1755b2867],
15	]	CD	NUMBER	]	num	17	SENT_48	[p1l1206t2798r1755b2867],
16	ohnson	NN	O	ohnson	nn	17	SENT_48	[p1l1206t2798r1755b2867],
17	syndrome	NN	O	syndrome	nsubj	12	SENT_48	[p1l1806t2798r2151b2867],
18	/	:	O	/	punct	24	SENT_48	[p1l1806t2798r2151b2867],
19	toxic	JJ	O	toxic	amod	21	SENT_48	[p1l8t2888r166b2942],
20	epidermal	JJ	O	epidermal	amod	21	SENT_48	[p1l186t2887r512b2956],
21	necrolysis	NN	O	necrolysis	dep	24	SENT_48	[p1l534t2887r855b2956],
22	(	NN	O	(	nn	24	SENT_48	[p1l878t2887r1178b2956],
23	SJS/TEN	NN	O	sjs/ten	nn	24	SENT_48	[p1l878t2887r1178b2956],
24	)	NN	O	)	dep	17	SENT_48	[p1l878t2887r1178b2956],
25	and	CC	O	and	_	0	SENT_48	[p1l1199t2887r1315b2942],
26	human	JJ	O	human	amod	29	SENT_48	[p1l1338t2887r1564b2942],
27	leucocyte	NN	O	leucocyte	nn	29	SENT_48	[p1l1585t2887r1890b2956],
28	antigen	NN	O	antigen	nn	29	SENT_48	[p1l1911t2888r2153b2956],
29	HLA	NN	O	hlum	dep	17	SENT_48	[p1l9t2976r402b3031],
30	.	.	O	.	_	0	SENT_48	[p1l9t2976r402b3031],

1	—	NN	O	—	_	0	SENT_49	[p1l9t2976r402b3031],
2	.	.	O	.	_	0	SENT_49	[p1l9t2976r402b3031],

1	B	NN	O	b	nsubj	15	SENT_50	[p1l9t2976r402b3031],
2	*	CD	NUMBER	*	number	3	SENT_50	[p1l9t2976r402b3031],
3	1502	CD	DATE	1502	num	4	SENT_50	[p1l9t2976r402b3031],
4	allele	NN	O	allele	npadvmod	5	SENT_50	[p1l430t2976r601b3031],
5	in	IN	O	in	dep	8	SENT_50	[p1l627t2977r686b3030],
6	Asians	NNPS	MISC	Asians	nn	7	SENT_50	[p1l709t2966r1027b3031],
7	.2	NN	NUMBER	.2	pobj	5	SENT_50	[p1l709t2966r1027b3031],
8	‘	NN	O	‘	rcmod	1	SENT_50	[p1l709t2966r1027b3031],
9	7	CD	NUMBER	7	num	8	SENT_50	[p1l709t2966r1027b3031],
10	In	IN	O	in	_	0	SENT_50	[p1l1054t2979r1114b3030],
11	order	NN	O	order	prep_in	15	SENT_50	[p1l1139t2976r1313b3031],
12	to	TO	O	to	_	0	SENT_50	[p1l1336t2984r1398b3031],
13	safer	JJR	O	safer	amod	14	SENT_50	[p1l1425t2976r1580b3031],
14	AEDs	NNS	MISC	aed	prep_to	11	SENT_50	[p1l1601t2978r1766b3031],
15	use	VBP	O	use	_	0	SENT_50	[p1l1793t2992r1916b3039],
16	,	,	O	,	_	0	SENT_50	[p1l1793t2992r1916b3039],
17	the	DT	O	the	det	19	SENT_50	[p1l1941t2976r2043b3031],
18	US	NNP	LOCATION	US	nn	19	SENT_50	[p1l2068t2979r2151b3031],
19	FDA	NNP	ORGANIZATION	FDA	nsubj	29	SENT_50	[p1l9t3067r140b3119],
20	and	CC	O	and	_	0	SENT_50	[p1l179t3065r296b3120],
21	similar	JJ	O	similar	amod	23	SENT_50	[p1l340t3065r564b3120],
22	control	NN	O	control	nn	23	SENT_50	[p1l604t3065r831b3120],
23	agencies	NNS	O	agency	conj_and	19	SENT_50	[p1l874t3066r1147b3133],
24	in	IN	O	in	_	0	SENT_50	[p1l1191t3066r1250b3119],
25	Canada	NNP	LOCATION	Canada	prep_in	19	SENT_50	[p1l1292t3065r1526b3120],
26	and	CC	O	and	_	0	SENT_50	[p1l1567t3065r1684b3120],
27	Taiwan	NNP	LOCATION	Taiwan	conj_and	25	SENT_50	[p1l1724t3066r1960b3120],
28	have	VBP	O	have	aux	29	SENT_50	[p1l2003t3065r2152b3120],
29	updated	VBN	O	update	parataxis	15	SENT_50	[p1l9t3153r273b3222],
30	the	DT	O	the	det	32	SENT_50	[p1l330t3153r432b3208],
31	CBZ	NNP	O	CBZ	nn	32	SENT_50	[p1l489t3156r611b3208],
32	label	NN	O	label	dobj	29	SENT_50	[p1l667t3153r818b3208],
33	to	TO	O	to	aux	34	SENT_50	[p1l876t3161r937b3208],
34	include	VB	O	include	xcomp	29	SENT_50	[p1l996t3153r1231b3208],
35	genetic	JJ	O	genetic	amod	36	SENT_50	[p1l1287t3154r1521b3222],
36	information	NN	O	information	dobj	34	SENT_50	[p1l1578t3153r1978b3216],
37	,	,	O	,	_	0	SENT_50	[p1l1578t3153r1978b3216],
38	and	CC	O	and	_	0	SENT_50	[p1l2035t3153r2151b3208],
39	recommended	VBD	O	recommend	conj_and	15	SENT_50	[p1l9t3243r475b3298],
40	screening	NN	O	screening	dobj	39	SENT_50	[p1l520t3243r830b3311],
41	for	IN	O	for	_	0	SENT_50	[p1l873t3242r962b3298],
42	HLA	NN	O	hlum	prep_for	39	SENT_50	[p1l1004t3242r1397b3298],
43	.	.	O	.	_	0	SENT_50	[p1l1004t3242r1397b3298],

1	—	NN	O	—	_	0	SENT_51	[p1l1004t3242r1397b3298],
2	.	.	O	.	_	0	SENT_51	[p1l1004t3242r1397b3298],

1	B	NN	O	b	_	0	SENT_52	[p1l1004t3242r1397b3298],
2	*	CD	NUMBER	*	number	3	SENT_52	[p1l1004t3242r1397b3298],
3	1502	CD	DATE	1502	num	4	SENT_52	[p1l1004t3242r1397b3298],
4	allele	NN	O	allele	dep	1	SENT_52	[p1l1443t3243r1613b3298],
5	before	IN	O	before	dep	1	SENT_52	[p1l1657t3242r1860b3298],
6	starting	VBG	O	start	pcomp	5	SENT_52	[p1l1905t3244r2154b3311],
7	CBZ	NN	ORGANIZATION	cbz	nn	8	SENT_52	[p1l9t3333r131b3385],
8	treatment	NN	O	treatment	dobj	6	SENT_52	[p1l159t3339r484b3385],
9	in	IN	O	in	_	0	SENT_52	[p1l512t3331r571b3385],
10	Asians	NNPS	MISC	Asians	prep_in	8	SENT_52	[p1l597t3321r853b3386],
11	.8	CD	NUMBER	.8	tmod	6	SENT_52	[p1l597t3321r853b3386],
12	These	DT	O	these	det	14	SENT_52	[p1l882t3331r1067b3385],
13	signiﬁcant	JJ	O	signiﬁcant	amod	14	SENT_52	[p1l1098t3330r1433b3399],
14	advances	NNS	O	advance	nsubj	18	SENT_52	[p1l1462t3331r1755b3385],
15	in	IN	O	in	_	0	SENT_52	[p1l1787t3331r1846b3385],
16	pharmacogenetic	JJ	O	pharmacogenetic	amod	17	SENT_52	[p1l1875t3331r2151b3399, p1l9t3421r315b3488],
17	study	NN	O	study	prep_in	14	SENT_52	[p1l339t3420r517b3488],
18	inspired	VBD	O	inspire	rcmod	11	SENT_52	[p1l539t3420r801b3488],
19	much	JJ	O	much	amod	21	SENT_52	[p1l825t3420r1005b3475],
20	scientiﬁc	NN	O	scientiﬁc	nn	21	SENT_52	[p1l1029t3420r1317b3475],
21	interest	NN	O	interest	dobj	18	SENT_52	[p1l1340t3421r1587b3475],
22	among	IN	O	among	_	0	SENT_52	[p1l1610t3436r1830b3488],
23	researchers	NNS	O	researcher	prep_among	18	SENT_52	[p1l1852t3420r2152b3475, p2l9t33r100b72],

1	to	TO	O	to	aux	2	SENT_53	[p2l129t25r191b72],
2	detect	VB	O	detect	_	0	SENT_53	[p2l219t17r418b72],
3	other	JJ	O	other	amod	6	SENT_53	[p2l445t17r617b72],
4	aromatic	JJ	O	aromatic	amod	6	SENT_53	[p2l643t18r929b72],
5	antiepileptic	JJ	O	antiepileptic	amod	6	SENT_53	[p2l956t17r1363b85],
6	drugs	NNS	O	drug	dobj	2	SENT_53	[p2l1390t17r1584b85],
7	,	,	O	,	_	0	SENT_53	[p2l1390t17r1584b85],
8	such	JJ	O	such	_	0	SENT_53	[p2l1614t17r1760b72],
9	as	IN	O	as	_	0	SENT_53	[p2l1787t33r1850b72],
10	PHT	NNP	ORGANIZATION	PHT	prep_such_as	6	SENT_53	[p2l1880t20r2009b71],
11	and	CC	O	and	_	0	SENT_53	[p2l2035t17r2151b72],
12	oxcarbazepine	JJ	O	oxcarbazepine	amod	15	SENT_53	[p2l9t105r476b174],
13	(	NN	O	(	nn	15	SENT_53	[p2l510t105r714b173],
14	OXC	NN	O	oxc	nn	15	SENT_53	[p2l510t105r714b173],
15	)	NN	O	)	prep_such_as	6	SENT_53	[p2l510t105r714b173],
16	.	.	O	.	_	0	SENT_53	[p2l510t105r714b173],

1	Recently	RB	DATE	recently	dep	5	SENT_54	[p2l750t105r1041b174],
2	,	,	O	,	_	0	SENT_54	[p2l750t105r1041b174],
3	a	DT	O	a	det	5	SENT_54	[p2l1076t121r1108b160],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_54	[p2l1142t105r1479b174],
5	association	NN	O	association	_	0	SENT_54	[p2l1510t106r1870b160],
6	of	IN	O	of	_	0	SENT_54	[p2l1903t105r1969b160],
7	PHTinduced	JJ	O	phtinduced	amod	8	SENT_54	[p2l1996t109r2152b160, p2l9t194r266b249],
8	SJS/TEN	NN	O	sjs/ten	prep_of	5	SENT_54	[p2l305t194r552b263],
9	with	IN	O	with	_	0	SENT_54	[p2l589t194r737b249],
10	HLA	NN	O	hlum	prep_with	8	SENT_54	[p2l776t194r1169b249],
11	.	.	O	.	_	0	SENT_54	[p2l776t194r1169b249],

1	—	NN	O	—	_	0	SENT_55	[p2l776t194r1169b249],
2	.	.	O	.	_	0	SENT_55	[p2l776t194r1169b249],

1	B	NN	O	b	nsubjpass	7	SENT_56	[p2l776t194r1169b249],
2	*	CD	NUMBER	*	num	1	SENT_56	[p2l776t194r1169b249],
3	1502	CD	DATE	1502	num	4	SENT_56	[p2l776t194r1169b249],
4	allele	NN	O	allele	dep	1	SENT_56	[p2l1209t194r1379b249],
5	had	VBD	O	have	aux	7	SENT_56	[p2l1418t194r1534b249],
6	been	VBN	O	be	auxpass	7	SENT_56	[p2l1572t194r1726b249],
7	observed	VBN	O	observe	_	0	SENT_56	[p2l1764t194r2054b249],
8	in	IN	O	in	_	0	SENT_56	[p2l2093t195r2152b249],
9	Thailand	NNP	LOCATION	Thailand	nn	12	SENT_56	[p2l6t283r288b338],
10	and	CC	O	and	_	0	SENT_56	[p2l319t283r436b338],
11	Taiwan	NNP	LOCATION	Taiwan	nn	12	SENT_56	[p2l465t284r702b338],
12	populations	NNS	O	population	prep_in	7	SENT_56	[p2l733t272r1206b351],
13	.5	CD	NUMBER	.5	dobj	7	SENT_56	[p2l733t272r1206b351],
14	'	''	O	'	_	0	SENT_56	[p2l733t272r1206b351],
15	5	CD	NUMBER	5	nsubj	21	SENT_56	[p2l733t272r1206b351],
16	However	RB	O	however	advmod	21	SENT_56	[p2l1238t286r1542b346],
17	,	,	O	,	_	0	SENT_56	[p2l1238t286r1542b346],
18	no	DT	O	no	det	20	SENT_56	[p2l1575t299r1652b338],
19	pertinent	JJ	O	pertinent	amod	20	SENT_56	[p2l1684t284r1985b351],
20	data	NNS	O	datum	nsubj	21	SENT_56	[p2l2015t283r2152b338],
21	exist	VBP	O	exist	rcmod	13	SENT_56	[p2l9t372r161b426],
22	in	IN	O	in	_	0	SENT_56	[p2l193t372r253b426],
23	mainland	NN	O	mainland	nn	24	SENT_56	[p2l285t371r589b426],
24	China	NNP	LOCATION	China	prep_in	21	SENT_56	[p2l623t371r805b426],
25	until	IN	O	until	prep	21	SENT_56	[p2l837t372r987b426],
26	recently	RB	DATE	recently	pcomp	25	SENT_56	[p2l1021t371r1298b440],
27	.	.	O	.	_	0	SENT_56	[p2l1021t371r1298b440],

1	In	IN	O	in	_	0	SENT_57	[p2l1332t375r1393b426],
2	the	DT	O	the	det	4	SENT_57	[p2l1424t371r1526b426],
3	present	JJ	DATE	present	amod	4	SENT_57	[p2l1559t380r1801b440],
4	study	NN	O	study	prep_in	7	SENT_57	[p2l1834t371r2026b440],
5	,	,	O	,	_	0	SENT_57	[p2l1834t371r2026b440],
6	we	PRP	O	we	nsubj	7	SENT_57	[p2l2058t387r2152b426],
7	report	VBP	O	report	_	0	SENT_57	[p2l10t469r208b529],
8	two	CD	NUMBER	two	num	11	SENT_57	[p2l225t469r347b516],
9	Chinese	JJ	MISC	chinese	amod	11	SENT_57	[p2l365t461r616b516],
10	Han	NN	O	han	nn	11	SENT_57	[p2l635t464r763b516],
11	cases	NNS	O	case	nsubj	15	SENT_57	[p2l780t477r945b516],
12	of	IN	O	of	_	0	SENT_57	[p2l965t461r1031b516],
13	PHT	NNP	O	PHT	nn	14	SENT_57	[p2l1042t461r1459b516],
14	—	NN	O	—	prep_of	11	SENT_57	[p2l1042t461r1459b516],
15	induced	VBD	O	induce	ccomp	7	SENT_57	[p2l1042t461r1459b516],
16	SJS	NNP	O	SJS	dobj	15	SENT_57	[p2l1478t464r1569b529],
17	who	WP	O	who	nsubj	18	SENT_57	[p2l1585t461r1725b516],
18	test	VBP	O	test	rcmod	16	SENT_57	[p2l1743t469r1862b516],
19	negative	JJ	O	negative	acomp	18	SENT_57	[p2l1880t462r2152b529],
20	for	IN	O	for	_	0	SENT_57	[p2l9t550r99b604],
21	HLA	NN	O	hlum	prep_for	18	SENT_57	[p2l125t550r518b604],
22	.	.	O	.	_	0	SENT_57	[p2l125t550r518b604],

1	—	NN	O	—	_	0	SENT_58	[p2l125t550r518b604],
2	.	.	O	.	_	0	SENT_58	[p2l125t550r518b604],

1	B	NN	O	b	_	0	SENT_59	[p2l125t550r518b604],
2	*	CD	NUMBER	*	num	1	SENT_59	[p2l125t550r518b604],
3	1502	CD	DATE	1502	num	4	SENT_59	[p2l125t550r518b604],
4	allele	NN	O	allele	dep	1	SENT_59	[p2l549t550r719b604],
5	and	CC	O	and	_	0	SENT_59	[p2l747t550r864b604],
6	review	VB	O	review	dep	1	SENT_59	[p2l893t551r1113b604],
7	the	DT	O	the	det	9	SENT_59	[p2l1138t550r1240b604],
8	related	JJ	O	related	amod	9	SENT_59	[p2l1270t550r1493b604],
9	literature	NN	O	literature	dobj	6	SENT_59	[p2l1523t550r1840b604],
10	.	.	O	.	_	0	SENT_59	[p2l1523t550r1840b604],

1	*	NN	O	*	_	0	SENT_60	[p2l54t791r73b810],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_60	[p2l108t792r488b846],
3	author	NN	O	author	dobj	2	SENT_60	[p2l509t792r692b836],
4	.	.	O	.	_	0	SENT_60	[p2l509t792r692b836],

1	Te1.	NNP	O	Te1.	_	0	SENT_61	[p2l714t792r820b836],
2	:	:	O	:	_	0	SENT_61	[p2l714t792r820b836],
3	+86 28 85423038	CD	NUMBER	+86 28 85423038	dep	1	SENT_61	[p2l1049t794r1325b842],[p2l848t794r941b835],
4	;	:	O	;	_	0	SENT_61	[p2l1049t794r1325b842],
5	fax	NN	O	fax	dep	1	SENT_61	[p2l1352t792r1444b836],
6	:	:	O	:	_	0	SENT_61	[p2l1352t792r1444b836],
7	+86 28 85423550	CD	NUMBER	+86 28 85423550	dep	5	SENT_61	[p2l1672t794r1945b836],[p2l1470t794r1564b835],
8	.	.	O	.	_	0	SENT_61	[p2l1672t794r1945b836],

1	E-mail	NN	O	e-mail	nn	2	SENT_62	[p2l109t870r272b913],
2	address	NN	O	address	_	0	SENT_62	[p2l293t870r495b914],
3	:	:	O	:	_	0	SENT_62	[p2l293t870r495b914],
4	zhoudong66@yahoo.de	NN	O	zhoudong66@yahoo.de	nn	8	SENT_62	[p2l519t870r1120b924],
5	(	CD	NUMBER	(	num	8	SENT_62	[p2l1143t870r1214b924],
6	D.	NNP	PERSON	D.	nn	8	SENT_62	[p2l1143t870r1214b924],
7	Zhou	NNP	PERSON	Zhou	nn	8	SENT_62	[p2l1237t870r1399b924],
8	)	NNP	O	)	dep	2	SENT_62	[p2l1237t870r1399b924],
9	.	.	O	.	_	0	SENT_62	[p2l1237t870r1399b924],

1	2	LS	NUMBER	2	_	0	SENT_63	[p2l10t1077r66b1130],
2	.	.	O	.	_	0	SENT_63	[p2l10t1077r66b1130],

1	Case	NNP	O	Case	_	0	SENT_64	[p2l105t1077r254b1129],
2	report	NN	O	report	dep	1	SENT_64	[p2l280t1082r494b1143],

1	2.1	CD	NUMBER	2.1	_	0	SENT_65	[p2l7t1256r113b1307],
2	.	.	O	.	_	0	SENT_65	[p2l7t1256r113b1307],

1	Case	NNP	O	Case	_	0	SENT_66	[p2l157t1256r293b1307],
2	1	CD	NUMBER	1	dep	1	SENT_66	[p2l328t1256r348b1306],

1	A	DT	O	a	det	4	SENT_67	[p2l110t1433r157b1485],
2	38-year-old	JJ	DURATION	38-year-old	amod	4	SENT_67	[p2l173t1431r553b1499],
3	Chinese	JJ	MISC	chinese	amod	4	SENT_67	[p2l574t1431r824b1486],
4	woman	NN	O	woman	nsubjpass	6	SENT_67	[p2l842t1447r1085b1486],
5	was	VBD	O	be	auxpass	6	SENT_67	[p2l1103t1447r1227b1486],
6	presented	VBN	O	present	_	0	SENT_67	[p2l1249t1431r1567b1500],
7	to	TO	O	to	_	0	SENT_67	[p2l1587t1439r1649b1486],
8	our	PRP$	O	we	poss	10	SENT_67	[p2l1669t1447r1778b1486],
9	emergency	NN	O	emergency	nn	10	SENT_67	[p2l1796t1447r2151b1499],
10	department	NN	O	department	prep_to	6	SENT_67	[p2l11t1520r392b1589],
11	due	JJ	O	due	_	0	SENT_67	[p2l427t1520r543b1575],
12	to	TO	O	to	_	0	SENT_67	[p2l579t1529r641b1575],
13	widespread	JJ	O	widespread	amod	15	SENT_67	[p2l675t1520r1050b1589],
14	skin	NN	O	skin	nn	15	SENT_67	[p2l1088t1520r1217b1575],
15	rashes	NNS	O	rash	prep_due_to	6	SENT_67	[p2l1254t1520r1456b1575],
16	and	CC	O	and	_	0	SENT_67	[p2l1493t1520r1609b1575],
17	high	JJ	O	high	amod	18	SENT_67	[p2l1647t1520r1787b1589],
18	fever	NN	O	fever	conj_and	15	SENT_67	[p2l1823t1520r1998b1576],
19	.	.	O	.	_	0	SENT_67	[p2l1823t1520r1998b1576],

1	The	DT	O	the	det	2	SENT_68	[p2l2033t1521r2150b1575],
2	patient	NN	O	patient	nsubj	3	SENT_68	[p2l11t1610r240b1678],
3	had	VBD	O	have	_	0	SENT_68	[p2l275t1609r391b1664],
4	a	DT	O	a	det	6	SENT_68	[p2l428t1625r460b1664],
5	5-year	JJ	DURATION	5-year	amod	6	SENT_68	[p2l499t1613r707b1678],
6	history	NN	O	history	dobj	3	SENT_68	[p2l742t1609r967b1678],
7	of	IN	O	of	_	0	SENT_68	[p2l1003t1609r1069b1664],
8	idiopathic	JJ	O	idiopathic	prep_of	6	SENT_68	[p2l1098t1609r1422b1678],
9	generalized	VBN	O	generalize	partmod	8	SENT_68	[p2l1457t1609r1829b1678],
10	epilepsy	NN	O	epilepsy	dobj	9	SENT_68	[p2l1867t1609r2148b1678],
11	.	.	O	.	_	0	SENT_68	[p2l1867t1609r2148b1678],

1	Sodium	NN	O	sodium	nn	2	SENT_69	[p2l11t1699r254b1754],
2	valproate	NN	O	valproate	nsubjpass	16	SENT_69	[p2l272t1699r577b1767],
3	(	CD	NUMBER	(	num	5	SENT_69	[p2l598t1699r779b1767],
4	VPA	NN	ORGANIZATION	vpa	nn	5	SENT_69	[p2l598t1699r779b1767],
5	)	NN	O	)	dep	2	SENT_69	[p2l598t1699r779b1767],
6	and	CC	O	and	_	0	SENT_69	[p2l799t1699r915b1754],
7	CBZ	NN	O	cbz	nn	8	SENT_69	[p2l937t1702r1059b1754],
8	(	NN	O	(	conj_and	2	SENT_69	[p2l1078t1699r1222b1767],
9	600	CD	NUMBER	600	num	10	SENT_69	[p2l1078t1699r1222b1767],
10	mg	NN	O	mg	dep	8	SENT_69	[p2l1245t1715r1345b1767],
11	daily	RB	SET	daily	advmod	10	SENT_69	[p2l1364t1699r1535b1767],
12	,	,	O	,	_	0	SENT_69	[p2l1364t1699r1535b1767],
13	respectively	RB	O	respectively	advmod	8	SENT_69	[p2l1557t1699r1971b1767],
14	)	CD	NUMBER	)	dep	8	SENT_69	[p2l1557t1699r1971b1767],
15	were	VBD	O	be	auxpass	16	SENT_69	[p2l1990t1715r2150b1754],
16	prescribed	VBN	O	prescribe	_	0	SENT_69	[p2l11t1788r348b1856],
17	since	IN	O	since	_	0	SENT_69	[p2l397t1789r558b1843],
18	2004	CD	DATE	2004	prep_since	16	SENT_69	[p2l604t1791r779b1843],
19	.	.	O	.	_	0	SENT_69	[p2l604t1791r779b1843],

1	The	DT	O	the	det	2	SENT_70	[p2l824t1788r941b1843],
2	number	NN	O	number	nsubjpass	8	SENT_70	[p2l989t1788r1244b1843],
3	of	IN	O	of	_	0	SENT_70	[p2l1289t1788r1355b1843],
4	epileptic	JJ	O	epileptic	amod	5	SENT_70	[p2l1394t1788r1673b1856],
5	seizures	NNS	O	seizure	prep_of	2	SENT_70	[p2l1719t1789r1977b1843],
6	was	VBD	O	be	auxpass	8	SENT_70	[p2l2024t1804r2148b1843],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_70	[p2l12t1876r408b1945],
8	reduced	VBN	O	reduce	_	0	SENT_70	[p2l439t1876r697b1931],
9	to	TO	O	to	aux	10	SENT_70	[p2l730t1884r792b1931],
10	about	IN	O	about	xcomp	8	SENT_70	[p2l825t1876r1009b1931],
11	one	CD	NUMBER	one	pobj	10	SENT_70	[p2l1042t1892r1156b1931],
12	in	IN	O	in	_	0	SENT_70	[p2l1190t1877r1249b1931],
13	every	DT	SET	every	det	14	SENT_70	[p2l1282t1892r1458b1945],
14	one	CD	SET	one	prep_in	10	SENT_70	[p2l1491t1892r1605b1931],
15	to	TO	SET	to	_	0	SENT_70	[p2l1638t1884r1700b1931],
16	two	CD	SET	two	num	17	SENT_70	[p2l1733t1884r1855b1931],
17	months	NNS	NUMBER	month	prep_to	8	SENT_70	[p2l1889t1876r2148b1932],
18	.	.	O	.	_	0	SENT_70	[p2l1889t1876r2148b1932],

1	Since	IN	O	since	_	0	SENT_71	[p2l11t1966r177b2021],
2	July	NNP	DATE	July	prep_since	8	SENT_71	[p2l196t1966r326b2034],
3	5	CD	DATE	5	num	2	SENT_71	[p2l353t1969r404b2029],
4	,	,	DATE	,	_	0	SENT_71	[p2l353t1969r404b2029],
5	2009	CD	DATE	2009	num	2	SENT_71	[p2l431t1968r589b2021],
6	CBZ	NNP	ORGANIZATION	CBZ	nsubjpass	8	SENT_71	[p2l618t1968r739b2021],
7	was	VBD	O	be	auxpass	8	SENT_71	[p2l763t1981r888b2021],
8	withdrawn	VBN	O	withdraw	_	0	SENT_71	[p2l914t1966r1274b2021],
9	due	JJ	O	due	acomp	8	SENT_71	[p2l1300t1966r1416b2021],
10	to	TO	O	to	_	0	SENT_71	[p2l1443t1974r1505b2021],
11	incomplete	JJ	O	incomplete	amod	13	SENT_71	[p2l1533t1966r1895b2034],
12	seizure	NN	O	seizure	nn	13	SENT_71	[p2l1922t1966r2150b2021],
13	control	NN	O	control	prep_to	9	SENT_71	[p2l11t2055r254b2118],
14	,	,	O	,	_	0	SENT_71	[p2l11t2055r254b2118],
15	and	CC	O	and	_	0	SENT_71	[p2l277t2054r393b2109],
16	PHT	NNP	O	PHT	acomp	8	SENT_71	[p2l417t2058r546b2109],
17	(	CD	NUMBER	(	num	16	SENT_71	[p2l566t2054r711b2123],
18	150	CD	NUMBER	150	num	20	SENT_71	[p2l566t2054r711b2123],
19	mg/day	JJ	O	mg/day	amod	20	SENT_71	[p2l733t2054r1000b2123],
20	)	NN	O	)	nsubjpass	22	SENT_71	[p2l733t2054r1000b2123],
21	was	VBD	O	be	auxpass	22	SENT_71	[p2l1022t2070r1146b2109],
22	introduced	VBN	O	introduce	rcmod	16	SENT_71	[p2l1170t2054r1521b2109],
23	into	IN	O	into	_	0	SENT_71	[p2l1545t2055r1669b2109],
24	her	PRP$	O	she	poss	25	SENT_71	[p2l1693t2054r1798b2109],
25	therapy	NN	O	therapy	prep_into	22	SENT_71	[p2l1818t2054r2067b2123],
26	to	TO	O	to	aux	27	SENT_71	[p2l2088t2063r2149b2109],
27	replace	VB	O	replace	infmod	25	SENT_71	[p2l11t2144r242b2212],
28	CBZ	NNP	O	CBZ	dobj	27	SENT_71	[p2l281t2147r417b2199],
29	.	.	O	.	_	0	SENT_71	[p2l281t2147r417b2199],

1	Unfortunately	RB	O	unfortunately	advmod	8	SENT_72	[p2l456t2144r925b2212],
2	,	,	O	,	_	0	SENT_72	[p2l456t2144r925b2212],
3	moderate	JJ	O	moderate	amod	4	SENT_72	[p2l965t2144r1273b2199],
4	fever	NN	O	fever	nsubj	8	SENT_72	[p2l1311t2144r1473b2199],
5	and	CC	O	and	_	0	SENT_72	[p2l1509t2144r1625b2199],
6	maculopapular	JJ	O	maculopapular	amod	7	SENT_72	[p2l1665t2144r2152b2212],
7	rashes	NNS	O	rash	conj_and	4	SENT_72	[p2l11t2233r213b2288],
8	occurred	VBD	O	occur	_	0	SENT_72	[p2l241t2233r523b2288],
9	all	DT	O	all	dobj	8	SENT_72	[p2l550t2233r624b2288],
10	over	IN	O	over	_	0	SENT_72	[p2l652t2249r793b2288],
11	the	DT	O	the	det	12	SENT_72	[p2l818t2233r919b2288],
12	cheeks	NNS	O	cheek	prep_over	8	SENT_72	[p2l947t2233r1161b2288],
13	and	CC	O	and	_	0	SENT_72	[p2l1190t2233r1306b2288],
14	arms	NNS	O	arm	prep_over	8	SENT_72	[p2l1334t2249r1490b2288],
15	of	IN	O	of	_	0	SENT_72	[p2l1519t2233r1585b2288],
16	the	DT	O	the	det	17	SENT_72	[p2l1604t2233r1705b2288],
17	patient	NN	O	patient	prep_of	12	SENT_72	[p2l1734t2234r1963b2301],
18	since	IN	O	since	_	0	SENT_72	[p2l1989t2234r2149b2288],
19	September	NNP	DATE	September	prep_since	8	SENT_72	[p2l11t2321r360b2390],
20	13	CD	DATE	13	num	19	SENT_72	[p2l410t2324r500b2385],
21	,	,	DATE	,	_	0	SENT_72	[p2l410t2324r500b2385],
22	2009	CD	DATE	2009	num	19	SENT_72	[p2l550t2324r725b2377],
23	.	.	O	.	_	0	SENT_72	[p2l550t2324r725b2377],

1	Starting	VBG	O	start	prep	10	SENT_73	[p2l776t2322r1031b2390],
2	from	IN	O	from	pcomp	1	SENT_73	[p2l1079t2321r1232b2376],
3	September	NNP	DATE	September	pobj	2	SENT_73	[p2l1282t2321r1631b2390],
4	15	CD	DATE	15	num	3	SENT_73	[p2l1681t2324r1771b2385],
5	,	,	DATE	,	_	0	SENT_73	[p2l1681t2324r1771b2385],
6	2009	CD	DATE	2009	num	3	SENT_73	[p2l1821t2324r1995b2385],
7	,	,	O	,	_	0	SENT_73	[p2l1821t2324r1995b2385],
8	her	PRP$	O	she	poss	9	SENT_73	[p2l2047t2321r2152b2376],
9	temperature	NN	O	temperature	nsubj	10	SENT_73	[p2l10t2418r414b2479],
10	reached	VBD	O	reach	_	0	SENT_73	[p2l448t2410r700b2465],
11	39.6	CD	NUMBER	39.6	num	12	SENT_73	[p2l733t2413r870b2466],
12	oC	NN	O	oc	dobj	10	SENT_73	[p2l893t2413r973b2474],
13	,	,	O	,	_	0	SENT_73	[p2l893t2413r973b2474],
14	and	CC	O	and	_	0	SENT_73	[p2l1007t2410r1124b2465],
15	blisters	NNS	O	blister	nsubj	16	SENT_73	[p2l1158t2410r1392b2465],
16	appeared	VBD	O	appear	conj_and	10	SENT_73	[p2l1426t2410r1723b2479],
17	on	IN	O	on	_	0	SENT_73	[p2l1758t2426r1836b2465],
18	her	PRP$	O	she	poss	19	SENT_73	[p2l1870t2410r1975b2465],
19	face	NN	O	face	prep_on	16	SENT_73	[p2l2007t2410r2148b2466],
20	.	.	O	.	_	0	SENT_73	[p2l2007t2410r2148b2466],

1	The	DT	O	the	det	2	SENT_74	[p2l8t2500r125b2555],
2	patient	NN	O	patient	nsubjpass	5	SENT_74	[p2l146t2500r375b2568],
3	was	VBD	O	be	auxpass	5	SENT_74	[p2l394t2515r518b2555],
4	then	RB	O	then	advmod	5	SENT_74	[p2l540t2500r685b2555],
5	admitted	VBN	O	admit	_	0	SENT_74	[p2l706t2500r998b2555],
6	to	TO	O	to	_	0	SENT_74	[p2l1019t2508r1081b2555],
7	the	DT	O	the	det	8	SENT_74	[p2l1102t2500r1204b2555],
8	Department	NNP	O	Department	prep_to	5	SENT_74	[p2l1225t2503r1615b2568],
9	of	IN	O	of	_	0	SENT_74	[p2l1634t2499r1701b2555],
10	Dermatology	NNP	O	Dermatology	prep_of	8	SENT_74	[p2l1715t2500r2149b2568],
11	.	.	O	.	_	0	SENT_74	[p2l1715t2500r2149b2568],

1	On	IN	O	on	_	0	SENT_75	[p2l113t2591r202b2643],
2	admission	NN	O	admission	prep_on	6	SENT_75	[p2l264t2588r608b2652],
3	,	,	O	,	_	0	SENT_75	[p2l264t2588r608b2652],
4	physical	JJ	O	physical	amod	5	SENT_75	[p2l672t2588r934b2657],
5	examination	NN	O	examination	nsubj	15	SENT_75	[p2l998t2589r1403b2643],
6	showed	VBD	O	show	_	0	SENT_75	[p2l1465t2588r1713b2643],
7	widespread	JJ	O	widespread	amod	9	SENT_75	[p2l1774t2588r2149b2657],
8	erythematous	JJ	O	erythematous	amod	9	SENT_75	[p2l11t2678r458b2746],
9	macules	NNS	O	macule	dobj	6	SENT_75	[p2l499t2678r761b2733],
10	and	CC	O	and	_	0	SENT_75	[p2l801t2678r917b2733],
11	papules	NNS	O	papule	dobj	6	SENT_75	[p2l957t2678r1203b2746],
12	with	IN	O	with	_	0	SENT_75	[p2l1242t2678r1390b2733],
13	blisters	NNS	O	blister	prep_with	6	SENT_75	[p2l1427t2678r1661b2733],
14	and	CC	O	and	_	0	SENT_75	[p2l1702t2678r1818b2733],
15	detached	VBN	O	detach	conj_and	6	SENT_75	[p2l1858t2678r2149b2733],
16	epidermis	NN	O	epidermis	dobj	15	SENT_75	[p2l11t2767r331b2835],
17	on	IN	O	on	_	0	SENT_75	[p2l372t2783r450b2822],
18	her	PRP$	O	she	poss	19	SENT_75	[p2l488t2767r594b2822],
19	face	NN	O	face	prep_on	15	SENT_75	[p2l631t2767r773b2830],
20	,	,	O	,	_	0	SENT_75	[p2l631t2767r773b2830],
21	neck	NN	O	neck	prep_on	15	SENT_75	[p2l813t2767r976b2830],
22	,	,	O	,	_	0	SENT_75	[p2l813t2767r976b2830],
23	trunk	NN	O	trunk	prep_on	15	SENT_75	[p2l1014t2767r1206b2830],
24	,	,	O	,	_	0	SENT_75	[p2l1014t2767r1206b2830],
25	feet	NNS	O	foot	conj_and	19	SENT_75	[p2l1246t2767r1380b2830],
26	,	,	O	,	_	0	SENT_75	[p2l1246t2767r1380b2830],
27	and	CC	O	and	_	0	SENT_75	[p2l1420t2767r1536b2822],
28	upper	JJ	O	upper	amod	29	SENT_75	[p2l1576t2783r1766b2835],
29	limbs	NNS	O	limb	conj_and	19	SENT_75	[p2l1803t2767r1994b2822],
30	.	.	O	.	_	0	SENT_75	[p2l1803t2767r1994b2822],

1	The	DT	O	the	det	4	SENT_76	[p2l2033t2767r2150b2822],
2	estimated	VBN	O	estimate	amod	4	SENT_76	[p2l11t2855r329b2910],
3	skin	NN	O	skin	nn	4	SENT_76	[p2l353t2855r483b2910],
4	detachment	NN	O	detachment	nsubj	8	SENT_76	[p2l506t2855r893b2910],
5	was	VBD	O	be	cop	8	SENT_76	[p2l913t2871r1037b2910],
6	approximately	RB	O	approximately	quantmod	7	SENT_76	[p2l1061t2855r1534b2924],
7	5	CD	PERCENT	5	num	8	SENT_76	[p2l1556t2858r1636b2910],
8	%	NN	PERCENT	%	_	0	SENT_76	[p2l1556t2858r1636b2910],
9	of	IN	O	of	_	0	SENT_76	[p2l1659t2855r1725b2910],
10	body	NN	O	body	nn	12	SENT_76	[p2l1739t2855r1899b2924],
11	surface	NN	O	surface	nn	12	SENT_76	[p2l1921t2855r2149b2910],
12	area	NN	O	area	prep_of	8	SENT_76	[p2l11t2960r161b2999],
13	.	.	O	.	_	0	SENT_76	[p2l11t2960r161b2999],

1	Scattered	VBN	O	scatter	csubjpass	14	SENT_77	[p2l198t2944r498b2998],
2	skin	NN	O	skin	nn	3	SENT_77	[p2l535t2944r665b2998],
3	rashes	NNS	O	rash	dobj	1	SENT_77	[p2l701t2944r903b2998],
4	on	IN	O	on	_	0	SENT_77	[p2l940t2960r1018b2998],
5	the	DT	O	the	det	7	SENT_77	[p2l1053t2944r1155b2998],
6	lower	JJR	O	lower	amod	7	SENT_77	[p2l1191t2944r1376b2998],
7	limbs	NNS	O	limb	prep_on	1	SENT_77	[p2l1410t2944r1584b2998],
8	and	CC	O	and	_	0	SENT_77	[p2l1622t2944r1738b2998],
9	diffuse	JJ	O	diffuse	amod	11	SENT_77	[p2l1775t2944r1992b2998],
10	oral	JJ	O	oral	amod	11	SENT_77	[p2l2028t2944r2149b2998],
11	ulcers	NNS	O	ulcer	prep_on	1	SENT_77	[p2l11t3033r200b3087],
12	were	VBD	O	be	auxpass	14	SENT_77	[p2l245t3048r405b3087],
13	also	RB	O	also	advmod	14	SENT_77	[p2l450t3032r574b3087],
14	observed	VBN	O	observe	_	0	SENT_77	[p2l621t3032r926b3088],
15	.	.	O	.	_	0	SENT_77	[p2l621t3032r926b3088],

1	Laboratory	NNP	O	Laboratory	nn	2	SENT_78	[p2l974t3032r1323b3101],
2	examinations	NNS	O	examination	nsubj	21	SENT_78	[p2l1367t3033r1802b3087],
3	including	VBG	O	include	_	0	SENT_78	[p2l1848t3032r2151b3101],
4	routine	JJ	O	routine	amod	6	SENT_78	[p2l11t3122r245b3176],
5	blood	NN	O	blood	nn	6	SENT_78	[p2l294t3121r473b3176],
6	chemistry	NN	O	chemistry	prep_including	2	SENT_78	[p2l525t3122r862b3190],
7	,	,	O	,	_	0	SENT_78	[p2l525t3122r862b3190],
8	abdominal	JJ	O	abdominal	amod	9	SENT_78	[p2l913t3121r1255b3176],
9	ultrasound	NN	O	ultrasound	appos	6	SENT_78	[p2l1306t3121r1656b3176],
10	scan	VB	O	scan	dep	9	SENT_78	[p2l1708t3137r1863b3185],
11	,	,	O	,	_	0	SENT_78	[p2l1708t3137r1863b3185],
12	thyroid	NN	O	thyroid	nn	13	SENT_78	[p2l1914t3121r2149b3190],
13	function	NN	O	function	conj_and	2	SENT_78	[p2l11t3211r295b3274],
14	,	,	O	,	_	0	SENT_78	[p2l11t3211r295b3274],
15	and	CC	O	and	_	0	SENT_78	[p2l348t3211r465b3266],
16	immunological	JJ	O	immunological	amod	17	SENT_78	[p2l519t3211r1004b3279],
17	inspection	NN	O	inspection	conj_and	2	SENT_78	[p2l1059t3212r1393b3279],
18	were	VBD	O	be	cop	21	SENT_78	[p2l1444t3227r1604b3266],
19	not	RB	O	not	neg	21	SENT_78	[p2l1658t3219r1763b3266],
20	signiﬁcant	JJ	O	signiﬁcant	amod	21	SENT_78	[p2l1816t3211r2151b3279],
21	abnormal	JJ	O	abnormal	_	0	SENT_78	[p2l11t3300r334b3355],
22	.	.	O	.	_	0	SENT_78	[p2l11t3300r334b3355],

1	The	DT	O	the	det	2	SENT_79	[p2l367t3300r484b3355],
2	patient	NN	O	patient	nsubjpass	4	SENT_79	[p2l519t3301r748b3368],
3	was	VBD	O	be	auxpass	4	SENT_79	[p2l779t3316r904b3355],
4	diagnosed	VBN	O	diagnose	_	0	SENT_79	[p2l939t3300r1266b3368],
5	as	IN	O	as	mark	8	SENT_79	[p2l1300t3316r1362b3355],
6	PHT	NNP	O	PHT	nn	7	SENT_79	[p2l1399t3300r1816b3355],
7	—	NN	O	—	nsubj	8	SENT_79	[p2l1399t3300r1816b3355],
8	induced	VBD	O	induce	advcl	4	SENT_79	[p2l1399t3300r1816b3355],
9	SJS	NNP	O	SJS	dobj	8	SENT_79	[p2l1851t3303r1957b3368],
10	.	.	O	.	_	0	SENT_79	[p2l1851t3303r1957b3368],

1	After	IN	O	after	_	0	SENT_80	[p2l1990t3300r2152b3355],

1	1059-1311	CD	DATE	1059-1311	_	0	SENT_81	[p2l344t3423r478b3443],
2	/	:	O	/	punct	1	SENT_81	[p2l483t3421r505b3449],
3	$	$	MONEY	$	nsubj	5	SENT_81	[p2l483t3421r505b3449],
4	—	CD	MONEY	—	num	3	SENT_81	[p2l517t3434r530b3437],
5	see	VBP	O	see	dep	1	SENT_81	[p2l542t3428r581b3443],
6	front	JJ	O	front	amod	7	SENT_81	[p2l592t3421r654b3443],
7	matter	NN	O	matter	nsubj	9	SENT_81	[p2l664t3425r750b3443],
8	©	CD	NUMBER	©	num	9	SENT_81	[p2l761t3425r780b3444],
9	2011	CD	DATE	2011	xcomp	5	SENT_81	[p2l792t3423r851b3443],
10	British	JJ	O	british	amod	12	SENT_81	[p2l866t3422r948b3443],
11	Epilepsy	NNP	ORGANIZATION	Epilepsy	nn	12	SENT_81	[p2l959t3422r1064b3449],
12	Association	NNP	ORGANIZATION	Association	dep	9	SENT_81	[p2l1074t3422r1224b3444],
13	.	.	O	.	_	0	SENT_81	[p2l1074t3422r1224b3444],

1	Published	VBN	O	publish	_	0	SENT_82	[p2l1236t3422r1358b3443],
2	by	IN	O	by	_	0	SENT_82	[p2l1370t3421r1400b3449],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	4	SENT_82	[p2l1411t3422r1509b3443],
4	Ltd.	NNP	ORGANIZATION	Ltd.	prep_by	1	SENT_82	[p2l1519t3422r1564b3444],
5	.	.	O	.	_	0	SENT_82	[p2l1519t3422r1564b3444],

1	All	DT	O	all	det	2	SENT_83	[p2l1575t3422r1608b3443],
2	rights	NNS	O	rights	nsubj	3	SENT_83	[p2l1620t3422r1691b3449],
3	reserved	VBN	O	reserve	_	0	SENT_83	[p2l1703t3422r1816b3444],
4	.	.	O	.	_	0	SENT_83	[p2l1703t3422r1816b3444],

1	doi	FW	O	doi	_	0	SENT_84	[p2l343t3457r772b3484],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_84	[p2l343t3457r772b3484],
3	/	:	O	/	punct	1	SENT_84	[p2l343t3457r772b3484],
4	j.	NN	O	j.	dep	1	SENT_84	[p2l343t3457r772b3484],
5	seizure	NN	O	seizure	prep	4	SENT_84	[p2l343t3457r772b3484],
6	.2011.01.005	CD	NUMBER	.2011.01.005	dep	5	SENT_84	[p2l343t3457r772b3484],

1	432	CD	NUMBER	432	_	0	SENT_85	[p2l408t3494r452b3515],
2	F.	NNP	O	F.	dep	1	SENT_85	[p2l1232t3494r1283b3515],
3	.	.	O	.	_	0	SENT_85	[p2l1232t3494r1283b3515],

1	—	NN	O	—	_	0	SENT_86	[p2l1232t3494r1283b3515],
2	.	.	O	.	_	0	SENT_86	[p2l1232t3494r1283b3515],

1	Y.	NNP	O	Y.	nn	2	SENT_87	[p2l1232t3494r1283b3515],
2	Hu	NNP	O	Hu	_	0	SENT_87	[p2l1294t3494r1328b3515],
3	et	FW	O	et	nn	4	SENT_87	[p2l1340t3496r1363b3515],
4	al.	FW	O	al.	dep	2	SENT_87	[p2l1372t3493r1504b3520],
5	/	:	O	/	punct	2	SENT_87	[p2l1372t3493r1504b3520],
6	Seizure	NN	O	seizure	dep	2	SENT_87	[p2l1372t3493r1504b3520],
7	20	CD	NUMBER	20	number	8	SENT_87	[p2l1513t3494r1544b3515],
8	(	CD	NUMBER	(	num	9	SENT_87	[p2l1554t3493r1635b3520],
9	2011	CD	DATE	2011	dep	6	SENT_87	[p2l1554t3493r1635b3520],
10	)	CD	NUMBER	)	number	11	SENT_87	[p2l1554t3493r1635b3520],
11	431-432	CD	NUMBER	431-432	num	9	SENT_87	[p2l1644t3494r1751b3515],

1	a	DT	O	a	det	4	SENT_88	[p3l10t77r42b116],
2	written	VBN	O	write	amod	4	SENT_88	[p3l81t62r321b116],
3	informed	VBN	O	inform	amod	4	SENT_88	[p3l362t61r657b116],
4	consent	NN	O	consent	nsubjpass	11	SENT_88	[p3l698t69r948b116],
5	was	VBD	O	be	auxpass	6	SENT_88	[p3l986t77r1110b116],
6	obtained	VBN	O	obtain	rcmod	4	SENT_88	[p3l1152t61r1450b124],
7	,	,	O	,	_	0	SENT_88	[p3l1152t61r1450b124],
8	genetic	JJ	O	genetic	amod	9	SENT_88	[p3l1490t62r1723b129],
9	testing	NN	O	testing	dobj	6	SENT_88	[p3l1763t62r1983b129],
10	was	VBD	O	be	auxpass	11	SENT_88	[p3l2021t77r2146b116],
11	performed	VBN	O	perform	_	0	SENT_88	[p3l11t149r348b218],
12	by	IN	O	by	_	0	SENT_88	[p3l370t149r448b218],
13	polymerase	NN	O	polymerase	nn	17	SENT_88	[p3l468t149r841b218],
14	chain	NN	O	chain	nn	17	SENT_88	[p3l863t149r1036b204],
15	reaction	NN	O	reaction	nn	17	SENT_88	[p3l1058t150r1319b204],
16	sequencing	NN	O	sequencing	nn	17	SENT_88	[p3l1341t149r1920b218],
17	—	NN	O	—	agent	11	SENT_88	[p3l1341t149r1920b218],
18	based	VBN	O	base	partmod	17	SENT_88	[p3l1341t149r1920b218],
19	typing	NN	O	typing	nn	21	SENT_88	[p3l1941t150r2148b218],
20	(	CD	NUMBER	(	num	21	SENT_88	[p3l10t238r331b306],
21	PCR	NN	O	pcr	dobj	18	SENT_88	[p3l10t238r331b306],
22	.	.	O	.	_	0	SENT_88	[p3l10t238r331b306],

1	—	NN	O	—	_	0	SENT_89	[p3l10t238r331b306],
2	.	.	O	.	_	0	SENT_89	[p3l10t238r331b306],

1	SBT	NN	O	sbt	_	0	SENT_90	[p3l10t238r331b306],
2	)	NN	O	)	nn	3	SENT_90	[p3l10t238r331b306],
3	method	NN	O	method	dep	1	SENT_90	[p3l378t238r642b293],
4	.	.	O	.	_	0	SENT_90	[p3l378t238r642b293],

1	HLA	NN	O	hlum	nsubj	6	SENT_91	[p3l690t240r822b292],
2	high	JJ	O	high	amod	5	SENT_91	[p3l866t238r1366b307],
3	—	NN	O	—	nn	5	SENT_91	[p3l866t238r1366b307],
4	resolution	NN	O	resolution	nn	5	SENT_91	[p3l866t238r1366b307],
5	genotyping	NN	O	genotyping	dep	1	SENT_91	[p3l1410t239r1775b307],
6	showed	VBD	O	show	_	0	SENT_91	[p3l1821t238r2068b293],
7	a	DT	O	a	det	9	SENT_91	[p3l2115t254r2147b293],
8	heterozygous	JJ	O	heterozygous	amod	9	SENT_91	[p3l11t327r442b396],
9	HLA	NN	O	hlum	dobj	6	SENT_91	[p3l469t327r855b382],
10	.	.	O	.	_	0	SENT_91	[p3l469t327r855b382],

1	—	NN	O	—	_	0	SENT_92	[p3l469t327r855b382],
2	.	.	O	.	_	0	SENT_92	[p3l469t327r855b382],

1	B	NN	O	b	nn	3	SENT_93	[p3l469t327r855b382],
2	*	CD	NUMBER	*	num	3	SENT_93	[p3l469t327r855b382],
3	460l	NN	O	460l	_	0	SENT_93	[p3l469t327r855b382],
4	/	:	O	/	punct	5	SENT_93	[p3l869t327r1122b396],
5	B	NN	O	b	dep	3	SENT_93	[p3l869t327r1122b396],
6	*	CD	NUMBER	*	num	8	SENT_93	[p3l869t327r1122b396],
7	5l02	NN	O	5l02	nn	8	SENT_93	[p3l869t327r1122b396],
8	allele	NN	O	allele	dep	5	SENT_93	[p3l1150t327r1335b383],
9	.	.	O	.	_	0	SENT_93	[p3l1150t327r1335b383],

1	After	IN	O	after	_	0	SENT_94	[p3l1359t327r1522b382],
2	being	VBG	O	be	auxpass	3	SENT_94	[p3l1544t327r1722b396],
3	treated	VBN	O	treat	prepc_after	15	SENT_94	[p3l1745t327r1974b382],
4	with	IN	O	with	_	0	SENT_94	[p3l1999t327r2147b382],
5	steroids	NNS	O	steroid	prep_with	3	SENT_94	[p3l11t416r262b471],
6	and	CC	O	and	_	0	SENT_94	[p3l319t416r435b471],
7	antihistamine	NN	O	antihistamine	prep_with	3	SENT_94	[p3l491t416r938b471],
8	for	IN	O	for	_	0	SENT_94	[p3l994t416r1083b471],
9	13	CD	DURATION	13	num	10	SENT_94	[p3l1140t419r1210b471],
10	days	NNS	NUMBER	day	prep_for	3	SENT_94	[p3l1269t416r1429b485],
11	,	,	O	,	_	0	SENT_94	[p3l1269t416r1429b485],
12	the	DT	O	the	det	13	SENT_94	[p3l1484t416r1586b471],
13	patient	NN	O	patient	nsubj	15	SENT_94	[p3l1642t417r1871b485],
14	greatly	RB	O	greatly	advmod	15	SENT_94	[p3l1923t416r2148b485],
15	improved	VBD	O	improve	_	0	SENT_94	[p3l11t506r319b574],
16	and	CC	O	and	_	0	SENT_94	[p3l348t506r464b561],
17	she	PRP	O	she	nsubjpass	19	SENT_94	[p3l494t506r599b561],
18	was	VBD	O	be	auxpass	19	SENT_94	[p3l626t522r750b561],
19	discharged	VBN	O	discharge	conj_and	15	SENT_94	[p3l780t506r1144b574],
20	.	.	O	.	_	0	SENT_94	[p3l780t506r1144b574],

1	2.2	CD	NUMBER	2.2	_	0	SENT_95	[p3l6t687r113b739],
2	.	.	O	.	_	0	SENT_95	[p3l6t687r113b739],

1	Case	NN	O	case	_	0	SENT_96	[p3l157t687r293b738],
2	2	CD	NUMBER	2	num	1	SENT_96	[p3l316t687r354b738],

1	A	DT	O	a	det	4	SENT_97	[p3l109t864r157b916],
2	63-year-old	JJ	DURATION	63-year-old	amod	4	SENT_97	[p3l177t861r555b930],
3	Chinese	JJ	MISC	chinese	amod	4	SENT_97	[p3l579t861r828b916],
4	man	NN	O	man	nsubjpass	17	SENT_97	[p3l851t877r1007b925],
5	,	,	O	,	_	0	SENT_97	[p3l851t877r1007b925],
6	with	IN	O	with	_	0	SENT_97	[p3l1028t861r1176b916],
7	a	DT	O	a	det	8	SENT_97	[p3l1198t877r1231b916],
8	history	NN	O	history	prep_with	4	SENT_97	[p3l1254t861r1479b930],
9	of	IN	O	of	_	0	SENT_97	[p3l1501t861r1567b916],
10	hypertension	NN	O	hypertension	nn	14	SENT_97	[p3l1583t861r2008b930],
11	and	CC	O	and	_	0	SENT_97	[p3l2030t861r2146b916],
12	cerebral	JJ	O	cerebral	nn	14	SENT_97	[p3l10t950r269b1005],
13	vascular	JJ	O	vascular	amod	14	SENT_97	[p3l306t950r575b1005],
14	accidents	NNS	O	accident	prep_of	8	SENT_97	[p3l612t950r927b1014],
15	,	,	O	,	_	0	SENT_97	[p3l612t950r927b1014],
16	was	VBD	O	be	auxpass	17	SENT_97	[p3l965t966r1090b1005],
17	admitted	VBN	O	admit	_	0	SENT_97	[p3l1129t950r1421b1005],
18	to	TO	O	to	_	0	SENT_97	[p3l1460t959r1521b1005],
19	our	PRP$	O	we	poss	20	SENT_97	[p3l1560t966r1669b1005],
20	hospital	NN	O	hospital	prep_to	17	SENT_97	[p3l1706t950r1962b1019],
21	with	IN	O	with	_	0	SENT_97	[p3l1999t950r2147b1005],
22	complaints	NNS	O	complaint	prep_with	17	SENT_97	[p3l10t1040r365b1108],
23	of	IN	O	of	_	0	SENT_97	[p3l392t1040r458b1095],
24	low	JJ	O	low	amod	27	SENT_97	[p3l477t1040r804b1108],
25	—	NN	O	—	nn	27	SENT_97	[p3l477t1040r804b1108],
26	grade	NN	O	grade	nn	27	SENT_97	[p3l477t1040r804b1108],
27	fever	NN	O	fever	prep_of	22	SENT_97	[p3l830t1040r991b1095],
28	and	CC	O	and	_	0	SENT_97	[p3l1014t1040r1131b1095],
29	erythema	NN	O	erythema	prep_of	22	SENT_97	[p3l1157t1040r1481b1108],
30	.	.	O	.	_	0	SENT_97	[p3l1157t1040r1481b1108],

1	The	DT	O	the	det	2	SENT_98	[p3l1504t1040r1621b1095],
2	patient	NN	O	patient	nsubjpass	6	SENT_98	[p3l1647t1041r1876b1108],
3	had	VBD	O	have	aux	6	SENT_98	[p3l1901t1040r2017b1095],
4	not	RB	O	not	neg	6	SENT_98	[p3l2043t1048r2148b1095],
5	been	VBN	O	be	auxpass	6	SENT_98	[p3l10t1129r163b1184],
6	diagnosed	VBN	O	diagnose	_	0	SENT_98	[p3l224t1129r549b1197],
7	with	IN	O	with	_	0	SENT_98	[p3l609t1129r757b1184],
8	hypertension	NN	O	hypertension	prep_with	6	SENT_98	[p3l817t1129r1243b1197],
9	until	IN	O	until	_	0	SENT_98	[p3l1303t1129r1452b1184],
10	the	DT	O	the	det	11	SENT_98	[p3l1512t1129r1615b1184],
11	occurrence	NN	O	occurrence	prep_until	6	SENT_98	[p3l1675t1145r2027b1184],
12	of	IN	O	of	_	0	SENT_98	[p3l2088t1129r2154b1184],
13	intracerebral	JJ	O	intracerebral	amod	14	SENT_98	[p3l11t1217r425b1272],
14	hemorrhage	NN	O	hemorrhage	prep_of	11	SENT_98	[p3l456t1217r847b1286],
15	due	JJ	O	due	_	0	SENT_98	[p3l877t1217r994b1272],
16	to	TO	O	to	_	0	SENT_98	[p3l1023t1225r1085b1272],
17	the	DT	O	the	det	18	SENT_98	[p3l1114t1217r1216b1272],
18	absence	NN	O	absence	prep_due_to	6	SENT_98	[p3l1246t1217r1501b1272],
19	of	IN	O	of	_	0	SENT_98	[p3l1531t1217r1597b1272],
20	routine	JJ	O	routine	amod	22	SENT_98	[p3l1620t1218r1853b1272],
21	physical	JJ	O	physical	amod	22	SENT_98	[p3l1884t1217r2146b1286],
22	examination	NN	O	examination	prep_of	18	SENT_98	[p3l10t1307r430b1361],
23	.	.	O	.	_	0	SENT_98	[p3l10t1307r430b1361],

1	Secondary	JJ	O	secondary	amod	2	SENT_99	[p3l468t1306r801b1375],
2	epilepsy	NN	O	epilepsy	nsubj	3	SENT_99	[p3l837t1306r1104b1375],
3	occurred	VBD	O	occur	_	0	SENT_99	[p3l1139t1306r1419b1361],
4	six	CD	DURATION	six	num	5	SENT_99	[p3l1458t1307r1546b1361],
5	months	NNS	NUMBER	month	tmod	3	SENT_99	[p3l1582t1306r1824b1361],
6	after	IN	O	after	_	0	SENT_99	[p3l1861t1306r2011b1361],
7	the	DT	O	the	det	9	SENT_99	[p3l2045t1306r2147b1361],
8	surgical	JJ	O	surgical	amod	9	SENT_99	[p3l11t1395r259b1464],
9	treatment	NN	O	treatment	prep_after	3	SENT_99	[p3l310t1404r634b1450],
10	of	IN	O	of	_	0	SENT_99	[p3l682t1395r748b1450],
11	the	DT	O	the	det	14	SENT_99	[p3l790t1395r891b1450],
12	left	JJ	O	left	amod	14	SENT_99	[p3l942t1395r1046b1450],
13	intracerebral	JJ	O	intracerebral	amod	14	SENT_99	[p3l1096t1395r1509b1450],
14	hemorrhage	NN	O	hemorrhage	prep_of	9	SENT_99	[p3l1561t1395r1968b1464],
15	.	.	O	.	_	0	SENT_99	[p3l1561t1395r1968b1464],

1	PHT	NNP	O	PHT	nsubjpass	7	SENT_100	[p3l2019t1399r2149b1450],
2	(	CD	NUMBER	(	num	1	SENT_100	[p3l10t1485r154b1553],
3	100	CD	NUMBER	100	num	5	SENT_100	[p3l10t1485r154b1553],
4	mg/day	JJ	O	mg/day	amod	5	SENT_100	[p3l177t1484r443b1553],
5	)	NN	O	)	dep	1	SENT_100	[p3l177t1484r443b1553],
6	was	VBD	O	be	auxpass	7	SENT_100	[p3l476t1500r600b1539],
7	administered	VBN	O	administer	_	0	SENT_100	[p3l635t1484r1062b1539],
8	since	IN	O	since	_	0	SENT_100	[p3l1098t1485r1258b1539],
9	the	DT	O	the	det	11	SENT_100	[p3l1292t1484r1394b1539],
10	ﬁrst	NN	O	ﬁrst	nn	11	SENT_100	[p3l1429t1484r1556b1539],
11	seizure	NN	O	seizure	prep_since	7	SENT_100	[p3l1590t1485r1833b1540],
12	.	.	O	.	_	0	SENT_100	[p3l1590t1485r1833b1540],

1	Unfortunately	RB	O	unfortunately	advmod	11	SENT_101	[p3l1867t1484r2146b1539, p3l11t1574r224b1642],
2	,	,	O	,	_	0	SENT_101	[p3l1867t1484r2146b1539, p3l11t1574r224b1642],
3	extensive	JJ	O	extensive	amod	5	SENT_101	[p3l247t1575r552b1629],
4	skin	NN	O	skin	nn	5	SENT_101	[p3l576t1574r705b1629],
5	rashes	NNS	O	rash	nsubj	11	SENT_101	[p3l728t1574r929b1629],
6	and	CC	O	and	_	0	SENT_101	[p3l954t1574r1070b1629],
7	low	JJ	O	low	amod	10	SENT_101	[p3l1094t1574r1421b1642],
8	—	NN	O	—	nn	10	SENT_101	[p3l1094t1574r1421b1642],
9	grade	NN	O	grade	nn	10	SENT_101	[p3l1094t1574r1421b1642],
10	fever	NN	O	fever	conj_and	5	SENT_101	[p3l1444t1574r1605b1629],
11	appeared	VBD	O	appear	_	0	SENT_101	[p3l1625t1574r1922b1642],
12	on	IN	O	on	_	0	SENT_101	[p3l1945t1590r2023b1629],
13	the	DT	O	the	det	15	SENT_101	[p3l2045t1574r2147b1629],
14	15th	JJ	ORDINAL	15th	amod	15	SENT_101	[p3l14t1663r158b1718],
15	day	NN	DURATION	day	prep_on	11	SENT_101	[p3l182t1663r296b1731],
16	after	IN	O	after	_	0	SENT_101	[p3l319t1663r470b1718],
17	the	DT	O	the	det	19	SENT_101	[p3l492t1663r593b1718],
18	antiepileptic	JJ	O	antiepileptic	amod	19	SENT_101	[p3l618t1663r1023b1731],
19	therapy	NN	O	therapy	prep_after	11	SENT_101	[p3l1047t1663r1310b1731],
20	.	.	O	.	_	0	SENT_101	[p3l1047t1663r1310b1731],

1	This	DT	O	this	nsubjpass	3	SENT_102	[p3l1333t1663r1466b1718],
2	was	VBD	O	be	auxpass	3	SENT_102	[p3l1490t1679r1614b1718],
3	followed	VBN	O	follow	_	0	SENT_102	[p3l1641t1663r1920b1718],
4	by	IN	O	by	_	0	SENT_102	[p3l1944t1663r2022b1731],
5	the	DT	O	the	det	6	SENT_102	[p3l2045t1663r2147b1718],
6	manifestation	NN	O	manifestation	agent	3	SENT_102	[p3l11t1751r457b1806],
7	of	IN	O	of	_	0	SENT_102	[p3l498t1751r564b1806],
8	blisters	NNS	O	blister	prep_of	6	SENT_102	[p3l596t1751r830b1806],
9	and	CC	O	and	_	0	SENT_102	[p3l872t1751r988b1806],
10	oral	JJ	O	oral	amod	11	SENT_102	[p3l1030t1751r1150b1806],
11	ulcers	NNS	O	ulcer	conj_and	8	SENT_102	[p3l1192t1751r1398b1807],
12	.	.	O	.	_	0	SENT_102	[p3l1192t1751r1398b1807],

1	Physical	JJ	O	physical	amod	2	SENT_103	[p3l1441t1751r1701b1820],
2	examination	NN	O	examination	nsubj	3	SENT_103	[p3l1742t1752r2147b1806],
3	showed	VBD	O	show	_	0	SENT_103	[p3l11t1840r258b1895],
4	widespread	JJ	O	widespread	amod	6	SENT_103	[p3l308t1840r682b1909],
5	erythematous	JJ	O	erythematous	amod	6	SENT_103	[p3l734t1840r1181b1909],
6	macules	NNS	O	macule	dobj	3	SENT_103	[p3l1233t1840r1495b1895],
7	with	IN	O	with	_	0	SENT_103	[p3l1546t1840r1694b1895],
8	blisters	NNS	O	blister	prep_with	3	SENT_103	[p3l1744t1840r1978b1895],
9	and	CC	O	and	_	0	SENT_103	[p3l2030t1840r2146b1895],
10	target	NN	O	target	prep_with	3	SENT_103	[p3l10t1929r346b1998],
11	—	CD	NUMBER	—	num	10	SENT_103	[p3l10t1929r346b1998],
12	like	IN	O	like	_	0	SENT_103	[p3l10t1929r346b1998],
13	lesions	NNS	O	lesion	prep_like	3	SENT_103	[p3l377t1929r596b1984],
14	on	IN	O	on	_	0	SENT_103	[p3l628t1945r706b1984],
15	his	PRP$	O	he	poss	16	SENT_103	[p3l736t1929r826b1984],
16	cheeks	NNS	O	cheek	prep_on	13	SENT_103	[p3l857t1929r1089b1993],
17	,	,	O	,	_	0	SENT_103	[p3l857t1929r1089b1993],
18	trunk	NN	O	trunk	conj_and	16	SENT_103	[p3l1119t1929r1310b1993],
19	,	,	O	,	_	0	SENT_103	[p3l1119t1929r1310b1993],
20	and	CC	O	and	_	0	SENT_103	[p3l1341t1929r1457b1984],
21	proximal	JJ	O	proximal	amod	22	SENT_103	[p3l1489t1929r1777b1998],
22	limbs	NNS	O	limb	prep_on	13	SENT_103	[p3l1809t1929r2000b1985],
23	.	.	O	.	_	0	SENT_103	[p3l1809t1929r2000b1985],

1	The	DT	O	the	det	3	SENT_104	[p3l2029t1929r2146b1984],
2	skin	NN	O	skin	nn	3	SENT_104	[p3l11t2018r140b2073],
3	detachment	NN	O	detachment	nsubj	7	SENT_104	[p3l184t2018r571b2073],
4	was	VBD	O	be	cop	7	SENT_104	[p3l611t2034r736b2073],
5	approximately	RB	O	approximately	quantmod	6	SENT_104	[p3l781t2018r1253b2087],
6	2	CD	PERCENT	2	num	7	SENT_104	[p3l1295t2021r1375b2073],
7	%	NN	PERCENT	%	_	0	SENT_104	[p3l1295t2021r1375b2073],
8	of	IN	O	of	_	0	SENT_104	[p3l1419t2018r1486b2073],
9	body	NN	O	body	nn	11	SENT_104	[p3l1521t2018r1680b2087],
10	surface	NN	O	surface	nn	11	SENT_104	[p3l1723t2018r1952b2073],
11	area	NN	O	area	prep_of	7	SENT_104	[p3l1995t2034r2145b2074],
12	.	.	O	.	_	0	SENT_104	[p3l1995t2034r2145b2074],

1	Numerous	JJ	O	numerous	amod	3	SENT_105	[p3l11t2111r344b2162],
2	oral	JJ	O	oral	amod	3	SENT_105	[p3l379t2108r500b2162],
3	ulcers	NNS	O	ulcer	nsubjpass	6	SENT_105	[p3l534t2108r723b2162],
4	were	VBD	O	be	auxpass	6	SENT_105	[p3l756t2124r916b2162],
5	also	RB	O	also	advmod	6	SENT_105	[p3l949t2108r1073b2162],
6	observed	VBN	O	observe	_	0	SENT_105	[p3l1108t2108r1413b2162],
7	.	.	O	.	_	0	SENT_105	[p3l1108t2108r1413b2162],

1	The	DT	O	the	det	2	SENT_106	[p3l1445t2108r1562b2162],
2	remainder	NN	O	remainder	nsubj	8	SENT_106	[p3l1596t2108r1933b2162],
3	of	IN	O	of	_	0	SENT_106	[p3l1964t2108r2030b2162],
4	his	PRP$	O	he	poss	6	SENT_106	[p3l2056t2108r2145b2162],
5	physical	JJ	O	physical	amod	6	SENT_106	[p3l11t2196r273b2264],
6	examination	NN	O	examination	prep_of	2	SENT_106	[p3l295t2197r700b2251],
7	was	VBD	O	be	cop	8	SENT_106	[p3l719t2212r844b2251],
8	normal	JJ	O	normal	_	0	SENT_106	[p3l867t2196r1112b2251],
9	.	.	O	.	_	0	SENT_106	[p3l867t2196r1112b2251],

1	Laboratory	NNP	O	Laboratory	nn	2	SENT_107	[p3l1135t2196r1484b2264],
2	examinations	NNS	O	examination	nsubj	3	SENT_107	[p3l1504t2197r1938b2251],
3	found	VBD	O	find	_	0	SENT_107	[p3l1961t2196r2146b2251],
4	no	DT	O	no	det	5	SENT_107	[p3l11t2300r88b2339],
5	evidence	NN	O	evidence	dobj	3	SENT_107	[p3l123t2284r407b2339],
6	of	IN	O	of	_	0	SENT_107	[p3l443t2284r509b2339],
7	internal	JJ	O	internal	amod	9	SENT_107	[p3l537t2284r788b2339],
8	organ	NN	O	organ	nn	9	SENT_107	[p3l824t2300r1006b2353],
9	involvement	NN	O	involvement	prep_of	5	SENT_107	[p3l1042t2284r1461b2340],
10	.	.	O	.	_	0	SENT_107	[p3l1042t2284r1461b2340],

1	Clinical	JJ	O	clinical	amod	2	SENT_108	[p3l1498t2284r1734b2339],
2	history	NN	O	history	_	0	SENT_108	[p3l1770t2284r1996b2353],
3	and	CC	O	and	_	0	SENT_108	[p3l2030t2284r2146b2339],
4	laboratory	NN	O	laboratory	nn	5	SENT_108	[p3l11t2373r345b2442],
5	tests	NNS	O	test	conj_and	2	SENT_108	[p3l396t2381r543b2428],
6	excluded	VBN	O	exclude	partmod	2	SENT_108	[p3l597t2373r886b2428],
7	other	JJ	O	other	amod	10	SENT_108	[p3l938t2373r1110b2428],
8	potential	JJ	O	potential	amod	10	SENT_108	[p3l1160t2373r1448b2442],
9	causative	JJ	O	causative	amod	10	SENT_108	[p3l1501t2374r1800b2428],
10	drugs	NNS	O	drug	dobj	6	SENT_108	[p3l1852t2373r2029b2442],
11	or	CC	O	or	_	0	SENT_108	[p3l2083t2389r2149b2428],
12	concomitant	JJ	O	concomitant	amod	13	SENT_108	[p3l10t2463r416b2517],
13	infections	NNS	O	infection	conj_or	10	SENT_108	[p3l442t2462r772b2526],
14	,	,	O	,	_	0	SENT_108	[p3l442t2462r772b2526],
15	including	VBG	O	include	prep	6	SENT_108	[p3l800t2462r1102b2531],
16	over	IN	O	over	pcomp	15	SENT_108	[p3l1127t2462r1682b2517],
17	—	CD	NUMBER	—	pobj	16	SENT_108	[p3l1127t2462r1682b2517],
18	the	DT	O	the	det	19	SENT_108	[p3l1127t2462r1682b2517],
19	—	NN	O	—	dep	21	SENT_108	[p3l1127t2462r1682b2517],
20	counter	NN	O	counter	dep	19	SENT_108	[p3l1127t2462r1682b2517],
21	drugs	NNS	O	drug	dep	2	SENT_108	[p3l1706t2462r1900b2531],
22	,	,	O	,	_	0	SENT_108	[p3l1706t2462r1900b2531],
23	NSAID	NN	O	nsaid	conj_and	21	SENT_108	[p3l1928t2465r2146b2526],
24	,	,	O	,	_	0	SENT_108	[p3l1928t2465r2146b2526],
25	antibiotics	NNS	O	antibiotic	conj_and	21	SENT_108	[p3l10t2551r347b2606],
26	and	CC	O	and	_	0	SENT_108	[p3l369t2551r485b2606],
27	HIV	NN	O	hiv	conj_and	21	SENT_108	[p3l506t2555r639b2607],
28	.	.	O	.	_	0	SENT_108	[p3l506t2555r639b2607],

1	The	DT	O	the	det	2	SENT_109	[p3l658t2551r775b2606],
2	patient	NN	O	patient	nsubjpass	4	SENT_109	[p3l796t2552r1024b2620],
3	was	VBD	O	be	auxpass	4	SENT_109	[p3l1042t2567r1166b2606],
4	diagnosed	VBN	O	diagnose	_	0	SENT_109	[p3l1188t2551r1513b2620],
5	as	IN	O	as	mark	8	SENT_109	[p3l1534t2567r1596b2606],
6	PHT	NNP	O	PHT	nn	7	SENT_109	[p3l1619t2551r2035b2606],
7	—	NN	O	—	nsubj	8	SENT_109	[p3l1619t2551r2035b2606],
8	induced	VBD	O	induce	advcl	4	SENT_109	[p3l1619t2551r2035b2606],
9	SJS	NN	O	sj	dobj	8	SENT_109	[p3l2056t2554r2146b2620],
10	by	IN	O	by	_	0	SENT_109	[p3l10t2641r87b2709],
11	two	CD	NUMBER	two	num	12	SENT_109	[p3l124t2649r246b2696],
12	dermatologist	NN	O	dermatologist	prep_by	8	SENT_109	[p3l284t2641r749b2709],
13	.	.	O	.	_	0	SENT_109	[p3l284t2641r749b2709],

1	HLA	NN	O	hlum	nn	2	SENT_110	[p3l789t2643r921b2695],
2	genotyping	NN	O	genotyping	nsubj	3	SENT_110	[p3l956t2642r1321b2709],
3	showed	VBD	O	show	_	0	SENT_110	[p3l1358t2641r1605b2696],
4	a	DT	O	a	det	6	SENT_110	[p3l1643t2657r1676b2696],
5	heterozygous	JJ	O	heterozygous	amod	6	SENT_110	[p3l1715t2641r2146b2709],
6	HLA	NN	O	hlum	dobj	3	SENT_110	[p3l11t2729r658b2798],
7	.	.	O	.	_	0	SENT_110	[p3l11t2729r658b2798],

1	—	NN	O	—	_	0	SENT_111	[p3l11t2729r658b2798],
2	.	.	O	.	_	0	SENT_111	[p3l11t2729r658b2798],

1	B	NN	O	b	_	0	SENT_112	[p3l11t2729r658b2798],
2	*	CD	NUMBER	*	num	3	SENT_112	[p3l11t2729r658b2798],
3	3701/B	NN	O	3701/b	dep	1	SENT_112	[p3l11t2729r658b2798],
4	*	CD	NUMBER	*	number	5	SENT_112	[p3l11t2729r658b2798],
5	4601	CD	NUMBER	4601	num	6	SENT_112	[p3l11t2729r658b2798],
6	allele	NN	O	allele	dep	3	SENT_112	[p3l694t2730r879b2785],
7	.	.	O	.	_	0	SENT_112	[p3l694t2730r879b2785],

1	3	LS	NUMBER	3	_	0	SENT_113	[p3l8t2911r65b2963],
2	.	.	O	.	_	0	SENT_113	[p3l8t2911r65b2963],

1	Discussion	NN	O	discussion	_	0	SENT_114	[p3l105t2908r466b2962],

1	SJS	NN	O	sj	nsubjpass	5	SENT_115	[p3l112t3089r203b3154],
2	and	CC	O	and	_	0	SENT_115	[p3l231t3086r347b3141],
3	TEN	CD	NUMBER	ten	nsubjpass	5	SENT_115	[p3l373t3089r503b3140],
4	are	VBP	O	be	auxpass	5	SENT_115	[p3l531t3102r628b3141],
5	characterized	VBN	O	characterize	_	0	SENT_115	[p3l657t3086r1091b3141],
6	by	IN	O	by	_	0	SENT_115	[p3l1119t3086r1196b3154],
7	rapidly	RB	O	rapidly	advmod	8	SENT_115	[p3l1224t3086r1451b3154],
8	expanding	VBG	O	expand	agent	5	SENT_115	[p3l1478t3086r1815b3154],
9	blistering	JJ	O	blistering	amod	10	SENT_115	[p3l1842t3086r2148b3154],
10	exanthema	NN	O	exanthema	dobj	8	SENT_115	[p3l10t3175r369b3230],
11	of	IN	O	of	_	0	SENT_115	[p3l397t3175r463b3230],
12	purpuric	JJ	O	purpuric	amod	13	SENT_115	[p3l483t3176r761b3243],
13	macules	NNS	O	macule	prep_of	10	SENT_115	[p3l788t3175r1050b3230],
14	and	CC	O	and	_	0	SENT_115	[p3l1078t3175r1195b3230],
15	target	NN	O	target	prep_of	10	SENT_115	[p3l1223t3175r1559b3243],
16	—	CD	NUMBER	—	num	15	SENT_115	[p3l1223t3175r1559b3243],
17	like	IN	O	like	_	0	SENT_115	[p3l1223t3175r1559b3243],
18	lesions	NNS	O	lesion	prep_like	8	SENT_115	[p3l1587t3175r1805b3230],
19	accompanied	VBN	O	accompany	partmod	18	SENT_115	[p3l1834t3191r2146b3243, p3l11t3262r147b3317],
20	by	IN	O	by	_	0	SENT_115	[p3l197t3262r274b3331],
21	mucosal	JJ	O	mucosal	amod	22	SENT_115	[p3l323t3262r588b3317],
22	involvement	NN	O	involvement	agent	19	SENT_115	[p3l639t3262r1045b3317],
23	and	CC	O	and	_	0	SENT_115	[p3l1093t3262r1209b3317],
24	skin	NN	O	skin	nn	25	SENT_115	[p3l1259t3262r1389b3317],
25	detachment	NN	O	detachment	agent	19	SENT_115	[p3l1438t3252r1869b3326],
26	,9	CD	NUMBER	,9	dobj	19	SENT_115	[p3l1438t3252r1869b3326],
27	with	IN	O	with	_	0	SENT_115	[p3l1918t3262r2066b3317],
28	a	DT	O	a	det	30	SENT_115	[p3l2115t3278r2147b3317],
29	mortality	NN	O	mortality	nn	30	SENT_115	[p3l11t3350r312b3419],
30	rate	NN	O	rate	prep_with	26	SENT_115	[p3l332t3358r455b3405],
31	that	WDT	O	that	nsubj	33	SENT_115	[p3l476t3350r606b3405],
32	can	MD	O	can	aux	33	SENT_115	[p3l625t3366r734b3405],
33	reach	VB	O	reach	rcmod	26	SENT_115	[p3l755t3350r929b3405],
34	up	RP	O	up	prt	33	SENT_115	[p3l949t3366r1029b3419],
35	to	TO	O	to	_	0	SENT_115	[p3l1050t3358r1111b3405],
36	40	CD	PERCENT	40	num	37	SENT_115	[p3l1131t3340r1332b3406],
37	%	NN	PERCENT	%	prep_to	33	SENT_115	[p3l1131t3340r1332b3406],
38	.	.	O	.	_	0	SENT_115	[p3l1131t3340r1332b3406],

1	“	NN	O	“	nsubjpass	9	SENT_116	[p3l1131t3340r1332b3406],
2	)	CD	NUMBER	)	num	1	SENT_116	[p3l1131t3340r1332b3406],
3	The	DT	O	the	det	5	SENT_116	[p3l1350t3350r1467b3405],
4	diagnostic	JJ	O	diagnostic	amod	5	SENT_116	[p3l1488t3350r1818b3419],
5	criteria	NNS	O	criterion	dep	1	SENT_116	[p3l1838t3351r2067b3405],
6	of	IN	O	of	_	0	SENT_116	[p3l2088t3350r2154b3405],
7	SJS/TEN	NNP	O	SJS/TEN	prep_of	1	SENT_116	[p3l11t3439r257b3508],
8	are	VBP	O	be	auxpass	9	SENT_116	[p3l278t3455r376b3495],
9	based	VBN	O	base	_	0	SENT_116	[p3l395t3440r578b3495],
10	on	IN	O	on	_	0	SENT_116	[p3l599t3455r677b3495],
11	the	DT	O	the	det	13	SENT_116	[p3l696t3440r798b3495],
12	clinical	JJ	O	clinical	amod	13	SENT_116	[p3l818t3440r1045b3495],
13	morphology	NN	O	morphology	prep_on	9	SENT_116	[p3l1066t3440r1473b3508],
14	.	.	O	.	_	0	SENT_116	[p3l1066t3440r1473b3508],

1	SJS	NN	O	sj	dep	99	SENT_117	[p3l1495t3442r1585b3508],
2	is	VBZ	O	be	dep	99	SENT_117	[p3l1605t3440r1652b3495],
3	deﬁned	VBN	O	deﬁned	dep	99	SENT_117	[p3l1674t3439r1913b3495],
4	as	IN	O	as	dep	99	SENT_117	[p3l1933t3455r1995b3495],
5	skin	NN	O	skin	dep	99	SENT_117	[p3l2018t3440r2147b3495],
6	detachment	NN	O	detachment	dep	99	SENT_117	[p3l10t3528r397b3583],
7	of	IN	O	of	dep	99	SENT_117	[p3l414t3528r480b3583],
8	less	JJR	O	less	dep	99	SENT_117	[p3l493t3528r608b3583],
9	than	IN	O	than	dep	99	SENT_117	[p3l627t3528r772b3583],
10	10	CD	PERCENT	10	dep	99	SENT_117	[p3l794t3531r912b3583],
11	%	NN	PERCENT	%	dep	99	SENT_117	[p3l794t3531r912b3583],
12	of	IN	O	of	dep	99	SENT_117	[p3l931t3528r997b3583],
13	body	NN	O	body	dep	99	SENT_117	[p3l1008t3528r1167b3597],
14	surface	NN	O	surface	dep	99	SENT_117	[p3l1185t3528r1413b3583],
15	area	NN	O	area	dep	99	SENT_117	[p3l1432t3544r1582b3592],
16	,	,	O	,	_	0	SENT_117	[p3l1432t3544r1582b3592],
17	an	DT	O	a	dep	99	SENT_117	[p3l1602t3544r1677b3583],
18	overlap	VBP	O	overlap	dep	99	SENT_117	[p3l1695t3528r1934b3597],
19	of	IN	O	of	dep	99	SENT_117	[p3l1953t3528r2019b3583],
20	S	NN	O	s	dep	99	SENT_117	[p3l2031t3528r2145b3597],
21	]	CD	NUMBER	]	dep	99	SENT_117	[p3l2031t3528r2145b3597],
22	S	NN	O	s	dep	99	SENT_117	[p3l2031t3528r2145b3597],
23	/	:	O	/	dep	99	SENT_117	[p3l2031t3528r2145b3597],
24	TEN	CD	NUMBER	ten	dep	99	SENT_117	[p3l8t3621r136b3672],
25	is	VBZ	O	be	dep	99	SENT_117	[p3l158t3619r205b3672],
26	deﬁned	VBN	O	deﬁned	dep	99	SENT_117	[p3l227t3618r466b3672],
27	as	IN	O	as	dep	99	SENT_117	[p3l486t3634r549b3672],
28	skin	NN	O	skin	dep	99	SENT_117	[p3l572t3618r701b3672],
29	detachment	NN	O	detachment	dep	99	SENT_117	[p3l721t3618r1107b3672],
30	of	IN	O	of	dep	99	SENT_117	[p3l1127t3618r1193b3672],
31	10-30	CD	PERCENT	10-30	dep	99	SENT_117	[p3l1209t3621r1449b3672],
32	%	NN	PERCENT	%	dep	99	SENT_117	[p3l1209t3621r1449b3672],
33	and	CC	O	and	dep	99	SENT_117	[p3l1469t3618r1586b3672],
34	TEN	CD	NUMBER	ten	dep	99	SENT_117	[p3l1604t3621r1734b3672],
35	is	VBZ	O	be	dep	99	SENT_117	[p3l1755t3619r1801b3672],
36	deﬁned	VBN	O	deﬁned	dep	99	SENT_117	[p3l1823t3618r2062b3672],
37	as	IN	O	as	dep	99	SENT_117	[p3l2082t3634r2145b3672],
38	skin	NN	O	skin	dep	99	SENT_117	[p4l11t28r140b83],
39	detachment	NN	O	detachment	dep	99	SENT_117	[p4l183t28r570b83],
40	of	IN	O	of	dep	99	SENT_117	[p4l611t28r677b83],
41	greater	JJR	O	greater	dep	99	SENT_117	[p4l712t36r943b96],
42	than	IN	O	than	dep	99	SENT_117	[p4l982t28r1127b83],
43	3O	CD	PERCENT	3o	dep	99	SENT_117	[p4l1169t18r1338b83],
44	%	NN	PERCENT	%	dep	99	SENT_117	[p4l1169t18r1338b83],
45	.9	CD	NUMBER	.9	dep	99	SENT_117	[p4l1169t18r1338b83],
46	In	IN	O	in	dep	99	SENT_117	[p4l1382t31r1442b82],
47	this	DT	O	this	dep	99	SENT_117	[p4l1484t28r1601b83],
48	study	NN	O	study	dep	99	SENT_117	[p4l1646t28r1837b96],
49	,	,	O	,	_	0	SENT_117	[p4l1646t28r1837b96],
50	the	DT	O	the	dep	99	SENT_117	[p4l1880t28r1982b83],
51	two	CD	NUMBER	two	dep	99	SENT_117	[p4l2024t36r2146b83],
52	patients	NNS	O	patient	dep	99	SENT_117	[p4l11t117r268b185],
53	met	VBD	O	meet	dep	99	SENT_117	[p4l293t124r418b171],
54	the	DT	O	the	dep	99	SENT_117	[p4l440t116r541b171],
55	diagnostic	JJ	O	diagnostic	dep	99	SENT_117	[p4l565t116r894b185],
56	criteria	NNS	O	criterion	dep	99	SENT_117	[p4l917t117r1146b171],
57	for	IN	O	for	dep	99	SENT_117	[p4l1170t116r1259b171],
58	PHT	NNP	O	PHT	dep	99	SENT_117	[p4l1280t116r1697b171],
59	—	NN	O	—	dep	99	SENT_117	[p4l1280t116r1697b171],
60	induced	VBD	O	induce	dep	99	SENT_117	[p4l1280t116r1697b171],
61	SJS	NNP	O	SJS	dep	99	SENT_117	[p4l1720t119r1810b185],
62	according	VBG	O	accord	dep	99	SENT_117	[p4l1834t116r2148b185],
63	to	TO	O	to	dep	99	SENT_117	[p4l10t212r71b259],
64	Roujeau	NNP	PERSON	Roujeau	dep	99	SENT_117	[p4l95t205r399b273],
65	’s	POS	O	’s	dep	99	SENT_117	[p4l95t205r399b273],
66	classiﬁcation	NN	O	classiﬁcation	dep	99	SENT_117	[p4l423t194r887b260],
67	.9	CD	NUMBER	.9	dep	99	SENT_117	[p4l423t194r887b260],
68	The	DT	O	the	dep	99	SENT_117	[p4l907t204r1024b259],
69	ﬁrst	NN	O	ﬁrst	dep	99	SENT_117	[p4l1047t204r1174b259],
70	case	NN	O	case	dep	99	SENT_117	[p4l1195t220r1329b259],
71	was	VBD	O	be	dep	99	SENT_117	[p4l1350t220r1475b259],
72	on	IN	O	on	dep	99	SENT_117	[p4l1498t220r1577b259],
73	two	CD	NUMBER	two	dep	99	SENT_117	[p4l1598t212r1720b259],
74	antiepileptic	JJ	O	antiepileptic	dep	99	SENT_117	[p4l1742t204r2148b273],
75	drugs	NNS	O	drug	dep	99	SENT_117	[p4l10t293r187b362],
76	(	VBP	O	(	dep	99	SENT_117	[p4l223t294r379b362],
77	PHT	NNP	ORGANIZATION	PHT	dep	99	SENT_117	[p4l223t294r379b362],
78	and	CC	O	and	dep	99	SENT_117	[p4l411t294r527b349],
79	VPA	NNP	ORGANIZATION	VPA	dep	99	SENT_117	[p4l559t294r731b362],
80	)	CD	NUMBER	)	dep	99	SENT_117	[p4l559t294r731b362],
81	,	,	O	,	_	0	SENT_117	[p4l559t294r731b362],
82	in	IN	O	in	dep	99	SENT_117	[p4l766t294r825b348],
83	which	WDT	O	which	dep	99	SENT_117	[p4l857t294r1055b349],
84	VPA	NNP	ORGANIZATION	VPA	dep	99	SENT_117	[p4l1086t296r1220b348],
85	was	VBD	O	be	dep	99	SENT_117	[p4l1249t309r1374b349],
86	continuously	RB	O	continuously	dep	99	SENT_117	[p4l1409t294r1830b362],
87	administrated	VBN	O	administrate	dep	99	SENT_117	[p4l1862t293r2147b349, p4l10t382r202b437],
88	for	IN	O	for	dep	99	SENT_117	[p4l223t382r311b437],
89	more	JJR	DURATION	more	dep	99	SENT_117	[p4l329t398r494b437],
90	than	IN	DURATION	than	dep	99	SENT_117	[p4l513t382r658b437],
91	four	CD	DURATION	four	dep	99	SENT_117	[p4l677t382r808b437],
92	years	NNS	NUMBER	year	dep	99	SENT_117	[p4l823t398r992b451],
93	and	CC	O	and	dep	99	SENT_117	[p4l1013t382r1129b437],
94	no	DT	O	no	dep	99	SENT_117	[p4l1149t398r1226b437],
95	adverse	JJ	O	adverse	dep	99	SENT_117	[p4l1245t382r1491b437],
96	drug	NN	O	drug	dep	99	SENT_117	[p4l1511t382r1659b451],
97	reactions	NNS	O	reaction	dep	99	SENT_117	[p4l1677t383r1969b437],
98	were	VBD	O	be	dep	99	SENT_117	[p4l1987t398r2147b437],
99	observed	VBN	O	observe	_	0	SENT_117	[p4l10t472r316b527],
100	.	.	O	.	_	0	SENT_117	[p4l10t472r316b527],

1	Other	JJ	O	other	amod	4	SENT_118	[p4l344t472r527b527],
2	potential	JJ	O	potential	amod	4	SENT_118	[p4l551t472r839b540],
3	causative	JJ	O	causative	amod	4	SENT_118	[p4l866t473r1166b527],
4	drugs	NNS	O	drug	nsubjpass	18	SENT_118	[p4l1193t472r1370b540],
5	or	CC	O	or	_	0	SENT_118	[p4l1398t488r1463b527],
6	infections	NNS	O	infection	nsubjpass	18	SENT_118	[p4l1488t472r1818b535],
7	,	,	O	,	_	0	SENT_118	[p4l1488t472r1818b535],
8	including	VBG	O	include	_	0	SENT_118	[p4l1846t472r2148b540],
9	NSAID	NN	O	nsaid	prep_including	4	SENT_118	[p4l11t562r229b622],
10	,	,	O	,	_	0	SENT_118	[p4l11t562r229b622],
11	antibiotics	NNS	O	antibiotic	prep_including	4	SENT_118	[p4l264t560r601b614],
12	and	CC	O	and	_	0	SENT_118	[p4l635t560r751b614],
13	HIV	NN	MISC	hiv	prep_including	4	SENT_118	[p4l787t563r919b622],
14	,	,	O	,	_	0	SENT_118	[p4l787t563r919b622],
15	have	VBP	O	have	aux	18	SENT_118	[p4l954t560r1103b614],
16	also	RB	O	also	advmod	18	SENT_118	[p4l1137t560r1261b614],
17	been	VBN	O	be	auxpass	18	SENT_118	[p4l1294t560r1448b614],
18	excluded	VBN	O	exclude	_	0	SENT_118	[p4l1482t560r1787b614],
19	.	.	O	.	_	0	SENT_118	[p4l1482t560r1787b614],

1	Therefore	RB	O	therefore	advmod	5	SENT_119	[p4l1819t560r2146b622],
2	,	,	O	,	_	0	SENT_119	[p4l1819t560r2146b622],
3	PHT	NNP	ORGANIZATION	PHT	nsubjpass	5	SENT_119	[p4l11t651r140b702],
4	was	VBD	O	be	auxpass	5	SENT_119	[p4l159t663r283b702],
5	identiﬁed	VBN	O	identiﬁed	_	0	SENT_119	[p4l308t647r615b702],
6	as	IN	O	as	_	0	SENT_119	[p4l638t663r700b702],
7	the	DT	O	the	det	9	SENT_119	[p4l724t647r826b702],
8	culprit	NN	O	culprit	nn	9	SENT_119	[p4l848t647r1060b716],
9	agent	NN	O	agent	prep_as	5	SENT_119	[p4l1081t655r1273b716],
10	,	,	O	,	_	0	SENT_119	[p4l1081t655r1273b716],
11	although	IN	O	although	mark	14	SENT_119	[p4l1296t647r1583b716],
12	it	PRP	O	it	nsubj	14	SENT_119	[p4l1605t648r1649b702],
13	is	VBZ	O	be	cop	14	SENT_119	[p4l1671t648r1717b702],
14	unusual	JJ	O	unusual	advcl	5	SENT_119	[p4l1741t647r1996b702],
15	that	IN	O	that	complm	17	SENT_119	[p4l2019t647r2148b702],
16	SJS	NN	O	sj	nsubj	17	SENT_119	[p4l11t739r100b805],
17	occurred	VBD	O	occur	ccomp	14	SENT_119	[p4l132t736r413b791],
18	after	IN	O	after	_	0	SENT_119	[p4l444t736r594b791],
19	taking	VBG	O	take	prepc_after	17	SENT_119	[p4l622t736r824b805],
20	the	DT	O	the	det	21	SENT_119	[p4l853t736r955b791],
21	medication	NN	O	medication	dobj	19	SENT_119	[p4l986t736r1348b791],
22	for	IN	O	for	_	0	SENT_119	[p4l1378t736r1467b791],
23	over	IN	O	over	amod	25	SENT_119	[p4l1496t752r1636b791],
24	2	CD	DURATION	2	num	25	SENT_119	[p4l1665t739r1699b791],
25	months	NNS	NUMBER	month	prep_for	21	SENT_119	[p4l1733t736r1992b792],
26	.	.	O	.	_	0	SENT_119	[p4l1733t736r1992b792],

1	It	PRP	O	it	nsubj	3	SENT_120	[p4l2024t740r2069b791],
2	is	VBZ	O	be	cop	3	SENT_120	[p4l2099t737r2145b791],
3	worth	JJ	O	worth	_	0	SENT_120	[p4l9t825r204b881],
4	noting	VBG	O	note	xcomp	3	SENT_120	[p4l236t826r443b894],
5	that	IN	O	that	complm	18	SENT_120	[p4l473t826r617b889],
6	,	,	O	,	_	0	SENT_120	[p4l473t826r617b889],
7	when	WRB	O	when	advmod	8	SENT_120	[p4l648t826r828b881],
8	combined	VBN	O	combine	advcl	18	SENT_120	[p4l859t826r1177b881],
9	treatment	NN	O	treatment	dobj	8	SENT_120	[p4l1209t834r1532b881],
10	with	IN	O	with	_	0	SENT_120	[p4l1561t826r1710b881],
11	VPA	NN	ORGANIZATION	vpa	prep_with	8	SENT_120	[p4l1738t828r1885b889],
12	,	,	O	,	_	0	SENT_120	[p4l1738t828r1885b889],
13	plasma	NN	O	plasma	nn	14	SENT_120	[p4l1918t826r2147b894],
14	concentration	NN	O	concentration	nsubj	18	SENT_120	[p4l10t915r458b969],
15	of	IN	O	of	_	0	SENT_120	[p4l514t914r580b969],
16	PHT	NNP	ORGANIZATION	PHT	prep_of	14	SENT_120	[p4l630t918r760b969],
17	may	MD	O	may	aux	18	SENT_120	[p4l815t930r953b983],
18	have	VB	O	have	ccomp	4	SENT_120	[p4l1009t914r1158b969],
19	a	DT	O	a	det	21	SENT_120	[p4l1215t930r1247b969],
20	larger	JJR	O	larger	amod	21	SENT_120	[p4l1305t914r1493b983],
21	change	NN	O	change	dobj	18	SENT_120	[p4l1547t914r1773b983],
22	owing	VBG	O	owe	partmod	21	SENT_120	[p4l1830t915r2029b983],
23	to	TO	O	to	_	0	SENT_120	[p4l2085t923r2146b969],
24	competitive	JJ	O	competitive	amod	25	SENT_120	[p4l10t1005r394b1072],
25	binding	NN	O	binding	prep_to	22	SENT_120	[p4l456t1004r703b1072],
26	with	IN	O	with	_	0	SENT_120	[p4l763t1004r912b1059],
27	the	DT	O	the	det	28	SENT_120	[p4l974t1004r1075b1059],
28	protein	NN	O	protein	prep_with	22	SENT_120	[p4l1139t1005r1372b1072],
29	between	IN	O	between	_	0	SENT_120	[p4l1434t1004r1711b1059],
30	drugs	NNS	O	drug	prep_between	28	SENT_120	[p4l1774t1004r1968b1072],
31	.	.	O	.	_	0	SENT_120	[p4l1774t1004r1968b1072],

1	The	DT	O	the	det	2	SENT_121	[p4l2029t1004r2146b1059],
2	interactions	NNS	O	interaction	nsubj	8	SENT_121	[p4l11t1094r393b1148],
3	between	IN	O	between	_	0	SENT_121	[p4l436t1093r713b1148],
4	drugs	NNS	O	drug	prep_between	2	SENT_121	[p4l756t1093r933b1161],
5	may	MD	O	may	aux	8	SENT_121	[p4l977t1109r1114b1161],
6	be	VB	O	be	cop	8	SENT_121	[p4l1155t1093r1229b1148],
7	partly	RB	O	partly	advmod	8	SENT_121	[p4l1272t1093r1463b1161],
8	responsible	JJ	O	responsible	_	0	SENT_121	[p4l1505t1093r1873b1161],
9	for	IN	O	for	_	0	SENT_121	[p4l1916t1093r2005b1148],
10	the	DT	O	the	det	12	SENT_121	[p4l2045t1093r2147b1148],
11	delayed	VBN	O	delay	amod	12	SENT_121	[p4l10t1181r259b1250],
12	development	NN	O	development	prep_for	8	SENT_121	[p4l283t1181r708b1250],
13	of	IN	O	of	_	0	SENT_121	[p4l730t1181r796b1236],
14	SJS	NNP	O	SJS	prep_of	12	SENT_121	[p4l812t1184r918b1250],
15	,	,	O	,	_	0	SENT_121	[p4l812t1184r918b1250],
16	but	CC	O	but	_	0	SENT_121	[p4l942t1181r1049b1236],
17	this	DT	O	this	det	18	SENT_121	[p4l1071t1181r1187b1236],
18	need	NN	O	need	nsubj	22	SENT_121	[p4l1213t1181r1365b1236],
19	to	TO	O	to	aux	21	SENT_121	[p4l1388t1189r1450b1236],
20	be	VB	O	be	cop	21	SENT_121	[p4l1473t1181r1547b1236],
21	further	JJ	O	further	infmod	18	SENT_121	[p4l1571t1181r1798b1236],
22	conﬁrmed	VBN	O	conﬁrmed	conj_but	8	SENT_121	[p4l1818t1181r2146b1236],
23	in	IN	O	in	_	0	SENT_121	[p4l11t1271r70b1324],
24	future	NN	DATE	future	prep_in	22	SENT_121	[p4l99t1270r310b1325],
25	.	.	O	.	_	0	SENT_121	[p4l99t1270r310b1325],

1	Owing	VBG	O	owe	partmod	15	SENT_122	[p4l112t1359r322b1427],
2	to	TO	O	to	_	0	SENT_122	[p4l351t1367r413b1413],
3	the	DT	O	the	det	5	SENT_122	[p4l444t1358r545b1413],
4	similar	JJ	O	similar	amod	5	SENT_122	[p4l577t1358r800b1413],
5	structure	NN	O	structure	prep_to	1	SENT_122	[p4l829t1367r1122b1413],
6	between	IN	O	between	_	0	SENT_122	[p4l1151t1358r1429b1413],
7	PHT	NNP	ORGANIZATION	PHT	prep_between	5	SENT_122	[p4l1460t1362r1589b1413],
8	and	CC	O	and	_	0	SENT_122	[p4l1617t1358r1733b1413],
9	CBZ	NNP	ORGANIZATION	CBZ	prep_between	5	SENT_122	[p4l1765t1361r1900b1422],
10	,	,	O	,	_	0	SENT_122	[p4l1765t1361r1900b1422],
11	the	DT	O	the	det	13	SENT_122	[p4l1931t1358r2033b1413],
12	US	NNP	LOCATION	US	nn	13	SENT_122	[p4l2063t1361r2146b1413],
13	FDA	NNP	ORGANIZATION	FDA	nsubj	15	SENT_122	[p4l11t1450r141b1502],
14	is	VBZ	O	be	aux	15	SENT_122	[p4l158t1448r205b1502],
15	investigating	VBG	O	investigate	_	0	SENT_122	[p4l225t1448r644b1516],
16	the	DT	O	the	det	18	SENT_122	[p4l661t1447r762b1502],
17	genetic	JJ	O	genetic	amod	18	SENT_122	[p4l780t1448r1013b1516],
18	link	NN	O	link	dobj	15	SENT_122	[p4l1031t1447r1152b1502],
19	with	IN	O	with	_	0	SENT_122	[p4l1168t1447r1316b1502],
20	PHT	NNP	O	PHT	nn	25	SENT_122	[p4l1335t1447r1751b1502],
21	—	NN	O	—	nn	25	SENT_122	[p4l1335t1447r1751b1502],
22	induced	VBD	O	induce	amod	25	SENT_122	[p4l1335t1447r1751b1502],
23	serious	JJ	O	serious	amod	25	SENT_122	[p4l1771t1448r1997b1502],
24	skin	NN	O	skin	nn	25	SENT_122	[p4l2018t1447r2147b1502],
25	reactions	NNS	O	reaction	prep_with	15	SENT_122	[p4l10t1538r318b1600],
26	,	,	O	,	_	0	SENT_122	[p4l10t1538r318b1600],
27	including	VBG	O	include	_	0	SENT_122	[p4l344t1537r646b1605],
28	SJS	NNP	O	SJS	prep_including	25	SENT_122	[p4l668t1540r758b1605],
29	and	CC	O	and	_	0	SENT_122	[p4l782t1537r899b1592],
30	TEN	NNP	NUMBER	TEN	prep_including	25	SENT_122	[p4l920t1540r1065b1592],
31	.	.	O	.	_	0	SENT_122	[p4l920t1540r1065b1592],

1	While	IN	O	while	mark	5	SENT_123	[p4l1088t1537r1281b1592],
2	insufﬁcient	JJ	O	insufﬁcient	amod	3	SENT_123	[p4l1306t1537r1669b1592],
3	information	NN	O	information	nsubj	5	SENT_123	[p4l1691t1537r2075b1592],
4	is	VBZ	O	be	cop	5	SENT_123	[p4l2099t1538r2145b1592],
5	available	JJ	O	available	_	0	SENT_123	[p4l10t1625r296b1680],
6	to	TO	O	to	aux	7	SENT_123	[p4l321t1633r383b1680],
7	recommend	VB	O	recommend	xcomp	5	SENT_123	[p4l410t1625r796b1680],
8	testing	NN	O	testing	dobj	7	SENT_123	[p4l822t1626r1043b1694],
9	for	IN	O	for	_	0	SENT_123	[p4l1068t1625r1157b1680],
10	HLA	NN	O	hlum	prep_for	7	SENT_123	[p4l1181t1625r1573b1680],
11	.	.	O	.	_	0	SENT_123	[p4l1181t1625r1573b1680],

1	—	NN	O	—	_	0	SENT_124	[p4l1181t1625r1573b1680],
2	.	.	O	.	_	0	SENT_124	[p4l1181t1625r1573b1680],

1	B	NN	O	b	ccomp	16	SENT_125	[p4l1181t1625r1573b1680],
2	*	CD	NUMBER	*	number	3	SENT_125	[p4l1181t1625r1573b1680],
3	1502	CD	DATE	1502	dobj	1	SENT_125	[p4l1181t1625r1573b1680],
4	in	IN	O	in	_	0	SENT_125	[p4l1602t1626r1661b1680],
5	Asian	JJ	LOCATION	asian	amod	6	SENT_125	[p4l1684t1626r1861b1680],
6	patients	NNS	O	patient	prep_in	3	SENT_125	[p4l1888t1626r2145b1694],
7	in	IN	O	in	_	0	SENT_125	[p4l10t1715r70b1768],
8	line	NN	O	line	prep_in	1	SENT_125	[p4l92t1714r209b1769],
9	for	IN	O	for	_	0	SENT_125	[p4l232t1714r321b1769],
10	PHT	NNP	ORGANIZATION	PHT	nn	11	SENT_125	[p4l342t1717r471b1768],
11	treatment	NN	O	treatment	prep_for	8	SENT_125	[p4l491t1722r829b1777],
12	,	,	O	,	_	0	SENT_125	[p4l491t1722r829b1777],
13	physicians	NNS	O	physician	nsubjpass	16	SENT_125	[p4l852t1714r1189b1783],
14	are	VBP	O	be	auxpass	16	SENT_125	[p4l1212t1730r1310b1769],
15	still	RB	O	still	advmod	16	SENT_125	[p4l1333t1714r1449b1769],
16	advised	VBN	O	advise	_	0	SENT_125	[p4l1472t1714r1715b1769],
17	to	TO	O	to	aux	18	SENT_125	[p4l1738t1722r1800b1769],
18	avoid	VB	O	avoid	xcomp	16	SENT_125	[p4l1823t1714r1996b1769],
19	PHT	NNP	ORGANIZATION	PHT	dobj	18	SENT_125	[p4l2019t1717r2148b1768],
20	and	CC	O	and	_	0	SENT_125	[p4l10t1803r126b1858],
21	fosphenytoin	NN	O	fosphenytoin	conj_and	19	SENT_125	[p4l157t1803r580b1872],
22	as	IN	O	as	_	0	SENT_125	[p4l609t1819r672b1858],
23	alternatives	NNS	O	alternative	prep_as	18	SENT_125	[p4l703t1803r1081b1858],
24	to	TO	O	to	_	0	SENT_125	[p4l1111t1812r1173b1858],
25	CBZ	NN	ORGANIZATION	cbz	nn	26	SENT_125	[p4l1203t1806r1325b1858],
26	therapy	NN	O	therapy	prep_to	23	SENT_125	[p4l1353t1803r1602b1872],
27	in	IN	O	in	_	0	SENT_125	[p4l1631t1804r1690b1858],
28	patients	NNS	O	patient	prep_in	26	SENT_125	[p4l1720t1804r1977b1872],
29	who	WP	O	who	nsubj	30	SENT_125	[p4l2006t1803r2146b1858],
30	test	VBP	O	test	rcmod	28	SENT_125	[p4l9t1900r128b1946],
31	positive	JJ	O	positive	acomp	30	SENT_125	[p4l150t1892r402b1960],
32	for	IN	O	for	_	0	SENT_125	[p4l426t1891r515b1946],
33	the	DT	O	the	det	34	SENT_125	[p4l535t1891r636b1946],
34	HLA	NN	O	hlum	prep_for	30	SENT_125	[p4l660t1891r1052b1946],
35	.	.	O	.	_	0	SENT_125	[p4l660t1891r1052b1946],

1	—	NN	O	—	_	0	SENT_126	[p4l660t1891r1052b1946],
2	.	.	O	.	_	0	SENT_126	[p4l660t1891r1052b1946],

1	B	NN	O	b	_	0	SENT_127	[p4l660t1891r1052b1946],
2	*	CD	NUMBER	*	number	3	SENT_127	[p4l660t1891r1052b1946],
3	1502	CD	DATE	1502	dep	1	SENT_127	[p4l660t1891r1052b1946],
4	allele	NN	O	allele	dep	3	SENT_127	[p4l1077t1882r1319b1947],
5	.	.	O	.	_	0	SENT_127	[p4l1077t1882r1319b1947],

1	“	NN	O	“	nn	3	SENT_128	[p4l1077t1882r1319b1947],
2	Previous	JJ	O	previous	amod	3	SENT_128	[p4l1348t1892r1620b1946],
3	studies	NNS	O	study	nsubj	9	SENT_128	[p4l1645t1892r1871b1946],
4	in	IN	O	in	_	0	SENT_128	[p4l1896t1892r1955b1946],
5	Hong	NNP	LOCATION	Hong	nn	6	SENT_128	[p4l1978t1895r2148b1960],
6	Kong	NNP	LOCATION	Kong	prep_in	3	SENT_128	[p4l10t1984r173b2049],
7	and	CC	O	and	_	0	SENT_128	[p4l192t1981r309b2036],
8	Thailand	NNP	LOCATION	Thailand	prep_in	3	SENT_128	[p4l328t1981r609b2036],
9	observed	VBD	O	observe	_	0	SENT_128	[p4l631t1981r920b2036],
10	a	DT	O	a	det	12	SENT_128	[p4l942t1997r974b2036],
11	100	CD	PERCENT	100	number	12	SENT_128	[p4l999t1984r1157b2036],
12	%	NN	PERCENT	%	dobj	9	SENT_128	[p4l999t1984r1157b2036],
13	positive	JJ	O	positive	amod	12	SENT_128	[p4l1179t1982r1431b2049],
14	for	IN	O	for	_	0	SENT_128	[p4l1453t1981r1542b2036],
15	HLA	NN	O	hlum	prep_for	12	SENT_128	[p4l1561t1981r1953b2036],
16	.	.	O	.	_	0	SENT_128	[p4l1561t1981r1953b2036],

1	—	NN	O	—	_	0	SENT_129	[p4l1561t1981r1953b2036],
2	.	.	O	.	_	0	SENT_129	[p4l1561t1981r1953b2036],

1	B	NN	O	b	nsubj	29	SENT_130	[p4l1561t1981r1953b2036],
2	*	CD	NUMBER	*	number	3	SENT_130	[p4l1561t1981r1953b2036],
3	1502	CD	DATE	1502	num	4	SENT_130	[p4l1561t1981r1953b2036],
4	allele	NN	O	allele	nsubj	10	SENT_130	[p4l1977t1981r2146b2036],
5	among	IN	O	among	_	0	SENT_130	[p4l10t2085r230b2137],
6	patients	NNS	O	patient	prep_among	4	SENT_130	[p4l257t2070r515b2137],
7	with	IN	O	with	_	0	SENT_130	[p4l543t2069r691b2124],
8	PHT	NN	O	pht	nn	9	SENT_130	[p4l720t2069r1137b2124],
9	—	NN	O	—	prep_with	6	SENT_130	[p4l720t2069r1137b2124],
10	induced	VBD	O	induce	rcmod	1	SENT_130	[p4l720t2069r1137b2124],
11	S	NN	O	s	iobj	10	SENT_130	[p4l1166t2059r1346b2137],
12	]	CD	NUMBER	]	num	13	SENT_130	[p4l1166t2059r1346b2137],
13	S.	NNP	O	S.	dobj	10	SENT_130	[p4l1166t2059r1346b2137],
14	4	CD	NUMBER	4	num	13	SENT_130	[p4l1166t2059r1346b2137],
15	'	''	O	'	_	0	SENT_130	[p4l1166t2059r1346b2137],
16	5	CD	NUMBER	5	num	18	SENT_130	[p4l1166t2059r1346b2137],
17	Recent	JJ	O	recent	amod	18	SENT_130	[p4l1377t2072r1593b2124],
18	study	NN	O	study	nsubj	22	SENT_130	[p4l1621t2069r1798b2137],
19	in	IN	O	in	_	0	SENT_130	[p4l1826t2070r1885b2123],
20	Taiwan	NNP	LOCATION	Taiwan	prep_in	18	SENT_130	[p4l1910t2070r2147b2124],
21	also	RB	O	also	advmod	22	SENT_130	[p4l10t2157r134b2212],
22	showed	VBD	O	show	rcmod	13	SENT_130	[p4l168t2157r415b2212],
23	a	DT	O	a	det	25	SENT_130	[p4l449t2173r481b2212],
24	signiﬁcant	JJ	O	signiﬁcant	amod	25	SENT_130	[p4l515t2157r849b2226],
25	association	NN	O	association	dobj	22	SENT_130	[p4l881t2158r1239b2212],
26	between	IN	O	between	_	0	SENT_130	[p4l1270t2157r1547b2212],
27	PHT	NNP	O	PHT	nn	28	SENT_130	[p4l1581t2157r1997b2212],
28	—	NN	O	—	prep_between	25	SENT_130	[p4l1581t2157r1997b2212],
29	induced	VBD	O	induce	_	0	SENT_130	[p4l1581t2157r1997b2212],
30	S	NN	O	s	dep	29	SENT_130	[p4l2031t2157r2145b2226],
31	]	CD	NUMBER	]	num	32	SENT_130	[p4l2031t2157r2145b2226],
32	S	NN	O	s	dep	30	SENT_130	[p4l2031t2157r2145b2226],
33	/	:	O	/	punct	30	SENT_130	[p4l2031t2157r2145b2226],
34	TEN	CD	NUMBER	ten	dep	30	SENT_130	[p4l7t2248r136b2300],
35	and	CC	O	and	_	0	SENT_130	[p4l180t2245r296b2300],
36	HLA	NN	O	hlum	conj_and	34	SENT_130	[p4l340t2245r732b2300],
37	.	.	O	.	_	0	SENT_130	[p4l340t2245r732b2300],

1	—	NN	O	—	_	0	SENT_131	[p4l340t2245r732b2300],
2	.	.	O	.	_	0	SENT_131	[p4l340t2245r732b2300],

1	B	NN	O	b	nsubj	16	SENT_132	[p4l340t2245r732b2300],
2	*	CD	NUMBER	*	number	3	SENT_132	[p4l340t2245r732b2300],
3	1502	CD	DATE	1502	num	4	SENT_132	[p4l340t2245r732b2300],
4	allele	NN	O	allele	dep	1	SENT_132	[p4l777t2235r995b2301],
5	.5	CD	NUMBER	.5	num	4	SENT_132	[p4l777t2235r995b2301],
6	In	IN	O	in	_	0	SENT_132	[p4l1038t2248r1098b2299],
7	the	DT	O	the	det	9	SENT_132	[p4l1140t2245r1242b2300],
8	present	JJ	DATE	present	amod	9	SENT_132	[p4l1286t2253r1527b2314],
9	study	NN	O	study	prep_in	4	SENT_132	[p4l1569t2245r1760b2314],
10	,	,	O	,	_	0	SENT_132	[p4l1569t2245r1760b2314],
11	HLA	NN	O	hlum	nn	13	SENT_132	[p4l1805t2248r1937b2300],
12	highresolution	NN	O	highresolution	nn	13	SENT_132	[p4l1978t2245r2146b2314, p4l10t2334r337b2389],
13	genotyping	NN	O	genotyping	appos	1	SENT_132	[p4l361t2335r726b2403],
14	did	VBD	O	do	aux	16	SENT_132	[p4l750t2334r850b2389],
15	not	RB	O	not	neg	16	SENT_132	[p4l878t2342r982b2389],
16	detect	VB	O	detect	_	0	SENT_132	[p4l1007t2334r1206b2389],
17	the	DT	O	the	det	18	SENT_132	[p4l1230t2334r1331b2389],
18	presence	NN	O	presence	dobj	16	SENT_132	[p4l1358t2350r1642b2403],
19	of	IN	O	of	_	0	SENT_132	[p4l1668t2334r1734b2389],
20	HLA	NN	O	hlum	prep_of	18	SENT_132	[p4l1752t2334r2144b2389],
21	.	.	O	.	_	0	SENT_132	[p4l1752t2334r2144b2389],

1	—	NN	O	—	_	0	SENT_133	[p4l1752t2334r2144b2389],
2	.	.	O	.	_	0	SENT_133	[p4l1752t2334r2144b2389],

1	B	NN	O	b	nn	4	SENT_134	[p4l1752t2334r2144b2389],
2	*	CD	NUMBER	*	num	4	SENT_134	[p4l1752t2334r2144b2389],
3	l502	NN	O	l502	nn	4	SENT_134	[p4l1752t2334r2144b2389],
4	allele	NN	O	allele	_	0	SENT_134	[p4l10t2423r179b2478],
5	in	IN	O	in	_	0	SENT_134	[p4l199t2424r259b2478],
6	both	DT	O	both	det	7	SENT_134	[p4l277t2423r424b2478],
7	patients	NNS	O	patient	prep_in	4	SENT_134	[p4l443t2424r717b2492],
8	,	,	O	,	_	0	SENT_134	[p4l443t2424r717b2492],
9	in	IN	O	in	_	0	SENT_134	[p4l738t2424r797b2478],
10	addition	NN	O	addition	_	0	SENT_134	[p4l816t2423r1084b2478],
11	to	TO	O	to	_	0	SENT_134	[p4l1102t2432r1164b2478],
12	a	DT	O	a	det	14	SENT_134	[p4l1183t2439r1215b2478],
13	common	JJ	O	common	amod	14	SENT_134	[p4l1235t2439r1518b2478],
14	HLA	NN	O	hlum	conj_in	7	SENT_134	[p4l1537t2423r1922b2478],
15	.	.	O	.	_	0	SENT_134	[p4l1537t2423r1922b2478],

1	—	NN	O	—	_	0	SENT_135	[p4l1537t2423r1922b2478],
2	.	.	O	.	_	0	SENT_135	[p4l1537t2423r1922b2478],

1	B	NN	O	b	_	0	SENT_136	[p4l1537t2423r1922b2478],
2	*	CD	NUMBER	*	number	3	SENT_136	[p4l1537t2423r1922b2478],
3	4601	CD	DATE	4601	dobj	1	SENT_136	[p4l1537t2423r1922b2478],
4	which	WDT	O	which	nsubjpass	7	SENT_136	[p4l1948t2423r2147b2478],
5	has	VBZ	O	have	aux	7	SENT_136	[p4l10t2513r115b2568],
6	been	VBN	O	be	auxpass	7	SENT_136	[p4l157t2513r311b2568],
7	conﬁrmed	VBN	O	conﬁrmed	rcmod	3	SENT_136	[p4l352t2513r680b2568],
8	as	IN	O	as	_	0	SENT_136	[p4l721t2529r784b2568],
9	a	DT	O	a	det	11	SENT_136	[p4l826t2529r859b2568],
10	frequent	JJ	O	frequent	amod	11	SENT_136	[p4l900t2513r1175b2581],
11	allele	NN	O	allele	prep_as	7	SENT_136	[p4l1215t2513r1385b2568],
12	in	IN	O	in	_	0	SENT_136	[p4l1427t2514r1486b2567],
13	Han	NNP	LOCATION	Han	nn	14	SENT_136	[p4l1528t2516r1655b2568],
14	population	NN	O	population	prep_in	11	SENT_136	[p4l1696t2513r2046b2581],
15	in	IN	O	in	_	0	SENT_136	[p4l2087t2514r2146b2567],
16	Southwest	NNP	LOCATION	Southwest	nn	17	SENT_136	[p4l10t2601r350b2655],
17	China	NNP	LOCATION	China	prep_in	7	SENT_136	[p4l375t2591r634b2655],
18	.	.	O	.	_	0	SENT_136	[p4l375t2591r634b2655],

1	”	NN	O	”	nsubj	18	SENT_137	[p4l375t2591r634b2655],
2	Our	PRP$	O	we	poss	3	SENT_137	[p4l661t2604r781b2655],
3	results	NNS	O	result	nsubj	4	SENT_137	[p4l805t2601r1018b2655],
4	indicate	VBP	O	indicate	rcmod	1	SENT_137	[p4l1046t2601r1301b2655],
5	that	IN	O	that	complm	14	SENT_137	[p4l1327t2601r1457b2655],
6	HLA-B	NN	O	hla-b	nsubj	14	SENT_137	[p4l1482t2601r1874b2655],
7	*	CD	NUMBER	*	num	6	SENT_137	[p4l1482t2601r1874b2655],
8	1502	CD	DATE	1502	num	9	SENT_137	[p4l1482t2601r1874b2655],
9	allele	NN	O	allele	dep	6	SENT_137	[p4l1902t2601r2071b2655],
10	is	VBZ	O	be	cop	14	SENT_137	[p4l2098t2602r2145b2655],
11	not	RB	O	not	neg	14	SENT_137	[p4l10t2696r115b2743],
12	a	DT	O	a	det	14	SENT_137	[p4l152t2704r185b2743],
13	universal	JJ	O	universal	amod	14	SENT_137	[p4l223t2688r517b2743],
14	marker	NN	O	marker	ccomp	4	SENT_137	[p4l557t2688r790b2743],
15	for	IN	O	for	_	0	SENT_137	[p4l826t2688r915b2743],
16	PHT	NNP	O	PHT	nn	17	SENT_137	[p4l951t2688r1368b2743],
17	—	NN	O	—	prep_for	14	SENT_137	[p4l951t2688r1368b2743],
18	induced	VBD	O	induce	_	0	SENT_137	[p4l951t2688r1368b2743],
19	SJS	NNP	O	SJS	dobj	18	SENT_137	[p4l1407t2691r1513b2757],
20	,	,	O	,	_	0	SENT_137	[p4l1407t2691r1513b2757],
21	and	CC	O	and	_	0	SENT_137	[p4l1552t2688r1668b2743],
22	other	JJ	O	other	amod	24	SENT_137	[p4l1707t2688r1879b2743],
23	genetic	JJ	O	genetic	amod	24	SENT_137	[p4l1913t2689r2147b2757],
24	markers	NNS	O	marker	nsubj	29	SENT_137	[p4l10t2777r271b2832],
25	or	CC	O	or	_	0	SENT_137	[p4l304t2793r370b2832],
26	environmental	JJ	O	environmental	amod	27	SENT_137	[p4l400t2777r874b2832],
27	factors	NNS	O	factor	nsubj	29	SENT_137	[p4l906t2777r1120b2832],
28	may	MD	O	may	aux	29	SENT_137	[p4l1154t2793r1292b2846],
29	contribute	VB	O	contribute	conj_and	18	SENT_137	[p4l1322t2777r1657b2832],
30	to	TO	O	to	_	0	SENT_137	[p4l1688t2785r1750b2832],
31	the	DT	O	the	det	33	SENT_137	[p4l1781t2777r1883b2832],
32	genetic	JJ	O	genetic	amod	33	SENT_137	[p4l1913t2778r2147b2846],
33	susceptibility	NN	O	susceptibility	prep_to	29	SENT_137	[p4l11t2866r443b2935],
34	of	IN	O	of	_	0	SENT_137	[p4l473t2866r539b2921],
35	PHT	NNP	O	PHT	nn	40	SENT_137	[p4l563t2866r979b2921],
36	—	NN	O	—	nn	40	SENT_137	[p4l563t2866r979b2921],
37	induced	VBD	O	induce	amod	40	SENT_137	[p4l563t2866r979b2921],
38	severe	JJ	O	severe	amod	40	SENT_137	[p4l1011t2882r1214b2921],
39	cutaneous	JJ	O	cutaneous	amod	40	SENT_137	[p4l1245t2875r1573b2921],
40	reactions	NNS	O	reaction	prep_of	33	SENT_137	[p4l1605t2867r1896b2921],
41	in	IN	O	in	_	0	SENT_137	[p4l1929t2867r1988b2921],
42	Han	NNP	LOCATION	Han	nn	43	SENT_137	[p4l2019t2870r2147b2921],
43	Chinese	NNP	LOCATION	Chinese	prep_in	40	SENT_137	[p4l10t2955r275b3011],
44	.	.	O	.	_	0	SENT_137	[p4l10t2955r275b3011],

1	However	RB	O	however	advmod	6	SENT_138	[p4l317t2959r620b3019],
2	,	,	O	,	_	0	SENT_138	[p4l317t2959r620b3019],
3	the	DT	O	the	det	4	SENT_138	[p4l661t2955r762b3010],
4	failure	NN	O	failure	nsubj	6	SENT_138	[p4l803t2955r1009b3010],
5	to	TO	O	to	aux	6	SENT_138	[p4l1048t2964r1110b3010],
6	detect	VB	O	detect	_	0	SENT_138	[p4l1150t2955r1349b3010],
7	a	DT	O	a	det	9	SENT_138	[p4l1387t2971r1419b3010],
8	positive	JJ	O	positive	amod	9	SENT_138	[p4l1460t2956r1712b3024],
9	HLA	NN	O	hlum	dobj	6	SENT_138	[p4l1752t2955r2144b3010],
10	.	.	O	.	_	0	SENT_138	[p4l1752t2955r2144b3010],

1	—	NN	O	—	_	0	SENT_139	[p4l1752t2955r2144b3010],
2	.	.	O	.	_	0	SENT_139	[p4l1752t2955r2144b3010],

1	B	NN	O	b	nn	4	SENT_140	[p4l1752t2955r2144b3010],
2	*	CD	NUMBER	*	num	4	SENT_140	[p4l1752t2955r2144b3010],
3	l502	NN	O	l502	nn	4	SENT_140	[p4l1752t2955r2144b3010],
4	allele	NN	O	allele	nsubj	10	SENT_140	[p4l10t3045r179b3100],
5	in	IN	O	in	_	0	SENT_140	[p4l199t3046r258b3099],
6	patients	NNS	O	patient	prep_in	4	SENT_140	[p4l277t3046r534b3113],
7	with	IN	O	with	_	0	SENT_140	[p4l552t3045r701b3100],
8	PHT	NN	O	pht	nn	9	SENT_140	[p4l720t3045r1136b3100],
9	—	NN	O	—	prep_with	6	SENT_140	[p4l720t3045r1136b3100],
10	induced	VBD	O	induce	_	0	SENT_140	[p4l720t3045r1136b3100],
11	SJS	NN	O	sj	nsubjpass	15	SENT_140	[p4l1155t3048r1246b3113],
12	should	MD	O	should	aux	15	SENT_140	[p4l1266t3045r1479b3100],
13	not	RB	O	not	neg	15	SENT_140	[p4l1499t3053r1604b3100],
14	be	VB	O	be	auxpass	15	SENT_140	[p4l1621t3045r1695b3100],
15	considered	VBN	O	consider	ccomp	10	SENT_140	[p4l1714t3045r2063b3100],
16	as	IN	O	as	_	0	SENT_140	[p4l2082t3061r2145b3100],
17	strong	JJ	O	strong	amod	18	SENT_140	[p4l11t3142r214b3202],
18	evidence	NN	O	evidence	prep_as	15	SENT_140	[p4l257t3134r540b3189],
19	against	IN	O	against	_	0	SENT_140	[p4l584t3135r814b3202],
20	the	DT	O	the	det	21	SENT_140	[p4l856t3134r958b3189],
21	FDA	NNP	ORGANIZATION	FDA	poss	23	SENT_140	[p4l1002t3136r1177b3189],
22	’s	POS	O	’s	_	0	SENT_140	[p4l1002t3136r1177b3189],
23	guideline	NN	O	guideline	prep_against	18	SENT_140	[p4l1221t3134r1520b3202],
24	due	JJ	O	due	_	0	SENT_140	[p4l1564t3134r1680b3189],
25	to	TO	O	to	_	0	SENT_140	[p4l1724t3142r1786b3189],
26	the	DT	O	the	det	29	SENT_140	[p4l1829t3134r1931b3189],
27	small	JJ	O	small	amod	29	SENT_140	[p4l1976t3134r2145b3189],
28	sample	NN	O	sample	nn	29	SENT_140	[p4l11t3222r239b3291],
29	size	NN	O	size	prep_due_to	23	SENT_140	[p4l287t3223r422b3278],
30	.	.	O	.	_	0	SENT_140	[p4l287t3223r422b3278],

1	Caution	NN	O	caution	nsubjpass	4	SENT_141	[p4l471t3223r719b3277],
2	should	MD	O	should	aux	4	SENT_141	[p4l766t3222r980b3277],
3	be	VB	O	be	auxpass	4	SENT_141	[p4l1026t3222r1100b3277],
4	exercised	VBN	O	exercise	_	0	SENT_141	[p4l1148t3222r1449b3277],
5	for	IN	O	for	_	0	SENT_141	[p4l1497t3222r1586b3277],
6	PHT	NNP	ORGANIZATION	PHT	prep_for	4	SENT_141	[p4l1632t3226r1761b3277],
7	no	DT	O	no	det	8	SENT_141	[p4l1806t3238r1883b3277],
8	matter	NN	O	matter	advmod	4	SENT_141	[p4l1931t3230r2149b3277],
9	whether	IN	O	whether	complm	12	SENT_141	[p4l8t3311r282b3366],
10	the	DT	O	the	det	11	SENT_141	[p4l317t3311r419b3366],
11	patients	NNS	O	patient	nsubj	12	SENT_141	[p4l457t3312r715b3380],
12	carry	VBP	O	carry	dep	8	SENT_141	[p4l755t3327r918b3380],
13	HLA	NN	O	hlum	dobj	12	SENT_141	[p4l955t3311r1347b3366],
14	.	.	O	.	_	0	SENT_141	[p4l955t3311r1347b3366],

1	—	NN	O	—	_	0	SENT_142	[p4l955t3311r1347b3366],
2	.	.	O	.	_	0	SENT_142	[p4l955t3311r1347b3366],

1	B	NN	O	b	_	0	SENT_143	[p4l955t3311r1347b3366],
2	*	CD	NUMBER	*	number	3	SENT_143	[p4l955t3311r1347b3366],
3	1502	CD	DATE	1502	dep	1	SENT_143	[p4l955t3311r1347b3366],
4	allele	NN	O	allele	dep	3	SENT_143	[p4l1387t3311r1572b3367],
5	.	.	O	.	_	0	SENT_143	[p4l1387t3311r1572b3367],

1	In	IN	O	in	_	0	SENT_144	[p4l1612t3314r1672b3365],
2	future	NN	DATE	future	prep_in	8	SENT_144	[p4l1711t3311r1922b3374],
3	,	,	O	,	_	0	SENT_144	[p4l1711t3311r1922b3374],
4	larger	JJR	O	larger	amod	5	SENT_144	[p4l1961t3311r2149b3380],
5	study	NN	O	study	nsubj	8	SENT_144	[p4l11t3400r188b3469],
6	should	MD	O	should	aux	8	SENT_144	[p4l239t3400r453b3455],
7	be	VB	O	be	cop	8	SENT_144	[p4l504t3400r578b3455],
8	necessary	JJ	O	necessary	_	0	SENT_144	[p4l630t3416r944b3469],
9	to	TO	O	to	aux	11	SENT_144	[p4l993t3409r1055b3455],
10	further	JJ	O	further	advmod	11	SENT_144	[p4l1107t3400r1334b3455],
11	evaluate	VB	O	evaluate	xcomp	8	SENT_144	[p4l1382t3400r1653b3455],
12	the	DT	O	the	det	14	SENT_144	[p4l1705t3400r1806b3455],
13	potential	JJ	O	potential	amod	14	SENT_144	[p4l1858t3400r2145b3469],
14	association	NN	O	association	dobj	11	SENT_144	[p4l10t3490r367b3544],
15	between	IN	O	between	_	0	SENT_144	[p4l390t3489r667b3544],
16	PHT	NNP	O	PHT	nn	21	SENT_144	[p4l692t3489r1108b3544],
17	—	NN	O	—	nn	21	SENT_144	[p4l692t3489r1108b3544],
18	induced	VBD	O	induce	amod	21	SENT_144	[p4l692t3489r1108b3544],
19	severe	JJ	O	severe	amod	21	SENT_144	[p4l1133t3505r1337b3544],
20	cutaneous	JJ	O	cutaneous	amod	21	SENT_144	[p4l1361t3498r1688b3544],
21	reactions	NNS	O	reaction	prep_between	14	SENT_144	[p4l1713t3490r2005b3544],
22	and	CC	O	and	_	0	SENT_144	[p4l2030t3489r2146b3543],
23	the	DT	O	the	det	24	SENT_144	[p4l9t3578r111b3633],
24	HLA	NN	O	hlum	prep_between	14	SENT_144	[p4l140t3578r532b3633],
25	.	.	O	.	_	0	SENT_144	[p4l140t3578r532b3633],

1	—	NN	O	—	_	0	SENT_145	[p4l140t3578r532b3633],
2	.	.	O	.	_	0	SENT_145	[p4l140t3578r532b3633],

1	B	NN	O	b	_	0	SENT_146	[p4l140t3578r532b3633],
2	*	CD	NUMBER	*	number	3	SENT_146	[p4l140t3578r532b3633],
3	1502	CD	DATE	1502	num	4	SENT_146	[p4l140t3578r532b3633],
4	allele	NN	O	allele	dep	1	SENT_146	[p4l562t3578r732b3633],
5	in	IN	O	in	_	0	SENT_146	[p4l761t3579r820b3632],
6	various	JJ	O	various	amod	7	SENT_146	[p4l846t3579r1081b3633],
7	populations	NNS	O	population	prep_in	4	SENT_146	[p4l1111t3578r1507b3646],
8	.	.	O	.	_	0	SENT_146	[p4l1111t3578r1507b3646],

1	Acknowledgement	NN	O	acknowledgement	_	0	SENT_147	[p5l6t63r624b131],

1	This	DT	O	this	det	2	SENT_148	[p5l109t242r241b297],
2	study	NN	O	study	nsubjpass	4	SENT_148	[p5l271t242r448b311],
3	was	VBD	O	be	auxpass	4	SENT_148	[p5l472t258r596b297],
4	supported	VBN	O	support	_	0	SENT_148	[p5l625t242r951b311],
5	by	IN	O	by	_	0	SENT_148	[p5l978t242r1055b311],
6	Program	NN	O	program	agent	4	SENT_148	[p5l1081t246r1354b311],
7	for	IN	O	for	_	0	SENT_148	[p5l1381t242r1470b297],
8	Changjiang	NNP	ORGANIZATION	Changjiang	nn	9	SENT_148	[p5l1495t242r1854b311],
9	Scholars	NNPS	ORGANIZATION	Scholars	prep_for	6	SENT_148	[p5l1880t242r2145b297],
10	and	CC	ORGANIZATION	and	_	0	SENT_148	[p5l10t332r126b387],
11	Innovative	JJ	ORGANIZATION	innovative	amod	13	SENT_148	[p5l145t332r484b387],
12	Research	NN	ORGANIZATION	research	nn	13	SENT_148	[p5l503t332r789b387],
13	Team	NNP	ORGANIZATION	Team	agent	4	SENT_148	[p5l803t335r980b387],
14	in	IN	ORGANIZATION	in	_	0	SENT_148	[p5l998t332r1057b386],
15	University	NNP	ORGANIZATION	University	prep_in	13	SENT_148	[p5l1074t332r1409b400],
16	of	IN	ORGANIZATION	of	_	0	SENT_148	[p5l1425t331r1491b387],
17	China	NNP	ORGANIZATION	China	prep_of	15	SENT_148	[p5l1502t332r1683b387],
18	(	CD	NUMBER	(	num	17	SENT_148	[p5l1701t332r1820b400],
19	no.	JJ	O	no.	amod	21	SENT_148	[p5l1701t332r1820b400],
20	lRT0847	NN	O	lrt0847	nn	21	SENT_148	[p5l1840t332r2145b400],
21	)	NN	O	)	dep	13	SENT_148	[p5l1840t332r2145b400],
22	.	.	O	.	_	0	SENT_148	[p5l1840t332r2145b400],

1	We	PRP	O	we	nsubj	3	SENT_149	[p5l7t424r116b476],
2	would	MD	O	would	aux	3	SENT_149	[p5l142t421r345b476],
3	like	VB	O	like	_	0	SENT_149	[p5l374t421r487b476],
4	to	TO	O	to	aux	5	SENT_149	[p5l515t429r576b476],
5	thank	VB	O	thank	xcomp	3	SENT_149	[p5l605t421r790b476],
6	all	DT	O	all	det	7	SENT_149	[p5l816t421r889b476],
7	subjects	NNS	O	subject	dobj	5	SENT_149	[p5l920t421r1178b489],
8	who	WP	O	who	nsubj	9	SENT_149	[p5l1206t420r1346b476],
9	took	VBD	O	take	rcmod	7	SENT_149	[p5l1374t421r1517b476],
10	part	NN	O	part	dobj	9	SENT_149	[p5l1543t429r1673b489],
11	in	IN	O	in	_	0	SENT_149	[p5l1701t421r1760b475],
12	this	DT	O	this	det	13	SENT_149	[p5l1787t421r1904b476],
13	study	NN	O	study	prep_in	9	SENT_149	[p5l1934t421r2126b489],
14	.	.	O	.	_	0	SENT_149	[p5l1934t421r2126b489],

1	References	NNS	O	reference	_	0	SENT_150	[p5l9t583r363b637],

1	9	CD	NUMBER	9	_	0	SENT_151	[p5l38t2337r66b2378],
2	.	.	O	.	_	0	SENT_151	[p5l71t786r80b794],

1	Arif	NN	PERSON	arif	nn	2	SENT_152	[p5l110t750r211b793],
2	H	NN	PERSON	h	_	0	SENT_152	[p5l222t753r272b800],
3	,	,	O	,	_	0	SENT_152	[p5l222t753r272b800],
4	Buchsbaum	NNP	PERSON	Buchsbaum	nn	5	SENT_152	[p5l289t750r589b793],
5	R	NNP	PERSON	R	appos	2	SENT_152	[p5l605t753r648b800],
6	,	,	O	,	_	0	SENT_152	[p5l605t753r648b800],
7	Weintraub	NNP	PERSON	Weintraub	nn	8	SENT_152	[p5l663t750r941b793],
8	D	NNP	O	D	appos	2	SENT_152	[p5l958t753r1007b800],
9	,	,	O	,	_	0	SENT_152	[p5l958t753r1007b800],
10	Koyfman	NNP	O	Koyfman	nn	11	SENT_152	[p5l1024t750r1255b804],
11	S	NNP	O	S	appos	2	SENT_152	[p5l1271t752r1308b800],
12	,	,	O	,	_	0	SENT_152	[p5l1271t752r1308b800],
13	Salas	NNP	PERSON	Salas	appos	2	SENT_152	[p5l1326t750r1686b793],
14	.	.	O	.	_	0	SENT_152	[p5l1326t750r1686b793],

1	—	NN	O	—	_	0	SENT_153	[p5l1326t750r1686b793],
2	.	.	O	.	_	0	SENT_153	[p5l1326t750r1686b793],

1	Humara	NN	O	humara	nn	2	SENT_154	[p5l1326t750r1686b793],
2	C	NN	O	c	_	0	SENT_154	[p5l1702t752r1745b800],
3	,	,	O	,	_	0	SENT_154	[p5l1702t752r1745b800],
4	Bazil	NNP	PERSON	Bazil	nn	5	SENT_154	[p5l1762t750r1883b793],
5	CW	NNP	O	CW	appos	2	SENT_154	[p5l1900t752r2002b800],
6	,	,	O	,	_	0	SENT_154	[p5l1900t752r2002b800],
7	et	FW	O	et	nn	8	SENT_154	[p5l2018t756r2068b793],
8	al.	FW	O	al.	appos	5	SENT_154	[p5l2084t752r2142b793],
9	.	.	O	.	_	0	SENT_154	[p5l2084t752r2142b793],

1	Comparison	NN	O	comparison	nsubj	6	SENT_155	[p5l112t817r422b870],
2	and	CC	O	and	_	0	SENT_155	[p5l453t816r547b860],
3	predictors	NNS	O	predictor	nsubj	6	SENT_155	[p5l580t816r839b870],
4	of	IN	O	of	_	0	SENT_155	[p5l873t816r926b860],
5	rash	NN	O	rash	prep_of	1	SENT_155	[p5l952t816r1060b860],
6	associated	VBN	O	associate	_	0	SENT_155	[p5l1092t816r1358b860],
7	with	IN	O	with	_	0	SENT_155	[p5l1389t816r1508b860],
8	15	CD	NUMBER	15	num	10	SENT_155	[p5l1543t818r1600b860],
9	antiepileptic	JJ	O	antiepileptic	amod	10	SENT_155	[p5l1634t816r1958b870],
10	drugs	NNS	O	drug	prep_with	6	SENT_155	[p5l1990t816r2145b870],
11	.	.	O	.	_	0	SENT_155	[p5l1990t816r2145b870],

1	Neurology	NNP	O	Neurology	_	0	SENT_156	[p5l110t882r364b936],
2	2007	CD	DATE	2007	num	1	SENT_156	[p5l386t884r829b932],
3	;	:	O	;	_	0	SENT_156	[p5l386t884r829b932],
4	68	CD	NUMBER	68	num	6	SENT_156	[p5l386t884r829b932],
5	:	:	O	:	_	0	SENT_156	[p5l386t884r829b932],
6	l701	CD	NUMBER	l701	dep	1	SENT_156	[p5l386t884r829b932],
7	—	CD	NUMBER	—	number	8	SENT_156	[p5l386t884r829b932],
8	9	CD	NUMBER	9	dep	6	SENT_156	[p5l386t884r829b932],
9	.	.	O	.	_	0	SENT_156	[p5l386t884r829b932],

1	.	.	O	.	_	0	SENT_157	[p5l71t984r80b992],

1	Chung	NNP	PERSON	Chung	nn	2	SENT_158	[p5l112t948r277b1002],
2	WH	NNP	PERSON	WH	_	0	SENT_158	[p5l290t950r402b998],
3	,	,	O	,	_	0	SENT_158	[p5l290t950r402b998],
4	Hung	NNP	O	Hung	nn	5	SENT_158	[p5l419t950r558b1002],
5	SI	NNP	O	SI	appos	2	SENT_158	[p5l573t950r628b998],
6	,	,	O	,	_	0	SENT_158	[p5l573t950r628b998],
7	Hong	NNP	LOCATION	Hong	nn	8	SENT_158	[p5l646t950r782b1002],
8	HS	NN	LOCATION	h	appos	5	SENT_158	[p5l797t950r877b998],
9	,	,	O	,	_	0	SENT_158	[p5l797t950r877b998],
10	Hsih	NN	O	hsih	nn	11	SENT_158	[p5l895t948r1010b991],
11	MS	NN	O	m	appos	5	SENT_158	[p5l1026t950r1117b998],
12	,	,	O	,	_	0	SENT_158	[p5l1026t950r1117b998],
13	Yang	NNP	ORGANIZATION	Yang	nn	14	SENT_158	[p5l1132t950r1260b1002],
14	LC	NNP	ORGANIZATION	LC	appos	5	SENT_158	[p5l1276t950r1347b998],
15	,	,	O	,	_	0	SENT_158	[p5l1276t950r1347b998],
16	Ho	NNP	O	Ho	nn	17	SENT_158	[p5l1364t950r1434b991],
17	HC	NNP	O	HC	appos	5	SENT_158	[p5l1450t950r1535b998],
18	,	,	O	,	_	0	SENT_158	[p5l1450t950r1535b998],
19	et	FW	O	et	nn	20	SENT_158	[p5l1551t954r1602b991],
20	al.	FW	O	al.	appos	5	SENT_158	[p5l1618t950r1676b991],
21	.	.	O	.	_	0	SENT_158	[p5l1618t950r1676b991],

1	Medical	JJ	O	medical	amod	2	SENT_159	[p5l1697t948r1899b991],
2	genetics	NNS	O	genetics	_	0	SENT_159	[p5l1915t948r2142b1002],
3	:	:	O	:	_	0	SENT_159	[p5l1915t948r2142b1002],
4	a	DT	O	a	det	5	SENT_159	[p5l112t1027r138b1058],
5	marker	NN	O	marker	dep	2	SENT_159	[p5l161t1014r347b1058],
6	for	IN	O	for	_	0	SENT_159	[p5l368t1014r440b1058],
7	Stevens	NNP	PERSON	Stevens	prep_for	5	SENT_159	[p5l461t1014r899b1069],
8	—	CD	NUMBER	—	num	7	SENT_159	[p5l461t1014r899b1069],
9	]	CD	NUMBER	]	num	11	SENT_159	[p5l461t1014r899b1069],
10	ohnson	NN	O	ohnson	nn	11	SENT_159	[p5l461t1014r899b1069],
11	syndrome	NN	O	syndrome	dep	5	SENT_159	[p5l922t1014r1190b1069],
12	.	.	O	.	_	0	SENT_159	[p5l922t1014r1190b1069],

1	Nature	NNP	O	Nature	_	0	SENT_160	[p5l1212t1017r1382b1058],
2	2004	CD	DATE	2004	num	1	SENT_160	[p5l1404t1016r1781b1065],
3	;	:	O	;	_	0	SENT_160	[p5l1404t1016r1781b1065],
4	428:486	CD	NUMBER	428:486	dep	1	SENT_160	[p5l1404t1016r1781b1065],
5	.	.	O	.	_	0	SENT_160	[p5l1404t1016r1781b1065],

1	.	.	O	.	_	0	SENT_161	[p5l71t1116r80b1124],

1	Hung	NNP	O	Hung	nn	2	SENT_162	[p5l112t1083r251b1134],
2	SI	NNP	O	SI	_	0	SENT_162	[p5l283t1082r338b1130],
3	,	,	O	,	_	0	SENT_162	[p5l283t1082r338b1130],
4	Chung	NNP	PERSON	Chung	nn	5	SENT_162	[p5l372t1080r536b1134],
5	WH	NNP	PERSON	WH	appos	2	SENT_162	[p5l565t1083r677b1130],
6	,	,	O	,	_	0	SENT_162	[p5l565t1083r677b1130],
7	Jee	NNP	PERSON	Jee	nn	8	SENT_162	[p5l704t1083r783b1134],
8	SH	NNP	O	SH	appos	5	SENT_162	[p5l815t1082r896b1130],
9	,	,	O	,	_	0	SENT_162	[p5l815t1082r896b1130],
10	Chen	NNP	ORGANIZATION	Chen	nn	11	SENT_162	[p5l929t1080r1057b1124],
11	WC	NNP	ORGANIZATION	WC	appos	5	SENT_162	[p5l1088t1082r1191b1130],
12	,	,	O	,	_	0	SENT_162	[p5l1088t1082r1191b1130],
13	Chang	NNP	PERSON	Chang	nn	14	SENT_162	[p5l1225t1080r1384b1134],
14	YT	NNP	PERSON	YT	appos	5	SENT_162	[p5l1414t1083r1491b1130],
15	,	,	O	,	_	0	SENT_162	[p5l1414t1083r1491b1130],
16	Lee	NNP	PERSON	Lee	nn	17	SENT_162	[p5l1524t1083r1607b1124],
17	WR	NNP	O	WR	appos	5	SENT_162	[p5l1637t1083r1742b1130],
18	,	,	O	,	_	0	SENT_162	[p5l1637t1083r1742b1130],
19	et	FW	O	et	nn	20	SENT_162	[p5l1774t1087r1825b1124],
20	al.	FW	O	al.	appos	5	SENT_162	[p5l1856t1083r1915b1124],
21	.	.	O	.	_	0	SENT_162	[p5l1856t1083r1915b1124],

1	Genetic	JJ	O	genetic	amod	2	SENT_163	[p5l1952t1081r2147b1124],
2	susceptibility	NN	O	susceptibility	_	0	SENT_163	[p5l113t1146r459b1200],
3	to	TO	O	to	_	0	SENT_163	[p5l489t1153r539b1190],
4	carbamazepine-induced	JJ	O	carbamazepine-induced	amod	8	SENT_163	[p5l571t1146r1194b1200],
5	cutaneous	JJ	O	cutaneous	amod	8	SENT_163	[p5l1226t1153r1488b1190],
6	adverse	JJ	O	adverse	amod	8	SENT_163	[p5l1520t1146r1717b1190],
7	drug	NN	O	drug	nn	8	SENT_163	[p5l1750t1146r1868b1200],
8	reactions	NNS	O	reaction	prep_to	2	SENT_163	[p5l1899t1147r2145b1190],
9	.	.	O	.	_	0	SENT_163	[p5l1899t1147r2145b1190],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_164	[p5l110t1212r496b1266],
2	Genomics	NNP	O	Genomics	_	0	SENT_164	[p5l516t1213r752b1255],
3	2006	CD	DATE	2006	num	2	SENT_164	[p5l774t1214r1250b1262],
4	;	:	O	;	_	0	SENT_164	[p5l774t1214r1250b1262],
5	16:297	CD	NUMBER	16:297	number	6	SENT_164	[p5l774t1214r1250b1262],
6	-306	CD	NUMBER	-306	dep	2	SENT_164	[p5l774t1214r1250b1262],
7	.	.	O	.	_	0	SENT_164	[p5l774t1214r1250b1262],

1	.	.	O	.	_	0	SENT_165	[p5l71t1314r80b1322],

1	Man	NN	O	man	_	0	SENT_166	[p5l112t1281r225b1321],
2	CB	NNP	O	CB	dep	1	SENT_166	[p5l247t1280r324b1328],
3	,	,	O	,	_	0	SENT_166	[p5l247t1280r324b1328],
4	Kwan	NNP	PERSON	Kwan	nn	5	SENT_166	[p5l346t1280r490b1321],
5	P	NN	O	p	appos	2	SENT_166	[p5l512t1281r552b1328],
6	,	,	O	,	_	0	SENT_166	[p5l512t1281r552b1328],
7	Baum	NNP	PERSON	Baum	nn	8	SENT_166	[p5l574t1281r720b1321],
8	L	NNP	O	L	appos	2	SENT_166	[p5l742t1281r778b1328],
9	,	,	O	,	_	0	SENT_166	[p5l742t1281r778b1328],
10	Yu	NNP	O	Yu	nn	11	SENT_166	[p5l798t1281r865b1321],
11	E	NNP	O	E	appos	2	SENT_166	[p5l887t1281r927b1328],
12	,	,	O	,	_	0	SENT_166	[p5l887t1281r927b1328],
13	Lau	NNP	PERSON	Lau	nn	14	SENT_166	[p5l949t1281r1037b1321],
14	KM	NNP	O	KM	appos	2	SENT_166	[p5l1059t1281r1156b1328],
15	,	,	O	,	_	0	SENT_166	[p5l1059t1281r1156b1328],
16	Cheng	NNP	PERSON	Cheng	nn	17	SENT_166	[p5l1179t1278r1339b1332],
17	AS	NNP	O	AS	appos	2	SENT_166	[p5l1357t1280r1434b1328],
18	,	,	O	,	_	0	SENT_166	[p5l1357t1280r1434b1328],
19	et	FW	O	et	nn	20	SENT_166	[p5l1455t1284r1506b1321],
20	al.	FW	O	al.	appos	2	SENT_166	[p5l1526t1280r1584b1321],
21	.	.	O	.	_	0	SENT_166	[p5l1526t1280r1584b1321],

1	Association	NNP	O	Association	_	0	SENT_167	[p5l1609t1278r1904b1321],
2	between	IN	O	between	_	0	SENT_167	[p5l1925t1278r2147b1321],
3	HLA-B	NN	O	hla-b	prep_between	1	SENT_167	[p5l113t1343r426b1387],
4	*	CD	NUMBER	*	number	5	SENT_167	[p5l113t1343r426b1387],
5	1502	CD	DATE	1502	num	6	SENT_167	[p5l113t1343r426b1387],
6	allele	NN	O	allele	dep	1	SENT_167	[p5l449t1343r585b1387],
7	and	CC	O	and	_	0	SENT_167	[p5l606t1343r699b1387],
8	antiepileptic	JJ	O	antiepileptic	amod	11	SENT_167	[p5l721t1344r1045b1398],
9	drug-induced	JJ	O	drug-induced	amod	11	SENT_167	[p5l1066t1343r1415b1398],
10	cutaneous	JJ	O	cutaneous	amod	11	SENT_167	[p5l1436t1350r1698b1387],
11	reactions	NNS	O	reaction	dep	1	SENT_167	[p5l1721t1344r1954b1387],
12	in	IN	O	in	_	0	SENT_167	[p5l1977t1344r2024b1387],
13	Han	NNP	LOCATION	Han	nn	14	SENT_167	[p5l2044t1346r2147b1387],
14	Chinese	NNP	LOCATION	Chinese	prep_in	11	SENT_167	[p5l112t1410r324b1454],
15	.	.	O	.	_	0	SENT_167	[p5l112t1410r324b1454],

1	Epilepsia	NNP	O	Epilepsia	_	0	SENT_168	[p5l347t1410r565b1464],
2	2007	CD	DATE	2007	num	1	SENT_168	[p5l588t1412r1030b1460],
3	;	:	O	;	_	0	SENT_168	[p5l588t1412r1030b1460],
4	48	CD	NUMBER	48	num	6	SENT_168	[p5l588t1412r1030b1460],
5	:	:	O	:	_	0	SENT_168	[p5l588t1412r1030b1460],
6	l015	CD	NUMBER	l015	dep	1	SENT_168	[p5l588t1412r1030b1460],
7	—	CD	NUMBER	—	number	8	SENT_168	[p5l588t1412r1030b1460],
8	8	CD	NUMBER	8	dep	6	SENT_168	[p5l588t1412r1030b1460],
9	.	.	O	.	_	0	SENT_168	[p5l588t1412r1030b1460],

1	.	.	O	.	_	0	SENT_169	[p5l71t1512r80b1520],

1	Locharernkul	NN	O	locharernkul	nn	2	SENT_170	[p5l113t1476r450b1520],
2	C	NN	O	c	_	0	SENT_170	[p5l468t1478r511b1526],
3	,	,	O	,	_	0	SENT_170	[p5l468t1478r511b1526],
4	Loplumlert	NNP	O	Loplumlert	nn	5	SENT_170	[p5l528t1476r854b1531],
5	]	NNP	O	]	appos	2	SENT_170	[p5l528t1476r854b1531],
6	,	,	O	,	_	0	SENT_170	[p5l528t1476r854b1531],
7	Limotai	NNP	ORGANIZATION	Limotai	nn	8	SENT_170	[p5l871t1477r1064b1520],
8	C	NNP	ORGANIZATION	C	appos	5	SENT_170	[p5l1081t1478r1124b1526],
9	,	,	O	,	_	0	SENT_170	[p5l1081t1478r1124b1526],
10	Korkij	NNP	PERSON	Korkij	nn	11	SENT_170	[p5l1141t1476r1291b1531],
11	W	NNP	PERSON	W	appos	5	SENT_170	[p5l1307t1479r1377b1526],
12	,	,	O	,	_	0	SENT_170	[p5l1307t1479r1377b1526],
13	Desudchit	NNP	ORGANIZATION	Desudchit	nn	14	SENT_170	[p5l1394t1476r1653b1520],
14	T	NN	ORGANIZATION	t	appos	5	SENT_170	[p5l1666t1479r1709b1526],
15	,	,	O	,	_	0	SENT_170	[p5l1666t1479r1709b1526],
16	Tongkobpetch	NNP	O	Tongkobpetch	nn	17	SENT_170	[p5l1723t1476r2092b1531],
17	S	NNP	O	S	appos	5	SENT_170	[p5l2108t1478r2146b1526],
18	,	,	O	,	_	0	SENT_170	[p5l2108t1478r2146b1526],
19	et	FW	O	et	nn	20	SENT_170	[p5l112t1548r162b1585],
20	al.	FW	O	al.	appos	5	SENT_170	[p5l190t1544r248b1585],
21	.	.	O	.	_	0	SENT_170	[p5l190t1544r248b1585],

1	Carbamazepine	NNP	O	Carbamazepine	nsubj	4	SENT_171	[p5l282t1542r680b1596],
2	and	CC	O	and	_	0	SENT_171	[p5l709t1542r802b1585],
3	phenytoin	NN	O	phenytoin	conj_and	1	SENT_171	[p5l831t1542r1094b1596],
4	induced	VBD	O	induce	_	0	SENT_171	[p5l1123t1542r1327b1585],
5	Stevens	NNP	PERSON	Stevens	dobj	4	SENT_171	[p5l1357t1542r1794b1596],
6	—	CD	NUMBER	—	num	5	SENT_171	[p5l1357t1542r1794b1596],
7	]	CD	NUMBER	]	num	9	SENT_171	[p5l1357t1542r1794b1596],
8	ohnson	NN	O	ohnson	nn	9	SENT_171	[p5l1357t1542r1794b1596],
9	syndrome	NN	O	syndrome	nsubjpass	11	SENT_171	[p5l1823t1542r2079b1596],
10	is	VBZ	O	be	auxpass	11	SENT_171	[p5l2109t1543r2146b1585],
11	associated	VBN	O	associate	rcmod	5	SENT_171	[p5l112t1608r378b1652],
12	with	IN	O	with	_	0	SENT_171	[p5l394t1608r513b1652],
13	HLA-B	NN	O	hla-b	prep_with	11	SENT_171	[p5l530t1608r843b1652],
14	*	CD	NUMBER	*	number	15	SENT_171	[p5l530t1608r843b1652],
15	1502	CD	DATE	1502	num	16	SENT_171	[p5l530t1608r843b1652],
16	allele	NN	O	allele	dobj	11	SENT_171	[p5l862t1608r998b1652],
17	in	IN	O	in	_	0	SENT_171	[p5l1015t1609r1063b1651],
18	Thai	NNP	LOCATION	Thai	nn	19	SENT_171	[p5l1077t1608r1188b1652],
19	population	NN	O	population	prep_in	16	SENT_171	[p5l1205t1608r1498b1662],
20	.	.	O	.	_	0	SENT_171	[p5l1205t1608r1498b1662],

1	Epilepsia	NNP	O	Epilepsia	_	0	SENT_172	[p5l1514t1608r1732b1662],
2	2008	CD	DATE	2008	num	1	SENT_172	[p5l1749t1610r2145b1658],
3	;	:	O	;	_	0	SENT_172	[p5l1749t1610r2145b1658],
4	49:2087	CD	NUMBER	49:2087	number	5	SENT_172	[p5l1749t1610r2145b1658],
5	—	CD	NUMBER	—	dep	1	SENT_172	[p5l1749t1610r2145b1658],
6	91	CD	NUMBER	91	dep	5	SENT_172	[p5l112t1677r187b1719],
7	.	.	O	.	_	0	SENT_172	[p5l112t1677r187b1719],

1	.	.	O	.	_	0	SENT_173	[p5l71t1777r80b1785],

1	Hung	NNP	O	Hung	nn	2	SENT_174	[p5l113t1743r251b1795],
2	SI	NNP	O	SI	_	0	SENT_174	[p5l267t1743r322b1791],
3	,	,	O	,	_	0	SENT_174	[p5l267t1743r322b1791],
4	Chung	NNP	PERSON	Chung	nn	5	SENT_174	[p5l339t1741r503b1795],
5	WH	NNP	PERSON	WH	appos	2	SENT_174	[p5l515t1743r628b1791],
6	,	,	O	,	_	0	SENT_174	[p5l515t1743r628b1791],
7	Liu	NNP	PERSON	Liu	nn	8	SENT_174	[p5l645t1741r720b1784],
8	ZS	NNP	O	ZS	appos	5	SENT_174	[p5l735t1743r806b1791],
9	,	,	O	,	_	0	SENT_174	[p5l735t1743r806b1791],
10	Chen	NNP	PERSON	Chen	nn	11	SENT_174	[p5l823t1741r952b1784],
11	CH	NN	O	ch	appos	5	SENT_174	[p5l968t1743r1053b1791],
12	,	,	O	,	_	0	SENT_174	[p5l968t1743r1053b1791],
13	Hsih	NN	O	hsih	nn	14	SENT_174	[p5l1069t1741r1184b1784],
14	MS	NN	O	m	appos	5	SENT_174	[p5l1201t1743r1292b1791],
15	,	,	O	,	_	0	SENT_174	[p5l1201t1743r1292b1791],
16	Hui	NNP	O	Hui	nn	17	SENT_174	[p5l1309t1741r1398b1784],
17	RC	NNP	O	RC	appos	5	SENT_174	[p5l1415t1743r1492b1791],
18	,	,	O	,	_	0	SENT_174	[p5l1415t1743r1492b1791],
19	et	FW	O	et	nn	20	SENT_174	[p5l1508t1747r1558b1784],
20	al.	FW	O	al.	appos	5	SENT_174	[p5l1574t1743r1632b1784],
21	.	.	O	.	_	0	SENT_174	[p5l1574t1743r1632b1784],

1	Common	JJ	O	common	amod	3	SENT_175	[p5l1653t1743r1886b1784],
2	risk	NN	O	risk	nn	3	SENT_175	[p5l1902t1741r1997b1784],
3	allele	NN	O	allele	nsubj	7	SENT_175	[p5l2011t1741r2146b1784],
4	in	IN	O	in	_	0	SENT_175	[p5l113t1808r160b1850],
5	aromatic	JJ	O	aromatic	amod	6	SENT_175	[p5l185t1808r413b1851],
6	antiepileptic-drug	NN	O	antiepileptic-drug	prep_in	3	SENT_175	[p5l437t1807r906b1862],
7	induced	VBD	O	induce	_	0	SENT_175	[p5l930t1807r1134b1851],
8	Stevens	NNP	PERSON	Stevens	dobj	7	SENT_175	[p5l1160t1807r1597b1862],
9	—	CD	NUMBER	—	number	10	SENT_175	[p5l1160t1807r1597b1862],
10	]	CD	NUMBER	]	num	12	SENT_175	[p5l1160t1807r1597b1862],
11	ohnson	NN	O	ohnson	nn	12	SENT_175	[p5l1160t1807r1597b1862],
12	syndrome	NN	O	syndrome	dep	8	SENT_175	[p5l1623t1807r1879b1862],
13	and	CC	O	and	_	0	SENT_175	[p5l1904t1807r1997b1851],
14	toxic	JJ	O	toxic	amod	16	SENT_175	[p5l2022t1808r2147b1851],
15	epidermal	JJ	O	epidermal	amod	16	SENT_175	[p5l112t1873r373b1927],
16	necrolysis	NN	O	necrolysis	dobj	7	SENT_175	[p5l397t1873r653b1927],
17	in	IN	O	in	_	0	SENT_175	[p5l677t1874r725b1916],
18	Han	NNP	LOCATION	Han	nn	19	SENT_175	[p5l747t1876r849b1917],
19	Chinese	NNP	LOCATION	Chinese	prep_in	16	SENT_175	[p5l872t1873r1084b1917],
20	.	.	O	.	_	0	SENT_175	[p5l872t1873r1084b1917],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_176	[p5l1105t1873r1584b1927],
2	2010	CD	DATE	2010	num	1	SENT_176	[p5l1607t1875r2050b1923],
3	;	:	O	;	_	0	SENT_176	[p5l1607t1875r2050b1923],
4	11:349	CD	NUMBER	11:349	number	5	SENT_176	[p5l1607t1875r2050b1923],
5	—	CD	NUMBER	—	dep	1	SENT_176	[p5l1607t1875r2050b1923],
6	56	CD	NUMBER	56	dep	5	SENT_176	[p5l1607t1875r2050b1923],
7	.	.	O	.	_	0	SENT_176	[p5l1607t1875r2050b1923],

1	.	.	O	.	_	0	SENT_177	[p5l71t1975r80b1983],

1	Mehta	NNP	ORGANIZATION	Mehta	nn	2	SENT_178	[p5l113t1939r276b1983],
2	TY	NNP	ORGANIZATION	TY	_	0	SENT_178	[p5l288t1942r366b1989],
3	,	,	O	,	_	0	SENT_178	[p5l288t1942r366b1989],
4	Prajapati	NNP	PERSON	Prajapati	nn	5	SENT_178	[p5l381t1940r609b1993],
5	LM	NNP	O	LM	appos	2	SENT_178	[p5l625t1942r714b1989],
6	,	,	O	,	_	0	SENT_178	[p5l625t1942r714b1989],
7	Mittal	NNP	PERSON	Mittal	nn	8	SENT_178	[p5l729t1939r884b1983],
8	B	NNP	O	B	appos	5	SENT_178	[p5l900t1939r1079b1993],
9	,	,	O	,	_	0	SENT_178	[p5l900t1939r1079b1993],
10	]	CD	NUMBER	]	num	12	SENT_178	[p5l900t1939r1079b1993],
11	oshi	NN	O	oshus	nn	12	SENT_178	[p5l900t1939r1079b1993],
12	CG	NN	O	cg	appos	5	SENT_178	[p5l1095t1941r1177b1989],
13	,	,	O	,	_	0	SENT_178	[p5l1095t1941r1177b1989],
14	Sheth	NNP	PERSON	Sheth	nn	16	SENT_178	[p5l1193t1939r1337b1983],
15	J	NNP	O	J	nn	16	SENT_178	[p5l1345t1942r1396b1993],
16	]	NN	O	]	appos	5	SENT_178	[p5l1345t1942r1396b1993],
17	,	,	O	,	_	0	SENT_178	[p5l1345t1942r1396b1993],
18	Patel	NNP	PERSON	Patel	nn	19	SENT_178	[p5l1412t1939r1536b1983],
19	DB	NNP	O	DB	appos	5	SENT_178	[p5l1551t1942r1634b1989],
20	,	,	O	,	_	0	SENT_178	[p5l1551t1942r1634b1989],
21	et	FW	O	et	nn	22	SENT_178	[p5l1649t1946r1700b1983],
22	al.	FW	O	al.	appos	5	SENT_178	[p5l1714t1942r1772b1983],
23	.	.	O	.	_	0	SENT_178	[p5l1714t1942r1772b1983],

1	Association	NNP	O	Association	_	0	SENT_179	[p5l1789t1940r2086b1983],
2	of	IN	O	of	_	0	SENT_179	[p5l2100t1939r2153b1983],
3	HLA-B	NN	O	hla-b	prep_of	1	SENT_179	[p5l113t2004r426b2048],
4	*	CD	NUMBER	*	num	3	SENT_179	[p5l113t2004r426b2048],
5	1502	CD	DATE	1502	num	6	SENT_179	[p5l113t2004r426b2048],
6	allele	NN	O	allele	dep	1	SENT_179	[p5l462t2005r598b2048],
7	and	CC	O	and	_	0	SENT_179	[p5l632t2005r726b2048],
8	carbamazepine-induced	JJ	O	carbamazepine-induced	amod	9	SENT_179	[p5l760t2005r1383b2059],
9	Stevens	NNP	PERSON	Stevens	dep	1	SENT_179	[p5l1418t2005r1856b2059],
10	.	.	O	.	_	0	SENT_179	[p5l1418t2005r1856b2059],

1	—	NN	O	—	_	0	SENT_180	[p5l1418t2005r1856b2059],
2	.	.	O	.	_	0	SENT_180	[p5l1418t2005r1856b2059],

1	Johnson	NNP	PERSON	Johnson	nn	2	SENT_181	[p5l1418t2005r1856b2059],
2	syndrome	NN	O	syndrome	_	0	SENT_181	[p5l1890t2005r2146b2059],
3	among	IN	O	among	_	0	SENT_181	[p5l112t2083r288b2125],
4	Indians	NNPS	MISC	Indians	prep_among	2	SENT_181	[p5l310t2071r510b2115],
5	.	.	O	.	_	0	SENT_181	[p5l310t2071r510b2115],

1	Indian	JJ	MISC	indian	amod	5	SENT_182	[p5l532t2071r728b2125],
2	]	NN	O	]	nn	5	SENT_182	[p5l532t2071r728b2125],
3	Dermatol	NN	O	dermatol	nn	5	SENT_182	[p5l745t2071r978b2114],
4	Venereol	NNP	O	Venereol	nn	5	SENT_182	[p5l1000t2071r1212b2114],
5	Leprol	NNP	O	Leprol	_	0	SENT_182	[p5l1232t2071r1384b2125],
6	2009	CD	DATE	2009	num	5	SENT_182	[p5l1405t2073r1848b2121],
7	;	:	O	;	_	0	SENT_182	[p5l1405t2073r1848b2121],
8	75:579	CD	NUMBER	75:579	number	9	SENT_182	[p5l1405t2073r1848b2121],
9	—	CD	NUMBER	—	dep	5	SENT_182	[p5l1405t2073r1848b2121],
10	82	CD	NUMBER	82	dep	9	SENT_182	[p5l1405t2073r1848b2121],
11	.	.	O	.	_	0	SENT_182	[p5l1405t2073r1848b2121],

1	.	.	O	.	_	0	SENT_183	[p5l71t2172r80b2180],

1	Ferrell	NNP	PERSON	Ferrell	nn	3	SENT_184	[p5l113t2136r276b2180],
2	Jr	NNP	PERSON	Jr	nn	3	SENT_184	[p5l299t2139r344b2191],
3	PB	NN	O	pb	_	0	SENT_184	[p5l371t2139r445b2187],
4	,	,	O	,	_	0	SENT_184	[p5l371t2139r445b2187],
5	McLeod	NNP	PERSON	McLeod	nn	6	SENT_184	[p5l475t2136r674b2180],
6	HL	NNS	O	hl	appos	3	SENT_184	[p5l704t2139r782b2180],
7	.	.	O	.	_	0	SENT_184	[p5l704t2139r782b2180],

1	Carbamazepine	NNP	O	Carbamazepine	_	0	SENT_185	[p5l813t2136r1224b2191],
2	,	,	O	,	_	0	SENT_185	[p5l813t2136r1224b2191],
3	HLA-B	NN	O	hla-b	conj_and	1	SENT_185	[p5l1254t2136r1567b2180],
4	*	CD	NUMBER	*	number	5	SENT_185	[p5l1254t2136r1567b2180],
5	1502	CD	DATE	1502	dep	3	SENT_185	[p5l1254t2136r1567b2180],
6	and	CC	O	and	_	0	SENT_185	[p5l1598t2136r1691b2180],
7	risk	NN	O	risk	conj_and	1	SENT_185	[p5l1721t2136r1815b2180],
8	of	IN	O	of	_	0	SENT_185	[p5l1842t2136r1895b2180],
9	StevensJohnson	NN	O	stevensjohnson	nn	10	SENT_185	[p5l1918t2139r2145b2180, p5l106t2203r318b2257],
10	syndrome	NN	O	syndrome	prep_of	7	SENT_185	[p5l339t2203r595b2257],
11	and	CC	O	and	_	0	SENT_185	[p5l616t2203r708b2247],
12	toxic	JJ	O	toxic	amod	14	SENT_185	[p5l729t2204r855b2247],
13	epidermal	JJ	O	epidermal	amod	14	SENT_185	[p5l875t2203r1135b2257],
14	necrolysis	NN	O	necrolysis	conj_and	1	SENT_185	[p5l1157t2203r1430b2257],
15	:	:	O	:	_	0	SENT_185	[p5l1157t2203r1430b2257],
16	US	NNP	LOCATION	US	nn	17	SENT_185	[p5l1454t2205r1520b2247],
17	FDA	NNP	ORGANIZATION	FDA	dep	1	SENT_185	[p5l1542t2205r1647b2246],
18	recommendations	NNS	O	recommendation	dep	17	SENT_185	[p5l1665t2203r2145b2247],
19	.	.	O	.	_	0	SENT_185	[p5l1665t2203r2145b2247],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_186	[p5l110t2269r589b2324],
2	2008	CD	DATE	2008	num	1	SENT_186	[p5l612t2271r1022b2320],
3	;	:	O	;	_	0	SENT_186	[p5l612t2271r1022b2320],
4	9	CD	NUMBER	9	num	6	SENT_186	[p5l612t2271r1022b2320],
5	:	:	O	:	_	0	SENT_186	[p5l612t2271r1022b2320],
6	l543	CD	NUMBER	l543	dep	1	SENT_186	[p5l612t2271r1022b2320],
7	—	CD	NUMBER	—	number	8	SENT_186	[p5l612t2271r1022b2320],
8	6	CD	NUMBER	6	dep	6	SENT_186	[p5l612t2271r1022b2320],
9	.	.	O	.	_	0	SENT_186	[p5l612t2271r1022b2320],

1	Roujeau	NNP	O	Roujeau	nn	2	SENT_187	[p5l113t2335r319b2389],
2	JC	NNP	O	JC	_	0	SENT_187	[p5l336t2337r403b2389],
3	.	.	O	.	_	0	SENT_187	[p5l336t2337r403b2389],

1	The	DT	O	the	det	2	SENT_188	[p5l426t2335r520b2378],
2	spectrum	NN	O	spectrum	dep	8	SENT_188	[p5l544t2341r786b2389],
3	of	IN	O	of	_	0	SENT_188	[p5l809t2335r862b2378],
4	Stevens	NNP	PERSON	Stevens	prep_of	2	SENT_188	[p5l879t2335r1317b2389],
5	—	CD	NUMBER	—	num	4	SENT_188	[p5l879t2335r1317b2389],
6	]	CD	NUMBER	]	num	7	SENT_188	[p5l879t2335r1317b2389],
7	ohnson	NN	O	ohnson	dep	8	SENT_188	[p5l879t2335r1317b2389],
8	syndrome	NN	O	syndrome	dep	16	SENT_188	[p5l1341t2335r1597b2389],
9	and	CC	O	and	_	0	SENT_188	[p5l1621t2335r1714b2378],
10	toxic	JJ	O	toxic	amod	12	SENT_188	[p5l1737t2336r1862b2378],
11	epidermal	JJ	O	epidermal	amod	12	SENT_188	[p5l1886t2335r2146b2389],
12	necrolysis	NN	O	necrolysis	conj_and	8	SENT_188	[p5l113t2401r386b2455],
13	:	:	O	:	_	0	SENT_188	[p5l113t2401r386b2455],
14	a	DT	O	a	det	16	SENT_188	[p5l412t2414r438b2445],
15	clinical	JJ	O	clinical	amod	16	SENT_188	[p5l461t2401r643b2445],
16	classiﬁcation	NN	O	classiﬁcation	_	0	SENT_188	[p5l666t2401r1012b2445],
17	.	.	O	.	_	0	SENT_188	[p5l666t2401r1012b2445],

1	J	NNP	O	J	nn	3	SENT_189	[p5l1025t2404r1052b2455],
2	Invest	NNP	O	Invest	nn	3	SENT_189	[p5l1070t2404r1220b2445],
3	Dermatol	NNP	O	Dermatol	_	0	SENT_189	[p5l1238t2401r1470b2445],
4	1994	CD	DATE	1994	num	3	SENT_189	[p5l1494t2403r1994b2451],
5	;	:	O	;	_	0	SENT_189	[p5l1494t2403r1994b2451],
6	102:28	CD	NUMBER	102:28	num	7	SENT_189	[p5l1494t2403r1994b2451],
7	S	NN	O	s	dep	3	SENT_189	[p5l1494t2403r1994b2451],
8	—	CD	NUMBER	—	num	9	SENT_189	[p5l1494t2403r1994b2451],
9	30S	NN	O	30	dep	7	SENT_189	[p5l1494t2403r1994b2451],
10	.	.	O	.	_	0	SENT_189	[p5l1494t2403r1994b2451],

1	10	CD	NUMBER	10	_	0	SENT_190	[p5l12t2469r83b2511],
2	.	.	O	.	_	0	SENT_190	[p5l12t2469r83b2511],

1	Roujeau	FW	O	roujeau	nn	3	SENT_191	[p5l117t2467r323b2521],
2	]	FW	O	]	nn	3	SENT_191	[p5l335t2469r402b2521],
3	C	NN	O	c	_	0	SENT_191	[p5l335t2469r402b2521],
4	,	,	O	,	_	0	SENT_191	[p5l335t2469r402b2521],
5	Stem	NN	O	stem	nn	6	SENT_191	[p5l420t2469r554b2510],
6	RS	NN	O	r	appos	3	SENT_191	[p5l572t2469r644b2511],
7	.	.	O	.	_	0	SENT_191	[p5l572t2469r644b2511],

1	Severe	JJ	O	severe	amod	4	SENT_192	[p5l663t2469r830b2510],
2	adverse	JJ	O	adverse	amod	4	SENT_192	[p5l848t2467r1045b2510],
3	cutaneous	JJ	O	cutaneous	amod	4	SENT_192	[p5l1063t2473r1325b2510],
4	reactions	NNS	O	reaction	_	0	SENT_192	[p5l1343t2467r1577b2510],
5	to	TO	O	to	_	0	SENT_192	[p5l1595t2473r1645b2510],
6	drugs	NNS	O	drug	prep_to	4	SENT_192	[p5l1663t2467r1818b2521],
7	.	.	O	.	_	0	SENT_192	[p5l1663t2467r1818b2521],

1	N	NN	O	n	nn	3	SENT_193	[p5l1835t2469r1876b2510],
2	Engl	NNP	O	Engl	nn	3	SENT_193	[p5l1888t2467r2027b2521],
3	]	NNP	O	]	nsubj	4	SENT_193	[p5l1888t2467r2027b2521],
4	Med	VBD	O	med	_	0	SENT_193	[p5l2041t2467r2148b2510],

1	1994	CD	DATE	1994	_	0	SENT_194	[p5l119t2535r627b2583],
2	;	:	O	;	_	0	SENT_194	[p5l119t2535r627b2583],
3	331:1272	CD	NUMBER	331:1272	number	4	SENT_194	[p5l119t2535r627b2583],
4	—	CD	NUMBER	—	dep	1	SENT_194	[p5l119t2535r627b2583],
5	85	CD	NUMBER	85	dep	4	SENT_194	[p5l119t2535r627b2583],
6	.	.	O	.	_	0	SENT_194	[p5l119t2535r627b2583],

1	Kuehn	NNP	PERSON	Kuehn	_	0	SENT_195	[p5l117t2599r282b2643],
2	BM	NN	O	bm	dep	1	SENT_195	[p5l323t2602r418b2643],
3	.	.	O	.	_	0	SENT_195	[p5l323t2602r418b2643],

1	FDA	NNP	O	FDA	_	0	SENT_196	[p5l460t2601r578b2643],
2	:	:	O	:	_	0	SENT_196	[p5l460t2601r578b2643],
3	Epilepsy	NNP	O	Epilepsy	nn	4	SENT_196	[p5l624t2599r839b2654],
4	drugs	NNS	O	drug	nsubj	6	SENT_196	[p5l879t2599r1021b2654],
5	may	MD	O	may	aux	6	SENT_196	[p5l1063t2612r1173b2654],
6	carry	VB	O	carry	dep	1	SENT_196	[p5l1212t2612r1343b2654],
7	skin	NN	O	skin	nn	8	SENT_196	[p5l1383t2599r1487b2643],
8	risks	NNS	O	risk	dobj	6	SENT_196	[p5l1527t2599r1644b2643],
9	for	IN	O	for	_	0	SENT_196	[p5l1686t2599r1758b2643],
10	Asians	NNPS	MISC	Asians	prep_for	6	SENT_196	[p5l1794t2600r1973b2643],
11	.	.	O	.	_	0	SENT_196	[p5l1794t2600r1973b2643],

1	JAMA	NNP	O	JAMA	_	0	SENT_197	[p5l2005t2601r2147b2654],
2	2008	CD	DATE	2008	num	1	SENT_197	[p5l117t2667r527b2715],
3	;	:	O	;	_	0	SENT_197	[p5l117t2667r527b2715],
4	300:2845	CD	NUMBER	300:2845	dep	1	SENT_197	[p5l117t2667r527b2715],
5	.	.	O	.	_	0	SENT_197	[p5l117t2667r527b2715],

1	12	CD	NUMBER	12	_	0	SENT_198	[p5l12t2733r84b2775],
2	.	.	O	.	_	0	SENT_198	[p5l12t2733r84b2775],

1	Yao	NNP	PERSON	Yao	nn	2	SENT_199	[p5l115t2734r209b2775],
2	Y	NN	PERSON	y	_	0	SENT_199	[p5l222t2734r268b2781],
3	,	,	O	,	_	0	SENT_199	[p5l222t2734r268b2781],
4	Shi	NNP	PERSON	Shi	nn	5	SENT_199	[p5l284t2731r360b2775],
5	L	NNP	PERSON	L	appos	2	SENT_199	[p5l376t2734r413b2781],
6	,	,	O	,	_	0	SENT_199	[p5l376t2734r413b2781],
7	Shi	NNP	PERSON	Shi	nn	8	SENT_199	[p5l429t2731r505b2775],
8	L	NNP	PERSON	L	appos	5	SENT_199	[p5l522t2734r558b2781],
9	,	,	O	,	_	0	SENT_199	[p5l522t2734r558b2781],
10	Matsushita	NNP	PERSON	Matsushita	nn	11	SENT_199	[p5l574t2731r861b2775],
11	M	NNP	O	M	appos	5	SENT_199	[p5l877t2734r938b2781],
12	,	,	O	,	_	0	SENT_199	[p5l877t2734r938b2781],
13	Yu	NNP	PERSON	Yu	nn	14	SENT_199	[p5l951t2734r1018b2775],
14	L	NNP	PERSON	L	appos	5	SENT_199	[p5l1034t2734r1071b2781],
15	,	,	O	,	_	0	SENT_199	[p5l1034t2734r1071b2781],
16	Lin	NNP	PERSON	Lin	nn	17	SENT_199	[p5l1087t2732r1163b2774],
17	K	NNP	PERSON	K	appos	5	SENT_199	[p5l1178t2734r1223b2781],
18	,	,	O	,	_	0	SENT_199	[p5l1178t2734r1223b2781],
19	et	FW	O	et	nn	20	SENT_199	[p5l1238t2738r1289b2775],
20	al.	FW	O	al.	appos	5	SENT_199	[p5l1303t2734r1362b2775],
21	.	.	O	.	_	0	SENT_199	[p5l1303t2734r1362b2775],

1	Distribution	NN	O	distribution	_	0	SENT_200	[p5l1382t2731r1694b2775],
2	of	IN	O	of	_	0	SENT_200	[p5l1709t2731r1762b2775],
3	HLA	NN	O	hlum	prep_of	1	SENT_200	[p5l1771t2733r1948b2781],
4	.	.	O	.	_	0	SENT_200	[p5l1771t2733r1948b2781],

1	—	NN	O	—	_	0	SENT_201	[p5l1771t2733r1948b2781],
2	.	.	O	.	_	0	SENT_201	[p5l1771t2733r1948b2781],

1	A	DT	O	a	det	14	SENT_202	[p5l1771t2733r1948b2781],
2	,	,	O	,	_	0	SENT_202	[p5l1771t2733r1948b2781],
3	-	:	O	-	_	0	SENT_202	[p5l1964t2734r2016b2774],
4	B	NN	O	b	dep	12	SENT_202	[p5l1964t2734r2016b2774],
5	-	:	O	-	_	0	SENT_202	[p5l2032t2733r2146b2781],
6	Cw	NN	O	cw	dep	4	SENT_202	[p5l2032t2733r2146b2781],
7	,	,	O	,	_	0	SENT_202	[p5l2032t2733r2146b2781],
8	and	CC	O	and	_	0	SENT_202	[p5l117t2797r210b2840],
9	-	:	O	-	_	0	SENT_202	[p5l232t2799r386b2840],
10	DRB1	NN	O	drb1	dep	11	SENT_202	[p5l232t2799r386b2840],
11	alleles	NNS	O	allele	conj_and	4	SENT_202	[p5l413t2797r573b2840],
12	and	CC	O	and	dep	13	SENT_202	[p5l595t2797r688b2840],
13	haplotypes	NNS	O	haplotype	npadvmod	14	SENT_202	[p5l710t2797r991b2851],
14	in	IN	O	in	dobj	16	SENT_202	[p5l1014t2797r1061b2840],
15	an	DT	O	a	pobj	14	SENT_202	[p5l1081t2809r1141b2840],
16	isolated	VBN	O	isolate	_	0	SENT_202	[p5l1162t2797r1362b2840],
17	Han	NNP	O	Han	nn	18	SENT_202	[p5l1384t2799r1486b2840],
18	population	NN	O	population	dep	16	SENT_202	[p5l1507t2797r1787b2851],
19	in	IN	O	in	_	0	SENT_202	[p5l1808t2797r1855b2840],
20	Southwest	NNP	LOCATION	Southwest	nn	21	SENT_202	[p5l1876t2797r2148b2840],
21	China	NNP	LOCATION	China	prep_in	16	SENT_202	[p5l117t2863r275b2907],
22	.	.	O	.	_	0	SENT_202	[p5l117t2863r275b2907],

1	Tissue	NN	O	tissue	nn	2	SENT_203	[p5l299t2864r446b2906],
2	Antigens	NNS	O	antigen	_	0	SENT_203	[p5l463t2864r679b2917],
3	2009	CD	DATE	2009	dep	2	SENT_203	[p5l701t2865r1111b2913],
4	;	:	O	;	_	0	SENT_203	[p5l701t2865r1111b2913],
5	73:561	CD	NUMBER	73:561	number	6	SENT_203	[p5l701t2865r1111b2913],
6	—	CD	NUMBER	—	dep	2	SENT_203	[p5l701t2865r1111b2913],
7	8	CD	NUMBER	8	dep	6	SENT_203	[p5l701t2865r1111b2913],
8	.	.	O	.	_	0	SENT_203	[p5l701t2865r1111b2913],

